Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
tRNA methylation (GO:0030488),6/26,0.0014960500995122165,1,0,0,4.615384615384615,30.022739589285415,TRMT112;TRMT1;MTO1;FTSJ1;ALKBH8;TARBP1
negative regulation of cardiocyte differentiation (GO:1905208),3/7,0.0037478971295969244,1,0,0,8.571428571428571,47.88480310052898,HEY2;FRS2;DKK1
purine-containing compound salvage (GO:0043101),4/14,0.004155574183572428,1,0,0,5.7142857142857135,31.333169538457483,DGUOK;GMPR2;GMPR;PRTFDC1
vasculogenesis (GO:0001570),6/32,0.004561104727721087,1,0,0,3.75,20.213214074797936,PDGFRB;APELA;NOTCH1;HEY2;TNNI3;CCM2
"DNA-templated transcription, termination (GO:0006353)",12/106,0.0066637026331270175,1,0,0,2.2641509433962264,11.345841504890547,CPSF7;DDX39B;RBM8A;PABPN1;CCNH;SRSF4;SNRPD3;SMN1;TTF1;POLR3K;SRSF11;SNRPB
response to muscle stretch (GO:0035994),3/9,0.008342411451160579,1,0,0,6.666666666666666,31.90935307720135,NPPA;ANKRD1;TCAP
negative regulation of protein exit from endoplasmic reticulum (GO:0070862),3/9,0.008342411451160579,1,0,0,6.666666666666666,31.90935307720135,INSIG1;DERL2;UBAC2
regulation of p38MAPK cascade (GO:1900744),5/26,0.008463012749957347,1,0,0,3.8461538461538463,18.354038660547634,DLG1;DUSP10;NCF1;GADD45B;MINK1
nucleobase-containing compound biosynthetic process (GO:0034654),4/17,0.008766901403579476,1,0,0,4.705882352941176,22.2906910717708,DGUOK;GMPR2;GMPR;POLL
regulation of astrocyte differentiation (GO:0048710),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,NOTCH1;SERPINE2;NOG
MAPK cascade (GO:0000165),23/278,0.012683558996089275,1,0,0,1.6546762589928057,7.2267136620796,PDGFRB;CAMK2B;PSMD11;PSMD14;EGF;RASGRF2;MINK1;RASGRF1;CUL1;FRS2;BRAF;MT3;DUSP7;MAPK8;PSMA4;PABPN1;ERBB3;PSMA2;UBC;NEFL;CCM2;IKBKG;CCR5
muscle tissue morphogenesis (GO:0060415),4/19,0.01318872540853091,1,0,0,4.2105263157894735,18.224812421427043,NOTCH1;HEY2;ANKRD1;TCAP
cellular response to cadmium ion (GO:0071276),5/29,0.013506098212759996,1,0,0,3.4482758620689657,14.843496469201975,MAPK9;MAPK8;NCF1;MT1M;MT3
regulation of cytokine-mediated signaling pathway (GO:0001959),10/90,0.01430957725527265,1,0,0,2.222222222222222,9.437391617244035,CD74;MADD;UBC;TNFAIP3;LIFR;IKBKG;RBCK1;CD24;BIRC2;IFNA21
"synaptic transmission, GABAergic (GO:0051932)",3/11,0.015204352818016067,1,0,0,5.454545454545454,22.833673759197463,GABRB2;GABRE;GABRG1
cellular response to reactive oxygen species (GO:0034614),8/65,0.015361461773367072,1,0,0,2.4615384615384617,10.279122186470978,MAPK9;MAPK8;PRDX5;NCF1;KCNC2;TNFAIP3;MT3;NFE2L2
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),5/30,0.01555659746473132,1,0,0,3.333333333333333,13.877568186921728,MAPK8;BAD;NMT1;DYNLL1;BBC3
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),5/30,0.01555659746473132,1,0,0,3.333333333333333,13.877568186921728,CCND2;CCNH;MAPRE3;CCNL1;PKD1
artery morphogenesis (GO:0048844),5/30,0.01555659746473132,1,0,0,3.333333333333333,13.877568186921728,PDGFRB;NOTCH1;HPGD;HEY2;NOG
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),5/30,0.01555659746473132,1,0,0,3.333333333333333,13.877568186921728,MAPK8;BAD;NMT1;DYNLL1;BBC3
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),9/78,0.01561152922012694,1,0,0,2.3076923076923075,9.599412888736792,PSMA4;PSMD11;NOTCH1;PSMD14;CITED2;PSMA2;UBC;ELOB;NFE2L2
response to cadmium ion (GO:0046686),5/31,0.017804675725432068,1,0,0,3.225806451612903,12.994497338628113,MAPK9;MAPK8;NCF1;MT1M;MT3
sarcomere organization (GO:0045214),5/31,0.017804675725432068,1,0,0,3.225806451612903,12.994497338628113,KRT19;OBSCN;TNNT1;ANKRD1;TCAP
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),4/21,0.018817877540921516,1,0,0,3.8095238095238093,15.135039725595712,CREB3;NOTCH1;MT3;NFE2L2
ventricular septum morphogenesis (GO:0060412),4/21,0.018817877540921516,1,0,0,3.8095238095238093,15.135039725595712,NOTCH1;CITED2;NOG;HEY2
meiosis I (GO:0007127),4/21,0.018817877540921516,1,0,0,3.8095238095238093,15.135039725595712,PTTG1;PTTG2;MEIKIN;BRDT
positive regulation of receptor internalization (GO:0002092),4/21,0.018817877540921516,1,0,0,3.8095238095238093,15.135039725595712,ATAD1;APELA;EGF;PCSK9
protein import into peroxisome matrix (GO:0016558),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,PEX5L;PEX10;PEX1
positive regulation of ruffle assembly (GO:1900029),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,PLEKHM1;DEF8;NDEL1
termination of RNA polymerase II transcription (GO:0006369),8/68,0.019756700283294275,1,0,0,2.352941176470588,9.233559036043712,CPSF7;DDX39B;RBM8A;PABPN1;SRSF4;SNRPD3;SRSF11;SNRPB
I-kappaB kinase/NF-kappaB signaling (GO:0007249),7/57,0.02292540668324337,1,0,0,2.4561403508771926,9.273181280311968,UBC;TLR9;IKBKG;RBCK1;CD14;BIRC2;TLR2
regulation of ERK1 and ERK2 cascade (GO:0070372),20/247,0.023531233611628212,1,0,0,1.6194331983805668,6.071945992605025,EPHB6;CCR1;PDGFRB;CD74;NTRK2;NOTCH1;PLA2G2A;HTR2C;BRAF;DUSP26;MT3;APELA;DLG1;DUSP10;ERBB3;P2RY1;GCNT2;ITGB1BP1;CCL18;CCL16
regulation of neuron differentiation (GO:0045664),9/84,0.02424035252289281,1,0,0,2.142857142857143,7.970864088992445,DISP3;BRINP2;MMD;ZC4H2;FBXO7;DKK1;BMP7;CDK5RAP3;NDEL1
glycerolipid catabolic process (GO:0046503),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,ABHD2;PNPLA6;ENPP6
muscle cell development (GO:0055001),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,MEGF10;HEY2;ANK2
regulation of necrotic cell death (GO:0010939),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,UBC;MT3;BIRC2
tRNA modification (GO:0006400),7/58,0.024986400078400667,1,0,0,2.413793103448276,8.90550523896042,TRMT112;TYW5;TRMT1;MTO1;FTSJ1;ALKBH8;TARBP1
cholesterol homeostasis (GO:0042632),7/58,0.024986400078400667,1,0,0,2.413793103448276,8.90550523896042,EHD1;DISP3;ACSM3;INSIG1;PCSK9;LCAT;CD24
sterol homeostasis (GO:0055092),7/58,0.024986400078400667,1,0,0,2.413793103448276,8.90550523896042,EHD1;DISP3;ACSM3;INSIG1;PCSK9;LCAT;CD24
protein K48-linked deubiquitination (GO:0071108),4/23,0.025734894590821872,1,0,0,3.4782608695652173,12.730112841155169,OTUB2;USP27X;USP5;TNFAIP3
regulation of JUN kinase activity (GO:0043506),5/34,0.02579993741840051,1,0,0,2.941176470588235,10.757009449120288,DUSP10;PDCD4;TLR9;DVL3;DKK1
nucleocytoplasmic transport (GO:0006913),6/46,0.026159334470466495,1,0,0,2.6086956521739126,9.504910939429989,NXT1;ANP32E;SNRPD3;SMN1;GEMIN7;SNRPB
negative regulation of cell cycle (GO:0045786),8/72,0.026917281476999108,1,0,0,2.222222222222222,8.033303921239105,LATS1;HEXIM1;BRINP2;DLG1;HPGD;PDCD4;RUNX3;BMP7
myofibril assembly (GO:0030239),6/47,0.028763410125455306,1,0,0,2.553191489361702,9.060385994914286,PDGFRB;KRT19;OBSCN;TNNT1;ANKRD1;TCAP
negative regulation of interleukin-6 production (GO:0032715),4/24,0.02969412469495944,1,0,0,3.333333333333333,11.722686914871057,TLR9;TNFAIP3;BPI;GHRL
regulation of secretion (GO:0051046),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,ERBB3;EGF;ACSL3
cell surface receptor signaling pathway involved in heart development (GO:0061311),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,NOTCH1;NOG;HEY2
negative regulation of secretion (GO:0051048),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,CD74;ERBB3;EGF
cardiac left ventricle morphogenesis (GO:0003214),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,NOTCH1;SFRP2;HEY2
regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),8/74,0.031098848162824908,1,0,0,2.1621621621621623,7.503966480103642,RGS3;GUCA1B;NMT1;PDE6B;RPGRIP1L;SYP;RGS8;CAMKMT
negative regulation of MAP kinase activity (GO:0043407),7/61,0.03192067196399525,1,0,0,2.2950819672131146,7.905413175681799,DUSP2;DUSP10;RGS3;PDCD4;BMP7;CDK5RAP3;DUSP7
muscle cell differentiation (GO:0042692),5/36,0.032227243715029656,1,0,0,2.7777777777777777,9.541508627909957,MEGF10;HEY2;GATA6;ANKRD1;SYNE1
cardiac muscle tissue morphogenesis (GO:0055008),5/36,0.032227243715029656,1,0,0,2.7777777777777777,9.541508627909957,NOTCH1;NOG;ANKRD1;TCAP;TNNI3
cellular response to lipoteichoic acid (GO:0071223),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,CD14;TLR2
negative regulation of transforming growth factor beta production (GO:0071635),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,GATA6;CD24
positive regulation of T-helper 17 type immune response (GO:2000318),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,IL12B;PRKCQ
vascular smooth muscle cell differentiation (GO:0035886),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,HEY2;GATA6
chromatin silencing at telomere (GO:0006348),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,DOT1L;DPY30
response to lipoteichoic acid (GO:0070391),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,CD14;TLR2
vascular smooth muscle cell development (GO:0097084),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,NOTCH1;HEY2
glomerular epithelial cell differentiation (GO:0072311),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PROM1;CD24
renal filtration cell differentiation (GO:0061318),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PROM1;CD24
intermediate filament bundle assembly (GO:0045110),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,NEFL;NEFM
negative regulation of vasculature development (GO:1901343),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PDCD4;BMP7
cellular response to bacterial lipopeptide (GO:0071221),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,CD14;TLR2
coronary vasculature development (GO:0060976),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,APELA;GATA6
negative regulation of smooth muscle cell differentiation (GO:0051151),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PDCD4;FOXO4
long term synaptic depression (GO:0060292),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,SLC24A2;PLK2
single strand break repair (GO:0000012),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,TNP1;APTX
cellular response to hypoxia (GO:0071456),12/132,0.03290365815824255,1,0,0,1.8181818181818181,6.207584431221539,OPRD1;PSMD11;PSMA4;PSMD14;PSMA2;BAD;UBC;GATA6;ELOB;MT3;BMP7;NOP53
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),7/62,0.03449145783432962,1,0,0,2.258064516129032,7.6030016426619955,PSMA4;PSMD11;PSMD14;PSMA2;UBC;CUL1;CDK5RAP3
stress-activated MAPK cascade (GO:0051403),7/62,0.03449145783432962,1,0,0,2.258064516129032,7.6030016426619955,MAPK9;MAPK8;MINK1;UBC;CUL1;CCM2;IKBKG
spliceosomal snRNP assembly (GO:0000387),5/37,0.03578300819815846,1,0,0,2.7027027027027026,9.000762512391741,PRPF6;SNRPD3;SMN1;GEMIN7;SNRPB
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),5/37,0.03578300819815846,1,0,0,2.7027027027027026,9.000762512391741,MAPK8;BAD;NMT1;DYNLL1;BBC3
positive regulation of response to external stimulus (GO:0032103),9/90,0.03581529681696861,1,0,0,2,6.65876038289141,PDGFRB;RARRES2;PLA2G2A;TLR9;PDCD4;IL12B;CCL18;CCL16;TLR2
positive regulation of NF-kappaB import into nucleus (GO:0042346),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,TLR9;IL12B;TLR2
endoderm development (GO:0007492),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,DUSP2;APELA;KIF16B
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),4/26,0.038635239533284925,1,0,0,3.076923076923077,10.01104762372913,CCND2;CCNH;MAPRE3;CCNL1
regulation of NF-kappaB import into nucleus (GO:0042345),4/26,0.038635239533284925,1,0,0,3.076923076923077,10.01104762372913,TLR9;IL12B;BMP7;TLR2
negative regulation of catalytic activity (GO:0043086),4/26,0.038635239533284925,1,0,0,3.076923076923077,10.01104762372913,GZMK;NOTCH1;TIMP1;MT3
regulation of rhodopsin mediated signaling pathway (GO:0022400),4/26,0.038635239533284925,1,0,0,3.076923076923077,10.01104762372913,GUCA1B;NMT1;PDE6B;CAMKMT
glycerophospholipid metabolic process (GO:0006650),7/64,0.04003620549436633,1,0,0,2.1875,7.039311774466222,PDGFRB;CPNE6;PIGP;PLA2G2A;LCAT;PNPLA6;ENPP6
negative regulation of striated muscle cell differentiation (GO:0051154),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,NOTCH1;FRS2;DKK1
guanosine-containing compound metabolic process (GO:1901068),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,DGUOK;GMPR2;PDE6B
cardiac epithelial to mesenchymal transition (GO:0060317),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,NOTCH1;HEY2;PDCD4
programmed necrotic cell death (GO:0097300),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,TRPM7;CD14;ALKBH7
cardiac atrium development (GO:0003230),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,NOTCH1;ANK2
regulation of ER to Golgi vesicle-mediated transport (GO:0060628),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,RINT1;STX18
positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,PROM1;CD24
negative regulation of cardiac muscle cell differentiation (GO:2000726),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,FRS2;DKK1
cellular response to leptin stimulus (GO:0044320),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,MT3;GCK
cellular response to sterol depletion (GO:0071501),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,NPC1L1;INSIG1
regulation of T-helper 17 type immune response (GO:2000316),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,IL12B;PRKCQ
regulation of interleukin-18 production (GO:0032661),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,TLR9;TLR2
positive regulation of phospholipid biosynthetic process (GO:0071073),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,HTR2C;ACSL3
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,DUSP26;CDK5RAP3
regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,NOTCH1;NOG
pericardium morphogenesis (GO:0003344),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,NOTCH1;BMP7
negative regulation of cardiac muscle tissue development (GO:0055026),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,FRS2;DKK1
negative regulation of necrotic cell death (GO:0060547),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,MT3;BIRC2
malate metabolic process (GO:0006108),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,FH;CELSR1
positive regulation of ERK1 and ERK2 cascade (GO:0070374),16/201,0.045193925976321166,1,0,0,1.5920398009950247,4.930217046334306,EPHB6;CCR1;PDGFRB;CD74;NTRK2;NOTCH1;PLA2G2A;HTR2C;BRAF;MT3;APELA;ERBB3;P2RY1;GCNT2;CCL18;CCL16
JNK cascade (GO:0007254),7/66,0.0461316060876481,1,0,0,2.121212121212121,6.525393563105938,SPAG9;MAPK9;MAPK8;MINK1;UBC;IKBKG;MAPK8IP3
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),8/80,0.046246853342135685,1,0,0,2,6.147523706367922,PDGFRB;NTRK2;NCF1;ERBB3;PIP4K2A;PIP4K2B;NOP53;IER3
positive regulation of protein localization to membrane (GO:1905477),9/95,0.04798081278095961,1,0,0,1.894736842105263,5.754228786415096,MAPK8;DLG1;ITGAM;BAD;RHOG;NMT1;ITGB1BP1;DYNLL1;BBC3
regulation of receptor internalization (GO:0002090),4/28,0.04895013769244342,1,0,0,2.8571428571428568,8.619865991683946,ATAD1;EGF;PCSK9;DKK1
ventricular septum development (GO:0003281),4/28,0.04895013769244342,1,0,0,2.8571428571428568,8.619865991683946,NOTCH1;CITED2;HEY2;NOG
protein K63-linked deubiquitination (GO:0070536),4/28,0.04895013769244342,1,0,0,2.8571428571428568,8.619865991683946,OTUB2;USP27X;PSMD14;TNFAIP3
regulation of actin polymerization or depolymerization (GO:0008064),4/28,0.04895013769244342,1,0,0,2.8571428571428568,8.619865991683946,LATS1;TMSB4Y;ARHGAP28;ARHGAP35
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),7/67,0.04938993805127162,1,0,0,2.08955223880597,6.285391018194011,LATS1;HEXIM1;CCND2;CCNH;MAPRE3;CCNL1;CDK5RAP3
microtubule nucleation (GO:0007020),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,SLAIN2;TUBG1;NDEL1
positive regulation of nitrogen compound metabolic process (GO:0051173),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,MAPK8;EGF;ACSL3
cardiac atrium morphogenesis (GO:0003209),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,NOTCH1;NOG;HEY2
positive regulation of signal transduction by p53 class mediator (GO:1901798),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,HEXIM1;ANKRD1;CDK5RAP3
negative regulation of cellular component organization (GO:0051129),6/54,0.05175964311269336,1,0,0,2.222222222222222,6.580321164119916,TMEFF2;SACS;WASHC2C;WASL;NOP53;RAPGEF3
spliceosomal complex assembly (GO:0000245),5/41,0.05234904272896249,1,0,0,2.4390243902439024,7.194686897103624,PRPF6;DDX39B;SNRPD3;SMN1;SRPK1
non-canonical Wnt signaling pathway (GO:0035567),11/127,0.05346852392712398,1,0,0,1.732283464566929,5.073272991547244,TCF7L2;SFRP2;PSMD11;PSMA4;PSMD14;PSMA2;UBC;DVL3;PDE6B;CELSR1;AP2A2
dicarboxylic acid transport (GO:0006835),4/29,0.05462119016329882,1,0,0,2.758620689655172,8.020229995291032,SLC1A1;ARL6IP5;SLC25A32;SLC1A7
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),4/29,0.05462119016329882,1,0,0,2.758620689655172,8.020229995291032,UBC;CD14;IKBKG;BIRC2
negative regulation of epithelial cell apoptotic process (GO:1904036),4/29,0.05462119016329882,1,0,0,2.758620689655172,8.020229995291032,CAST;TCF7L2;TNFAIP3;NFE2L2
negative regulation of cell cycle G2/M phase transition (GO:1902750),7/69,0.05633429201225767,1,0,0,2.028985507246377,5.836279085310245,FZR1;PSMA4;PSMD11;PSMD14;PSMA2;UBC;CUL1
positive regulation of smooth muscle cell apoptotic process (GO:0034393),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,PDCD4;IL12B
cell migration involved in heart development (GO:0060973),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,PDGFRB;NOTCH1
cellular response to nitric oxide (GO:0071732),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,KCNC2;MT3
negative regulation of glial cell differentiation (GO:0045686),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,NOTCH1;NOG
positive regulation of membrane potential (GO:0045838),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,BAD;GLRX
cytoskeletal anchoring at nuclear membrane (GO:0090286),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,SYNE3;SYNE1
intestinal cholesterol absorption (GO:0030299),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,NPC1L1;CEL
cellular response to reactive nitrogen species (GO:1902170),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,KCNC2;MT3
"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",2/8,0.05721089072209802,1,0,0,5,14.305055007400815,DERL2;UBAC2
regulation of type B pancreatic cell development (GO:2000074),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,BAD;RFX3
positive regulation of programmed cell death (GO:0043068),19/257,0.05794827160674987,1,0,0,1.4785992217898831,4.211353009299121,UNC13B;ARHGEF11;ARHGEF12;USP27X;GADD45B;BAD;RASGRF2;KALRN;BBC3;LATS1;GZMK;MAPK9;BCLAF1;MAPK8;SFRP2;OBSCN;UBC;ARL6IP5;ANKRD1
homologous chromosome segregation (GO:0045143),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,PTTG1;PTTG2;MEIKIN
skeletal muscle contraction (GO:0003009),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,TNNT1;TCAP;TNNI3
heart trabecula morphogenesis (GO:0061384),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,NOTCH1;NOG;BMP7
positive regulation of p38MAPK cascade (GO:1900745),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,GADD45B;NCF1;MINK1
regulation of cAMP-mediated signaling (GO:0043949),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,CXCL9;PEX5L;GNAI1
cellular response to molecule of bacterial origin (GO:0071219),8/84,0.05864138840443107,1,0,0,1.9047619047619047,5.402503895118576,MAPK8;PABPN1;ANKRD1;PDCD4;TNFAIP3;CD14;CCR5;TLR2
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),6/56,0.059923284693461636,1,0,0,2.142857142857143,6.031478835629902,MADD;UBC;TNFAIP3;IKBKG;RBCK1;BIRC2
anion transport (GO:0006820),6/56,0.059923284693461636,1,0,0,2.142857142857143,6.031478835629902,SLC22A24;SLC22A25;SLC17A5;VDAC2;LRRC8D;ABCC11
chordate embryonic development (GO:0043009),6/56,0.059923284693461636,1,0,0,2.142857142857143,6.031478835629902,ARNT2;RARRES2;NOG;ZNF358;PKD1;BMP7
phospholipid metabolic process (GO:0006644),7/70,0.06002223966632419,1,0,0,2,5.626080248664981,PLPP4;PLPPR2;PLPPR4;PLA2G2A;PIP4K2A;LCAT;PIP4K2B
MyD88-independent toll-like receptor signaling pathway (GO:0002756),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,UBC;CD14;IKBKG;BIRC2
actomyosin structure organization (GO:0031032),7/71,0.06385495665821075,1,0,0,1.9718309859154928,5.424785208031492,KRT19;OBSCN;TNNT1;ANKRD1;ZYX;TCAP;TNFAIP1
regulation of cation channel activity (GO:2001257),7/71,0.06385495665821075,1,0,0,1.9718309859154928,5.424785208031492,CRHBP;JPH2;DLG1;JPH3;KCNIP2;MINK1;ANK2
cellular divalent inorganic cation homeostasis (GO:0072503),9/101,0.06584023577812598,1,0,0,1.782178217821782,4.848458866115323,CCR1;SLC24A2;MT1M;HTR2C;ATP13A5;SLC39A8;ANK2;TNNI3;MT3
endoplasmic reticulum mannose trimming (GO:1904380),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,UBC;DERL2;MAN1B1
positive regulation of activated T cell proliferation (GO:0042104),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,TNFSF9;IL12B;CD24
gamma-aminobutyric acid signaling pathway (GO:0007214),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,GABRB2;GABRE;GABRG1
positive regulation of insulin secretion (GO:0032024),4/31,0.06697579978121662,1,0,0,2.5806451612903225,6.976577863571356,TCF7L2;BAD;GHRL;GCK
liver development (GO:0001889),4/31,0.06697579978121662,1,0,0,2.5806451612903225,6.976577863571356,CITED2;PCSK9;COBL;E2F8
negative regulation of canonical Wnt signaling pathway (GO:0090090),12/148,0.06766615426589831,1,0,0,1.6216216216216217,4.367301342263154,LATS1;WWTR1;TCF7L2;SFRP2;PSMD11;PSMA4;PSMD14;PSMA2;UBC;NOG;DVL3;DKK1
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),8/87,0.0691914842374525,1,0,0,1.839080459770115,4.911958591417849,FZR1;PSMA4;PSMD11;PSMD14;PSMA2;UBC;CUL1;CCDC22
organic substance transport (GO:0071702),8/87,0.0691914842374525,1,0,0,1.839080459770115,4.911958591417849,SLC22A24;SLC22A25;ABCA11P;SLC23A1;ABCA3;ABCA13;ABCC11;SLC18A1
regulation of G2/M transition of mitotic cell cycle (GO:0010389),12/149,0.07041999037716043,1,0,0,1.610738255033557,4.273736539980372,RINT1;PSMD11;PSMA4;PSMD14;PSMA2;CDK3;UBC;CNTRL;CUL1;TUBG1;DYNLL1;HAUS1
adult heart development (GO:0007512),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,APELA;TCAP
acidic amino acid transport (GO:0015800),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,SLC1A1;ARL6IP5
positive regulation of voltage-gated potassium channel activity (GO:1903818),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NPPA;LRRC55
postsynaptic membrane assembly (GO:0097104),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NRXN2;CEL
sarcoplasmic reticulum calcium ion transport (GO:0070296),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,ANK2;CCR5
pericardium development (GO:0060039),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NOTCH1;BMP7
sterol catabolic process (GO:0016127),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CEL;MT3
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,TLR9;TLR2
central nervous system neuron development (GO:0021954),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NTRK2;ARHGAP35
negative regulation of gluconeogenesis (GO:0045721),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,SOGA1;GCK
positive regulation of astrocyte differentiation (GO:0048711),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NOTCH1;SERPINE2
positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CCNH;CCNL1
positive regulation of autophagosome assembly (GO:2000786),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,PIP4K2A;PIP4K2B
intestinal lipid absorption (GO:0098856),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NPC1L1;CEL
Notch signaling involved in heart development (GO:0061314),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NOTCH1;HEY2
engulfment of apoptotic cell (GO:0043652),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,MEGF10;RHOG
cholesterol catabolic process (GO:0006707),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CEL;MT3
B cell homeostasis (GO:0001782),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,TNFRSF13B;TNFAIP3
proline transport (GO:0015824),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,SLC36A1;SLC6A15
tRNA wobble uridine modification (GO:0002098),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,MTO1;ALKBH8
regulation of nephron tubule epithelial cell differentiation (GO:0072182),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,PROM1;CD24
establishment of epithelial cell apical/basal polarity (GO:0045198),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,SYNE4;MYO9A
positive regulation of inflammatory response (GO:0050729),7/73,0.07195616104041558,1,0,0,1.917808219178082,5.0470924764132885,PLA2G2A;TLR9;PDCD4;IL12B;CCL18;CCL16;TLR2
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",8/88,0.0729501407916859,1,0,0,1.8181818181818181,4.759961952800132,PSMA4;PSMD11;PSMD14;PSMA2;UBC;DVL3;CELSR1;AP2A2
sister chromatid segregation (GO:0000819),4/32,0.07364989211173907,1,0,0,2.5,6.521081502381298,LATS1;CHAMP1;TUBG1;ZWINT
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),4/32,0.07364989211173907,1,0,0,2.5,6.521081502381298,TLR9;IL12B;CD14;TLR2
regulation of toll-like receptor signaling pathway (GO:0034121),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,TLR9;BIRC2;TLR2
inactivation of MAPK activity (GO:0000188),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,DUSP2;RGS3;DUSP10
positive regulation of defense response (GO:0031349),7/74,0.07622483813171252,1,0,0,1.8918918918918919,4.869858207482098,PLA2G2A;TLR9;PDCD4;IL12B;CCL18;CCL16;TLR2
regulation of establishment of planar polarity (GO:0090175),8/89,0.0768301842575915,1,0,0,1.797752808988764,4.613317198840263,PSMA4;PSMD11;PSMD14;PSMA2;UBC;DVL3;CELSR1;AP2A2
stem cell differentiation (GO:0048863),4/33,0.08064706826013496,1,0,0,2.4242424242424243,6.103449276278521,PSMD11;EPCAM;FOXO4;BATF
regulation of cell-substrate adhesion (GO:0010810),4/33,0.08064706826013496,1,0,0,2.4242424242424243,6.103449276278521,NOTCH1;MINK1;GCNT2;WASHC2C
regulation of tumor necrosis factor production (GO:0032680),6/61,0.08348906656118887,1,0,0,1.9672131147540983,4.884668055906092,TLR9;TNFAIP3;IL12B;BPI;CD14;TLR2
RNA 3'-end processing (GO:0031123),6/61,0.08348906656118887,1,0,0,1.9672131147540983,4.884668055906092,CPSF7;DDX39B;RBM8A;PABPN1;SRSF4;SRSF11
regulation of ruffle assembly (GO:1900027),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,PLEKHM1;DEF8;NDEL1
long-term synaptic potentiation (GO:0060291),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,SLC24A2;TSHZ3;PLK2
hepaticobiliary system development (GO:0061008),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,CITED2;PCSK9;COBL
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),7/76,0.08519720761440963,1,0,0,1.8421052631578945,4.536712195036593,FZR1;PSMA4;PSMD11;PSMD14;PSMA2;UBC;CUL1
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,NCF1;EGF
low-density lipoprotein particle receptor catabolic process (GO:0032802),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,PCSK9;AP2A2
superoxide anion generation (GO:0042554),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,NCF1;NOX4
regulation of actin filament length (GO:0030832),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,TMSB4Y;ARHGAP35
protein K11-linked deubiquitination (GO:0035871),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,OTUB2;TNFAIP3
phosphatidylglycerol biosynthetic process (GO:0006655),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,CDS1;CDS2
contractile actin filament bundle assembly (GO:0030038),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,ZYX;TNFAIP1
I-kappaB phosphorylation (GO:0007252),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,TLR9;TLR2
L-glutamate transport (GO:0015813),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,SLC1A1;ARL6IP5
positive regulation of bone remodeling (GO:0046852),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,PLEKHM1;DEF8
muscle cell migration (GO:0014812),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,MEGF10;ITGB1BP1
positive regulation of glial cell differentiation (GO:0045687),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,NOTCH1;SERPINE2
cellular copper ion homeostasis (GO:0006878),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,CCDC22;ATOX1
receptor guanylyl cyclase signaling pathway (GO:0007168),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,NPPA;GUCA1B
Rap protein signal transduction (GO:0032486),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,PLK2;RAPGEF3
positive regulation of bone resorption (GO:0045780),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,PLEKHM1;DEF8
polarized epithelial cell differentiation (GO:0030859),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,SYNE4;MYO9A
tRNA wobble base modification (GO:0002097),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,MTO1;ALKBH8
stress fiber assembly (GO:0043149),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,ZYX;TNFAIP1
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,NOG;DKK1
urate transport (GO:0015747),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,SLC22A24;SLC22A25
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,IL12B;PRKCQ
positive regulation of vacuole organization (GO:0044090),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,PIP4K2A;PIP4K2B
pulmonary valve development (GO:0003177),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,NOTCH1;HEY2
regulation of T cell apoptotic process (GO:0070232),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,PRKCQ;PDCD1
smooth muscle cell differentiation (GO:0051145),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,HEY2;GATA6
tRNA processing (GO:0008033),6/62,0.08873881335310585,1,0,0,1.9354838709677418,4.687854010251747,POP7;TYW5;ZBTB8OS;TRMT1;TRNT1;FTSJ1
nuclear export (GO:0051168),8/92,0.08919814687860968,1,0,0,1.7391304347826086,4.20329567741818,POM121L2;ANKLE1;NXT1;DDX39B;RBM8A;SRSF4;PKD1;SRSF11
positive regulation of MAPK cascade (GO:0043410),20/289,0.0892911579048934,1,0,0,1.384083044982699,3.343740915743597,EPHB6;CCR1;PDGFRB;CD74;NTRK2;NOTCH1;EGF;PLA2G2A;HTR2C;BRAF;MT3;APELA;ERBB3;P2RY1;ARL6IP5;TLR9;GCNT2;CD24;CCL18;CCL16
dephosphorylation (GO:0016311),10/124,0.09227027017297251,1,0,0,1.6129032258064515,3.8436020795588095,NT5C;DUSP2;PLPP4;DUSP10;PLPPR2;PLPPR4;PTPRM;PTPRH;DUSP26;DUSP7
regulation of small GTPase mediated signal transduction (GO:0051056),11/140,0.09230308564529764,1,0,0,1.5714285714285714,3.7442078259491387,ARHGEF11;ARHGAP21;OBSCN;ARHGEF12;RASGRF2;RASGRF1;RHOG;ARHGAP28;KALRN;MYO9A;ARHGAP35
cellular transition metal ion homeostasis (GO:0046916),8/93,0.09356252018893225,1,0,0,1.7204301075268817,4.075914668425191,MT1M;UBC;CUL1;SLC39A8;CCDC22;MT3;ATOX1;ABCG2
regulation of viral genome replication (GO:0045069),6/63,0.09416438282354153,1,0,0,1.9047619047619047,4.500406229636559,IFITM1;NR5A2;PDE12;MX1;IFNL3;SRPK1
histone lysine methylation (GO:0034968),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,DOT1L;KMT2B;DPY30
phosphatidylglycerol metabolic process (GO:0046471),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,CDS1;PLA2G2A;CDS2
purine-containing compound biosynthetic process (GO:0072522),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,DGUOK;GMPR2;GMPR
regulation of bone resorption (GO:0045124),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,PLEKHM1;TNFAIP3;DEF8
digestive system development (GO:0055123),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,GATA6;COBL;PKD1
regulation of mitochondrial membrane potential (GO:0051881),4/35,0.09558057758683013,1,0,0,2.2857142857142856,5.366367183732389,OPRD1;BAD;ARL6IP5;SLC25A36
RNA methylation (GO:0001510),5/49,0.0967823010309069,1,0,0,2.0408163265306123,4.765900289809773,TRMT112;MTO1;FTSJ1;ALKBH8;TARBP1
anaphase-promoting complex-dependent catabolic process (GO:0031145),7/79,0.0997335943841466,1,0,0,1.7721518987341771,4.085257956571327,FZR1;PSMA4;PSMD11;PTTG1;PSMD14;PSMA2;UBC
cellular response to decreased oxygen levels (GO:0036294),6/64,0.09976385224519034,1,0,0,1.875,4.321780056051918,OPRD1;BAD;GATA6;MT3;BMP7;NOP53
postsynapse assembly (GO:0099068),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,NRXN2;CEL
morphogenesis of an epithelial sheet (GO:0002011),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,NOTCH1;BMP7
regulation of trophoblast cell migration (GO:1901163),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,APELA;TIMP1
negative regulation of JUN kinase activity (GO:0043508),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,DUSP10;PDCD4
T-helper cell differentiation (GO:0042093),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,IL12B;BATF
regulation of long-term neuronal synaptic plasticity (GO:0048169),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,CAMK2B;SYP
attachment of mitotic spindle microtubules to kinetochore (GO:0051315),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,CDT1;CHAMP1
regulation of integrin-mediated signaling pathway (GO:2001044),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,ITGB1BP1;TIMP1
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,CCNH;CCNL1
response to sterol (GO:0036314),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,INSIG1;CCR5
negative regulation of receptor binding (GO:1900121),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,NOG;PCSK9
icosanoid biosynthetic process (GO:0046456),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,HPGD;MGST3
positive regulation of heterotypic cell-cell adhesion (GO:0034116),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,GCNT2;BMP7
response to nitric oxide (GO:0071731),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,KCNC2;MT3
low-density lipoprotein receptor particle metabolic process (GO:0032799),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,PCSK9;AP2A2
L-serine metabolic process (GO:0006563),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,SERINC3;SDSL
regulation of cardiac muscle cell differentiation (GO:2000725),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,FRS2;DKK1
alcohol catabolic process (GO:0046164),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,CEL;MT3
positive regulation of interferon-gamma biosynthetic process (GO:0045078),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,TLR9;IL12B
positive regulation of JUN kinase activity (GO:0043507),5/50,0.10336068197068972,1,0,0,2,4.5390612819119465,SPAG9;TLR9;DVL3;MAPK8IP3;DKK1
heart morphogenesis (GO:0003007),5/50,0.10336068197068972,1,0,0,2,4.5390612819119465,NOTCH1;HEY2;NOG;ANKRD1;TCAP
cardiac muscle tissue development (GO:0048738),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,NOTCH1;ANKRD1;TCAP;BMP7
spermatid development (GO:0007286),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,KLHL26;SPAG6;CCDC42;TNP1
NIK/NF-kappaB signaling (GO:0038061),7/80,0.10486246218988873,1,0,0,1.7499999999999998,3.9464349249119546,PSMA4;PSMD11;PSMD14;PSMA2;UBC;CUL1;BIRC2
negative regulation of MAPK cascade (GO:0043409),7/80,0.10486246218988873,1,0,0,1.7499999999999998,3.9464349249119546,DLG1;DUSP10;ITGB1BP1;DUSP26;BMP7;CDK5RAP3;DUSP7
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,LATS1;PSMD14;PKD1
phospholipid dephosphorylation (GO:0046839),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,PLPP4;PLPPR2;PLPPR4
defense response to Gram-positive bacterium (GO:0050830),6/65,0.10553500656937817,1,0,0,1.8461538461538463,4.1514693512884095,RARRES2;PLA2G2A;PGLYRP1;RPL39;SPACA7;TLR2
positive regulation of MAP kinase activity (GO:0043406),13/177,0.10701450833214873,1,0,0,1.4689265536723164,3.282743638835663,PDGFRB;GADD45B;EGF;FRS2;DKK1;DUSP7;MADD;UBC;TLR9;DVL3;GHRL;IKBKG;CD24
cellular metal ion homeostasis (GO:0006875),8/96,0.10737303817978314,1,0,0,1.6666666666666665,3.7190769493001,SLC24A2;CCR1;HTR2C;ATP13A5;ANK2;TNNI3;MT3;ATOX1
phosphatidylinositol metabolic process (GO:0046488),9/112,0.10822525381663513,1,0,0,1.6071428571428572,3.5735472970534112,PDGFRB;CDS1;PGAP3;PLA2G2A;INPP5J;PIP4K2A;PIP4K2B;PLEKHA3;PI4KB
carboxylic acid transport (GO:0046942),5/51,0.11015447203407641,1,0,0,1.9607843137254901,4.325238445226717,SLC36A1;SLC23A1;SLC6A15;SLC17A5;SLC1A7
epithelial to mesenchymal transition (GO:0001837),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,NOTCH1;HEY2;NOG;BMP7
regulation of dendrite development (GO:0050773),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,CAMK2B;COBL;RAB17;BMP7
regulation of macromolecule metabolic process (GO:0060255),10/129,0.1121294602199553,1,0,0,1.5503875968992247,3.3924049308497413,NLRP14;MAPK9;MAPK8;NLRX1;DDX39B;KIF16B;DPPA3;CDK3;DKK1;SRPK1
regulation of intracellular signal transduction (GO:1902531),27/422,0.1137968510625483,1,0,0,1.2796208530805686,2.7810517331214184,NLRX1;RASGRF2;KALRN;GNAI1;ARHGAP35;ARHGAP21;UBC;PIP4K2A;PIP4K2B;IKBKG;IER3;ARHGEF11;ARHGEF12;TOP3A;RHOG;ARHGAP28;MYO9A;BMP7;NLRP14;RINT1;PEX5L;OBSCN;RAD9B;CD24;NOP53;TAF3;BIRC2
negative regulation of NF-kappaB transcription factor activity (GO:0032088),7/82,0.11553692430953495,1,0,0,1.7073170731707317,3.6846721375201086,NLRP14;NLRX1;TLR9;TNFAIP3;RBCK1;BMP7;CDK5RAP3
positive regulation of ubiquitin protein ligase activity (GO:1904668),7/82,0.11553692430953495,1,0,0,1.7073170731707317,3.6846721375201086,FZR1;PSMA4;PSMD11;PSMD14;PSMA2;UBC;CUL1
receptor clustering (GO:0043113),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,DLG1;NRXN2;ITGB1BP1
negative regulation of developmental growth (GO:0048640),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,DUSP10;SEMA3G;MT3
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,PSMA4;PSMA2;NFE2L2
receptor catabolic process (GO:0032801),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,KIF16B;PCSK9;AP2A2
"protein alpha-1,2-demannosylation (GO:0036508)",3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,UBC;DERL2;MAN1B1
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,UBC;TNFAIP3;IKBKG
chemokine-mediated signaling pathway (GO:0070098),5/52,0.11715876376056604,1,0,0,1.9230769230769231,4.123510209226117,CCR1;CXCL9;GPR75;CCL18;CCL16
phosphatidylinositol biosynthetic process (GO:0006661),8/98,0.11716919712760449,1,0,0,1.6326530612244896,3.500630627798508,CDS1;PGAP3;PIGP;INPP5J;PIP4K2A;PIP4K2B;PLEKHA3;PI4KB
pulmonary valve morphogenesis (GO:0003184),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,NOTCH1;HEY2
"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,DERL2;UBAC2
regulation of nitric-oxide synthase biosynthetic process (GO:0051769),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,TLR9;TLR2
regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901836),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,NOL11;NOP53
negative regulation of ATPase activity (GO:0032780),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,TLR9;TNNI3
establishment of apical/basal cell polarity (GO:0035089),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,SYNE4;MYO9A
negative regulation of metabolic process (GO:0009892),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,GZMK;MT3
negative regulation of ERAD pathway (GO:1904293),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,DERL2;UBAC2
negative regulation of oxidoreductase activity (GO:0051354),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,GZMK;MT3
modification-dependent macromolecule catabolic process (GO:0043632),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,UBL4A;UBC
nucleoside catabolic process (GO:0009164),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,NT5C;DERA
positive regulation of potassium ion transmembrane transporter activity (GO:1901018),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,ANK2;LRRC55
positive regulation of DNA-dependent DNA replication (GO:2000105),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,CDT1;E2F8
skeletal muscle cell differentiation (GO:0035914),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,MEGF10;ANKRD1
pyrimidine deoxyribonucleotide catabolic process (GO:0009223),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,NT5C;DUT
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,TLR9;IL12B
negative regulation of neuron death (GO:1901215),7/83,0.12107906826619484,1,0,0,1.686746987951807,3.5612482964696746,NTRK2;ERBB3;AGAP2;IKBKG;FBXO7;MT3;RETREG1
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,UBC;TNFAIP3;IKBKG
neutral amino acid transport (GO:0015804),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,SLC36A1;SLC6A15;SLC1A1
positive regulation of interleukin-12 production (GO:0032735),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,TLR9;IL12B;TLR2
in utero embryonic development (GO:0001701),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,ARNT2;RARRES2;PKD1
"RNA splicing, via transesterification reactions (GO:0000375)",3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,PRPF6;SRSF4;SMNDC1
long-chain fatty acid transport (GO:0015909),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,LCN12;ACSL3;ACACB
regulation of cellular protein localization (GO:1903827),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,EGF;DVL3;NDEL1
L-amino acid transport (GO:0015807),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,SLC36A1;SLC1A1;ARL6IP5
regulation of inflammatory response (GO:0050727),12/166,0.12828161120857512,1,0,0,1.4457831325301203,2.9689551963531584,NLRP14;NLRX1;PLA2G2A;TLR9;PDCD4;IL12B;TNFAIP3;GHRL;CCL18;BIRC2;CCL16;TLR2
phosphate-containing compound metabolic process (GO:0006796),13/183,0.12878095975717016,1,0,0,1.4207650273224042,2.912060104344629,PLPPR2;PLPPR4;PLA2G2A;LCAT;APTX;GCK;NUDT4;NT5C;PLPP4;DUSP10;INPP5J;PIP4K2A;PIP4K2B
positive regulation of peptide hormone secretion (GO:0090277),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,TCF7L2;BAD;GHRL;GCK
mitotic DNA damage checkpoint (GO:0044773),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,ATF2;RAD9B;NOP53;CDK5RAP3
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),6/69,0.13028256049309653,1,0,0,1.7391304347826086,3.5444341652133744,CDC42EP5;PLEKHM1;WASL;DEF8;ARHGAP35;NDEL1
cytoplasmic translation (GO:0002181),5/54,0.13177730633611895,1,0,0,1.8518518518518516,3.7530404709585476,RPS29;EIF4H;RPL39;FTSJ1;RPL19
transcription from RNA polymerase II promoter (GO:0006366),30/485,0.13511965167737192,1,0,0,1.2371134020618557,2.4761994858087655,NOTCH1;RBM8A;CCNH;GATA6;NRL;YBX2;FOXO4;PTTG1;PABPN1;NPPA;ELOB;SNRPD3;RPRD1A;NFRKB;SRSF11;GTF2I;TCFL5;WWTR1;CPSF7;POU2F1;ELP2;RUNX3;GFI1B;NR5A2;DDX39B;TRIP11;SRSF4;TAF3;SNRPB;NFE2L2
regulation of plasma membrane bounded cell projection organization (GO:0120035),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,FBXO7;NDEL1
regulation of DNA-templated transcription in response to stress (GO:0043620),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,BCLAF1;RPS6KA1
atrial septum development (GO:0003283),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,HEY2;ANK2
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,TLR9;IL12B
copper ion homeostasis (GO:0055070),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,CCDC22;ATOX1
protein localization to endoplasmic reticulum (GO:0070972),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,ANK2;UBAC2
regulation of oxidoreductase activity (GO:0051341),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,GZMK;MT3
positive regulation of interleukin-17 production (GO:0032740),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,IL12B;PRKCQ
glomerular visceral epithelial cell differentiation (GO:0072112),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,PROM1;CD24
calcium ion transport (GO:0006816),9/118,0.13654988198303988,1,0,0,1.5254237288135593,3.0372182471277855,CCR1;PANX1;SLC24A2;ORAI2;ANK2;TRPM7;CCR5;PKD1;TRPM3
regulation of Notch signaling pathway (GO:0008593),6/70,0.13686946768775143,1,0,0,1.7142857142857142,3.4092473107677503,NOTCH1;YTHDF2;EGF;UBC;ITGB1BP1;RFNG
stress-activated protein kinase signaling cascade (GO:0031098),6/70,0.13686946768775143,1,0,0,1.7142857142857142,3.4092473107677503,MAPK8;MINK1;UBC;CUL1;CCM2;IKBKG
positive regulation of apoptotic process (GO:0043065),20/307,0.13772661095796362,1,0,0,1.3029315960912051,2.583041874624441,UNC13B;ARHGEF11;ARHGEF12;USP27X;GADD45B;BAD;RASGRF2;PCSK9;KALRN;BBC3;LATS1;GZMK;MAPK9;BCLAF1;MAPK8;SFRP2;OBSCN;UBC;ARL6IP5;ANKRD1
intraciliary transport involved in cilium assembly (GO:0035735),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,IFT43;IFT172;TRIP11;DYNLL1
positive regulation of epithelial to mesenchymal transition (GO:0010718),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,WWTR1;TCF7L2;NOTCH1;GCNT2
negative regulation of ERK1 and ERK2 cascade (GO:0070373),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,DLG1;DUSP10;ITGB1BP1;DUSP26
toll-like receptor signaling pathway (GO:0002224),7/86,0.1385007496507468,1,0,0,1.627906976744186,3.2181759965349643,ITGAM;UBC;TLR9;IKBKG;CD14;BIRC2;TLR2
lipid modification (GO:0030258),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,PLPP4;PLPPR2;PLPPR4
regulation of supramolecular fiber organization (GO:1902903),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,TMSB4Y;PRUNE1;ARHGAP35
regulation of viral entry into host cell (GO:0046596),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,CD74;IFITM1;PTX3
DNA recombination (GO:0006310),5/55,0.13937991022954382,1,0,0,1.8181818181818181,3.582821649166955,TREX1;TOP3A;DMC1;THAP9;PALB2
cytokine-mediated signaling pathway (GO:0019221),38/633,0.1398522239200549,1,0,0,1.2006319115323854,2.3618458254854224,OPRD1;CAMK2B;IFITM1;CXCL9;ITGAM;PSMD11;TNFRSF13B;PSMD14;PTAFR;CUL1;IL22RA2;UBC;NDN;IL12B;TIMP1;IKBKG;CCL18;CCR5;IFNL3;CCL16;IFNA21;CCR1;SERPINB2;POU2F1;IL11RA;MX1;GPR75;LIFR;NYX;MT3;BATF;IL22RA1;PSMA4;PSMA2;PDCD4;TNFSF9;HLA-DRA;BIRC2
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),19/291,0.1428820967656055,1,0,0,1.3058419243986255,2.5408229726499916,PSMD11;PSMD14;CUL1;DERL2;KLHL11;TNFAIP1;KLHL42;FZR1;PSMA4;PTTG1;UBE2R2;PSMA2;UBC;SPOPL;RBCK1;MAN1B1;BIRC2;SPSB4;NFE2L2
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),6/71,0.14360927069584972,1,0,0,1.6901408450704225,3.2799871526003956,FZR1;PSMA4;PSMD11;PSMD14;PSMA2;UBC
nuclear import (GO:0051170),6/71,0.14360927069584972,1,0,0,1.6901408450704225,3.2799871526003956,POM121L2;NXT1;SNRPD3;GEMIN7;SMN1;SNRPB
calcium ion homeostasis (GO:0055074),7/87,0.14456531199301625,1,0,0,1.6091954022988504,3.1122223475945634,SLC24A2;CCR1;JPH2;HTR2C;ATP13A5;ANK2;TNNI3
regulation of MAP kinase activity (GO:0043405),7/87,0.14456531199301625,1,0,0,1.6091954022988504,3.1122223475945634,PDGFRB;EGF;TRIB3;CD24;BMP7;CDK5RAP3;DUSP7
chromosome organization (GO:0051276),5/56,0.14716977791840904,1,0,0,1.7857142857142856,3.4217292978951037,LATS1;CDT1;TCF7L2;DOT1L;UBC
mesenchymal cell differentiation (GO:0048762),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,NOTCH1;HEY2;NOG;BMP7
positive regulation of receptor-mediated endocytosis (GO:0048260),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,ATAD1;EGF;PCSK9;WASL
regulation of calcium ion transmembrane transporter activity (GO:1901019),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,JPH2;JPH3;ANK2
negative regulation of smooth muscle cell proliferation (GO:0048662),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,PDCD4;TNFAIP3;IL12B
negative regulation of synaptic transmission (GO:0050805),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,SLC24A2;ATAD1;PLK2
cardiac muscle cell development (GO:0055013),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,PDGFRB;HEY2;TCAP
transition metal ion transport (GO:0000041),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,SLC39A8;MT3;ATOX1
microtubule polymerization (GO:0046785),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,SLAIN2;TUBG1;NDEL1
glycoprotein biosynthetic process (GO:0009101),6/72,0.15049803689681743,1,0,0,1.6666666666666665,3.1563420645887432,SERP2;MPI;ST8SIA4;GCNT2;FUT1;GAL3ST4
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),6/72,0.15049803689681743,1,0,0,1.6666666666666665,3.1563420645887432,PSMA4;PSMD11;PSMD14;PSMA2;UBC;CUL1
regulation of fat cell differentiation (GO:0045598),6/72,0.15049803689681743,1,0,0,1.6666666666666665,3.1563420645887432,ANKRD26;SFRP2;CCDC85B;RARRES2;TRIB3;AAMDC
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),6/72,0.15049803689681743,1,0,0,1.6666666666666665,3.1563420645887432,FZR1;PSMA4;PSMD11;PSMD14;PSMA2;UBC
regulation of stem cell differentiation (GO:2000736),7/88,0.1507542789330227,1,0,0,1.5909090909090908,3.0101655491711536,PSMA4;PSMD11;NOTCH1;YTHDF2;PSMD14;PSMA2;UBC
stimulatory C-type lectin receptor signaling pathway (GO:0002223),9/121,0.15201804550713838,1,0,0,1.487603305785124,2.802281719449235,PSMD11;PSMA4;MUCL1;PSMD14;PSMA2;CLEC10A;UBC;CUL1;IKBKG
neuron cell-cell adhesion (GO:0007158),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,NRXN2;CEL
acetyl-CoA metabolic process (GO:0006084),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,TDO2;ACACB
positive regulation of osteoclast differentiation (GO:0045672),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,CCR1;IL12B
regulation of platelet aggregation (GO:0090330),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,SERPINE2;PRKCQ
copper ion transport (GO:0006825),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,STEAP4;ATOX1
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,NOTCH1;ITGB1BP1
necroptotic process (GO:0070266),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,TRPM7;CD14
epiboly involved in wound healing (GO:0090505),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,TMEFF2;ARHGAP35
regulation of synapse organization (GO:0050807),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,CAMK2B;RAB17
regulation of interferon-gamma biosynthetic process (GO:0045072),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,TLR9;IL12B
positive regulation of interleukin-8 secretion (GO:2000484),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,CD14;TLR2
chloride transmembrane transport (GO:1902476),5/57,0.15514033768438892,1,0,0,1.7543859649122806,3.2691669601382802,GABRB2;SLC1A1;CLCNKA;GABRE;GABRG1
regulation of interleukin-6 production (GO:0032675),4/42,0.1567023472093967,1,0,0,1.9047619047619047,3.5302993347271023,TLR9;TNFAIP3;BPI;TLR2
regulation of protein modification process (GO:0031399),4/42,0.1567023472093967,1,0,0,1.9047619047619047,3.5302993347271023,PPP1R14B;ASPSCR1;MT3;NOP53
regulation of peptide hormone secretion (GO:0090276),6/73,0.1575316394218323,1,0,0,1.643835616438356,3.03802020110663,CRHBP;KCNC2;HTR2C;RFX3;RAPGEF3;GCK
ribonucleoprotein complex assembly (GO:0022618),11/156,0.15856898932161956,1,0,0,1.4102564102564101,2.597079574559515,PRPF6;DDX39B;EIF4H;SNRPD3;GEMIN7;SMN1;NOP53;MDN1;PATL1;SNRPB;SRPK1
DNA metabolic process (GO:0006259),20/314,0.16001302192716657,1,0,0,1.2738853503184713,2.3343950063888723,TCF7L2;DUT;LIG1;EGF;TREX1;TREX2;TOP3A;DOT1L;REV1;FANCA;TNFAIP1;PALB2;THAP9;ERI3;DMC1;UBC;POLL;RAD9B;NOP53;FAN1
RNA splicing (GO:0008380),8/106,0.16083721932026523,1,0,0,1.5094339622641508,2.758282997111417,PRPF6;DDX39B;SRSF4;SNRPD3;SMNDC1;SRSF11;SNRPB;SRPK1
negative regulation of response to DNA damage stimulus (GO:2001021),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,CD74;SFRP2;DDX39B
positive regulation of protein tyrosine kinase activity (GO:0061098),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,NCF1;ERBB3;EGF
regulation of NIK/NF-kappaB signaling (GO:1901222),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,PTP4A3;PDCD4;CD14
regulation of defense response to virus by virus (GO:0050690),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,CD8B;PACS1;AP2A2
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,UBC;TNFAIP3;IKBKG
negative regulation of Wnt signaling pathway (GO:0030178),12/174,0.16258345303883592,1,0,0,1.379310344827586,2.5056053129318974,LATS1;WWTR1;TCF7L2;SFRP2;PSMD11;PSMA4;PSMD14;PSMA2;UBC;NOG;DVL3;DKK1
mRNA 3'-end processing (GO:0031124),6/74,0.1647057705275506,1,0,0,1.6216216216216217,2.924748009429989,CPSF7;DDX39B;RBM8A;PABPN1;SRSF4;SRSF11
nitrogen compound transport (GO:0071705),6/74,0.1647057705275506,1,0,0,1.6216216216216217,2.924748009429989,SLC36A1;SLC22A24;SLC22A25;SLC23A1;SLC6A15;SLC18A1
cardiac ventricle morphogenesis (GO:0003208),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,NOTCH1;SFRP2;HEY2;TNNI3
digestive tract development (GO:0048565),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,RARRES2;GATA6;COBL;PKD1
regulation of response to external stimulus (GO:0032101),8/107,0.16677126238578838,1,0,0,1.495327102803738,2.6783283615039006,NLRP14;NLRX1;GUCA1B;NMT1;TNFAIP3;PDE6B;BIRC2;CAMKMT
innate immune response activating cell surface receptor signaling pathway (GO:0002220),9/124,0.16830852241653768,1,0,0,1.4516129032258065,2.5867111076463174,PSMD11;PSMA4;MUCL1;PSMD14;PSMA2;CLEC10A;UBC;CUL1;IKBKG
cellular response to lipopolysaccharide (GO:0071222),7/91,0.17003916876293382,1,0,0,1.5384615384615385,2.725733021512411,MAPK8;PABPN1;ANKRD1;PDCD4;TNFAIP3;CD14;CCR5
atrioventricular valve morphogenesis (GO:0003181),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,NOTCH1;HEY2
selective autophagy (GO:0061912),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,STBD1;RETREG1
maintenance of protein location in nucleus (GO:0051457),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,TAF3;SYNE1
endocardial cushion morphogenesis (GO:0003203),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,NOTCH1;NOG
positive regulation of small GTPase mediated signal transduction (GO:0051057),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,NOTCH1;RASGRF1
substrate-dependent cell migration (GO:0006929),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,VEGFC;ITGB1BP1
transport along microtubule (GO:0010970),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,ARHGAP21;DYNLL1
glycerophospholipid catabolic process (GO:0046475),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PNPLA6;ENPP6
mesenchyme morphogenesis (GO:0072132),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,NOTCH1;NOG
pyrimidine nucleoside metabolic process (GO:0006213),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,NT5C;UMPS
intra-S DNA damage checkpoint (GO:0031573),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,ATF2;RAD9B
regulation of mitotic sister chromatid separation (GO:0010965),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PTTG1;PTTG2
mesenchymal cell development (GO:0014031),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,NOTCH1;HEY2
negative regulation of muscle cell differentiation (GO:0051148),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,NOTCH1;FOXO4
negative regulation of viral entry into host cell (GO:0046597),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,IFITM1;PTX3
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,EHD1;RAPGEF3
toll-like receptor 4 signaling pathway (GO:0034142),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,ITGAM;CD14
positive regulation of potassium ion transport (GO:0043268),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,DLG1;ANK2
protein targeting to peroxisome (GO:0006625),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PEX10;PEX1
positive regulation of protein export from nucleus (GO:0046827),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,TCF7L2;RAPGEF3
cytoplasmic sequestering of protein (GO:0051220),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,LATS1;PKD1
inhibition of cysteine-type endopeptidase activity (GO:0097340),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,CAST;BIRC2
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",6/75,0.17201595491043623,1,0,0,1.5999999999999999,2.8162688725816674,PSMA4;PSMD11;NCF1;PSMD14;PSMA2;IKBKG
cellular response to tumor necrosis factor (GO:0071356),13/194,0.17457490590345454,1,0,0,1.3402061855670102,2.3391977113709883,PSMD11;TNFRSF13B;PSMD14;CRHBP;PSMA4;PSMA2;UBC;ANKRD1;TNFSF9;CCL18;CCL16;BIRC2;NFE2L2
superoxide metabolic process (GO:0006801),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,NCF1;NOX4;MT3
protein alkylation (GO:0008213),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,SNRPD3;CAMKMT;SNRPB
negative regulation of Notch signaling pathway (GO:0045746),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,YTHDF2;EGF;UBC
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,NOTCH1;MT3;NFE2L2
lysosome localization (GO:0032418),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,PLEKHM1;DEF8;NDEL1
regulation of activated T cell proliferation (GO:0046006),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,IL12B;TNFSF9;CD24
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,NCF1;EGF;UBC
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,UBC;CD14;TLR2
cholesterol transport (GO:0030301),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,NPC1L1;LCAT;CEL;ABCG2
positive regulation of viral life cycle (GO:1903902),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,CD74;NR5A2;PDE12;SRPK1
regulation of smooth muscle cell proliferation (GO:0048660),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,PDGFRB;TCF7L2;TNFAIP3;IL12B
negative regulation of immune response (GO:0050777),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,NLRP14;NLRX1;TNFAIP3;TRAFD1
regulation of hematopoietic stem cell differentiation (GO:1902036),6/76,0.17945756311992533,1,0,0,1.5789473684210524,2.712341867627267,PSMA4;PSMD11;YTHDF2;PSMD14;PSMA2;UBC
positive regulation of JNK cascade (GO:0046330),6/76,0.17945756311992533,1,0,0,1.5789473684210524,2.712341867627267,NCF1;GADD45B;MINK1;TLR9;DVL3;DKK1
G2/M transition of mitotic cell cycle (GO:0000086),9/126,0.1796039438966585,1,0,0,1.4285714285714284,2.4528588057423217,LATS1;CCNH;PPME1;UBC;CNTRL;CUL1;TUBG1;DYNLL1;HAUS1
response to reactive oxygen species (GO:0000302),5/60,0.18006686918004597,1,0,0,1.6666666666666665,2.8573783360576237,MAPK9;MAPK8;PRDX5;NCF1;APTX
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),7/93,0.18346339954975327,1,0,0,1.5053763440860215,2.552727015512764,PSMA4;PSMD11;PSMD14;PSMA2;UBC;ELOB;NFE2L2
neuron development (GO:0048666),10/144,0.18461991668402528,1,0,0,1.3888888888888888,2.346466766255298,EHD1;MAPK9;NTRK2;MAPK8;TDP2;RASGRF1;PTPRM;RUNX3;POU3F2;MANF
cell cycle G2/M phase transition (GO:0044839),9/127,0.18537679054393458,1,0,0,1.4173228346456692,2.388706043433952,LATS1;CCNH;PPME1;UBC;CNTRL;CUL1;TUBG1;DYNLL1;HAUS1
negative regulation of ossification (GO:0030279),4/45,0.18643368284604128,1,0,0,1.7777777777777777,2.98609722860718,CCR1;NOTCH1;NOG;DKK1
negative regulation of ubiquitin protein ligase activity (GO:1904667),6/77,0.18702582489369443,1,0,0,1.5584415584415583,2.612740629548293,FZR1;PSMA4;PSMD11;PSMD14;PSMA2;UBC
regulation of hematopoietic progenitor cell differentiation (GO:1901532),6/77,0.18702582489369443,1,0,0,1.5584415584415583,2.612740629548293,PSMA4;PSMD11;YTHDF2;PSMD14;PSMA2;UBC
cyclic purine nucleotide metabolic process (GO:0052652),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,NPPA;HTR2C;TAAR1
positive regulation of cation channel activity (GO:2001259),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,JPH2;ANK2;LRRC55
regulation of protein polymerization (GO:0032271),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,LATS1;PRUNE1;ARHGAP28
bile acid metabolic process (GO:0008206),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,OSBPL3;ACAA1;CYP8B1
positive regulation of leukocyte chemotaxis (GO:0002690),5/61,0.18868988871127926,1,0,0,1.6393442622950818,2.733853134392278,CCR1;CREB3;CXCL9;RARRES2;VEGFC
negative regulation of viral life cycle (GO:1903901),5/61,0.18868988871127926,1,0,0,1.6393442622950818,2.733853134392278,IFITM1;MX1;PTX3;IFNL3;SRPK1
neural tube development (GO:0021915),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,ZNF358;PKD1
negative regulation of NF-kappaB import into nucleus (GO:0042347),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CCDC22;BMP7
postsynaptic membrane organization (GO:0001941),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,NRXN2;CEL
dendritic cell chemotaxis (GO:0002407),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CCR1;CCR5
DNA strand elongation involved in DNA replication (GO:0006271),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,LIG1;GINS3
fibrinolysis (GO:0042730),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CPB2;SERPINB2
positive regulation of dendrite morphogenesis (GO:0050775),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CAMK2B;SS18L1
glucose 6-phosphate metabolic process (GO:0051156),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,GCK;DERA
regulation of RIG-I signaling pathway (GO:0039535),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,NOP53;BIRC2
cytoplasmic sequestering of transcription factor (GO:0042994),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CCDC22;PKD1
cardiac ventricle development (GO:0003231),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,NOTCH1;HEY2
positive regulation of macrophage derived foam cell differentiation (GO:0010744),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,MAPK9;PLA2G2A
regulation of necroptotic process (GO:0060544),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,UBC;BIRC2
aorta morphogenesis (GO:0035909),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PDGFRB;HEY2
embryonic heart tube development (GO:0035050),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,APELA;CITED2
myoblast differentiation (GO:0045445),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,TCF7L2;ANKRD1
neurotransmitter transport (GO:0006836),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,SLC6A15;SLC18A1
regulation of glucose transport (GO:0010827),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,BRAF;TRIB3
mesenchyme development (GO:0060485),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,SFRP2;BMP7
T cell receptor signaling pathway (GO:0050852),11/163,0.19351846366375716,1,0,0,1.3496932515337423,2.2167123764108663,PSMD11;PSMA4;PSMD14;PSMA2;UBC;CUL1;HLA-DRA;PRKCQ;RBCK1;IKBKG;CD3D
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),11/163,0.19351846366375716,1,0,0,1.3496932515337423,2.2167123764108663,CD74;PLK2;UBC;TLR9;IL12B;RBCK1;CCDC22;IKBKG;LITAF;BIRC2;TLR2
extracellular matrix disassembly (GO:0022617),6/78,0.19471584243590756,1,0,0,1.5384615384615385,2.5172523099552775,CAPNS1;EXOC8;MMP16;BSG;LAMA3;TIMP1
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),6/78,0.19471584243590756,1,0,0,1.5384615384615385,2.5172523099552775,PSMA4;PSMD11;NCF1;PSMD14;PSMA2;IKBKG
intraciliary transport (GO:0042073),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,IFT43;IFT172;TRIP11;DYNLL1
protein methylation (GO:0006479),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,TRMT112;SNRPD3;CAMKMT;SNRPB
pyruvate metabolic process (GO:0006090),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,PKLR;BSG;CELSR1;GCK
interleukin-1-mediated signaling pathway (GO:0070498),7/95,0.19731095294472298,1,0,0,1.4736842105263155,2.3917516785909614,PSMA4;PSMD11;PSMD14;PSMA2;UBC;CUL1;IKBKG
regulation of translational initiation (GO:0006446),5/62,0.19745752815386772,1,0,0,1.6129032258064515,2.616502846917968,YTHDF1;EIF4H;DAZ3;EIF1B;EIF4G2
glycerophospholipid biosynthetic process (GO:0046474),11/164,0.19877569871752643,1,0,0,1.3414634146341464,2.1672390918187117,CDS1;CPNE6;CHAT;PLA2G2A;INPP5J;PIP4K2A;LCAT;PIP4K2B;PLEKHA3;PI4KB;CDS2
negative regulation of toll-like receptor signaling pathway (GO:0034122),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,TLR9;TNFAIP3;CD14
positive regulation of protein dephosphorylation (GO:0035307),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,PDGFRB;CNEP1R1;DUSP26
zinc ion homeostasis (GO:0055069),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,MT1M;SLC39A8;MT3
positive regulation of viral genome replication (GO:0045070),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,NR5A2;PDE12;SRPK1
cellular zinc ion homeostasis (GO:0006882),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,MT1M;SLC39A8;MT3
negative regulation of mitotic cell cycle phase transition (GO:1901991),6/79,0.20252260341125683,1,0,0,1.5189873417721518,2.425676623110086,PSMA4;PSMD11;PSMD14;PSMA2;UBC;CUL1
cation transport (GO:0006812),6/79,0.20252260341125683,1,0,0,1.5189873417721518,2.425676623110086,PANX1;SLC36A1;SLC6A15;SLC1A1;TRPM3;ATOX1
regulation of cell death (GO:0010941),7/96,0.20438472217151854,1,0,0,1.4583333333333333,2.3154704536306197,DUS2;PDE12;GPR75;DKK1;MT3;BMP7;IER3
oligosaccharide metabolic process (GO:0009311),5/63,0.20636211070548938,1,0,0,1.5873015873015872,2.504956879983314,GALNT7;GALNT15;ST8SIA4;MAN1B1;GAL3ST4
negative regulation of neuron apoptotic process (GO:0043524),5/63,0.20636211070548938,1,0,0,1.5873015873015872,2.504956879983314,NTRK2;ERBB3;AGAP2;MT3;RETREG1
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,NLRX1;TNFAIP3;CCDC22;BMP7
positive regulation of tumor necrosis factor production (GO:0032760),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,TLR9;IL12B;CD14;TLR2
positive regulation of organelle assembly (GO:1902117),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,STX18;PIP4K2A;PIP4K2B;ARHGAP35
cardiac myofibril assembly (GO:0055003),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,PDGFRB;TCAP
response to interferon-alpha (GO:0035455),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,IFITM1;PDE12
positive regulation of monocyte chemotaxis (GO:0090026),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,CCR1;CREB3
negative regulation of B cell activation (GO:0050869),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,TNFRSF13B;TNFAIP3
negative regulation of interleukin-8 production (GO:0032717),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,TLR9;BPI
N-glycan processing (GO:0006491),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,ST8SIA4;MAN1B1
negative regulation of stress fiber assembly (GO:0051497),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,TMEFF2;ARHGAP28
negative regulation of cellular carbohydrate metabolic process (GO:0010677),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,SOGA1;GCK
DNA replication checkpoint (GO:0000076),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,CDT1;RAD9B
regulation of receptor recycling (GO:0001919),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,KIF16B;PCSK9
pharyngeal system development (GO:0060037),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,NOG;BMP7
phospholipid catabolic process (GO:0009395),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,PNPLA6;ENPP6
positive regulation of calcium ion transmembrane transporter activity (GO:1901021),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,JPH2;ANK2
nucleotide catabolic process (GO:0009166),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,NT5C;DERA
detection of mechanical stimulus (GO:0050982),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,TCAP;PKD1
mesonephric tubule development (GO:0072164),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,PKD1;BMP7
cellular response to inorganic substance (GO:0071241),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,KCNC2;MT3
mitotic G2 DNA damage checkpoint (GO:0007095),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,NOP53;CDK5RAP3
proteasomal protein catabolic process (GO:0010498),15/237,0.2084771820353401,1,0,0,1.2658227848101267,1.9847160536855117,PSMD11;PSMD14;CUL1;KLHL11;TNFAIP1;KLHL42;PSMA4;UBE2R2;PSMA2;UBC;SPOPL;RBCK1;BIRC2;SPSB4;NFE2L2
RNA transport (GO:0050658),6/80,0.21044099394584637,1,0,0,1.4999999999999998,2.337824968427116,POM121L2;NXT1;DDX39B;RBM8A;SRSF4;SRSF11
nucleic acid metabolic process (GO:0090304),6/80,0.21044099394584637,1,0,0,1.4999999999999998,2.337824968427116,ANKLE1;PDE12;TREX1;ERI3;TREX2;RAD9B
regulation of mitotic cell cycle phase transition (GO:1901990),12/184,0.21119863106114353,1,0,0,1.3043478260869563,2.0282037507249226,FZR1;PSMD11;PSMA4;PSMD14;PSMA2;CDK3;UBC;CNTRL;CUL1;TUBG1;DYNLL1;HAUS1
positive regulation of dendrite development (GO:1900006),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,SS18L1;COBL;BMP7
mitochondrial transmembrane transport (GO:1990542),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,UCP2;ACACB;SLC25A36
negative regulation of fat cell differentiation (GO:0045599),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,ANKRD26;CCDC85B;TRIB3
G2 DNA damage checkpoint (GO:0031572),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,FZR1;NOP53;CDK5RAP3
positive regulation of T cell differentiation (GO:0045582),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,DUSP10;IL12B;TNFSF9
positive regulation of transcription factor import into nucleus (GO:0042993),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,TLR9;IL12B;TLR2
positive regulation of myeloid leukocyte differentiation (GO:0002763),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,CCR1;CD74;IL12B
inorganic anion transmembrane transport (GO:0098661),5/64,0.21539586226514373,1,0,0,1.5625,2.3988714437251204,GABRB2;SLC1A1;CLCNKA;GABRE;GABRG1
negative regulation of mitotic cell cycle (GO:0045930),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,CDT1;BRINP2;DLG1;BMP7
cellular response to interleukin-1 (GO:0071347),10/150,0.21843788140048373,1,0,0,1.3333333333333333,2.028338134021495,PSMD11;PSMA4;PSMD14;PSMA2;UBC;CUL1;ANKRD1;IKBKG;CCL18;CCL16
regulation of insulin secretion (GO:0050796),7/98,0.21881398496006546,1,0,0,1.4285714285714284,2.1707618483434215,TCF7L2;KCNC2;BAD;RFX3;GHRL;RAPGEF3;GCK
positive regulation of cell growth (GO:0030307),7/98,0.21881398496006546,1,0,0,1.4285714285714284,2.1707618483434215,MACF1;SFRP2;EXOSC9;CPNE6;RPS6KA1;DERL2;EIF4G2
positive regulation of cytosolic calcium ion concentration (GO:0007204),9/133,0.22164004840978987,1,0,0,1.3533834586466165,2.0391436915940395,CCR1;GPR17;JPH2;JPH3;P2RY1;HTR2C;GHRL;CD24;CCR5
chromatin remodeling (GO:0006338),8/116,0.22432316253884624,1,0,0,1.379310344827586,2.0616104508948703,INO80C;CECR2;TOX2;KMT2B;ANP32E;TOX;TNP1;BRDT
regulation of JAK-STAT cascade (GO:0046425),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,NOTCH1;DOT1L;IL12B;NYX;IL22RA2
negative regulation of blood vessel morphogenesis (GO:2000181),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,ATF2;PTPRM;GHRL;FOXO4;GTF2I
membrane protein ectodomain proteolysis (GO:0006509),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,ERAP1;PRKCQ
regulation of mitochondrial membrane permeability (GO:0046902),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,BAD;ALKBH7
regulation of chemokine production (GO:0032642),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,TLR9;TLR2
regulation of dephosphorylation (GO:0035303),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PPP1R14B;CDK5RAP3
positive regulation of metabolic process (GO:0009893),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,DISP3;ACACB
regulation of cardiac muscle cell proliferation (GO:0060043),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,NOTCH1;NOG
regulation of cardiac muscle cell membrane repolarization (GO:0099623),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,NPPA;ANK2
regulation of microtubule polymerization or depolymerization (GO:0031110),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PRUNE1;SKA2
establishment of epithelial cell polarity (GO:0090162),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,SYNE4;MYO9A
positive regulation of protein secretion (GO:0050714),6/82,0.22659177650802834,1,0,0,1.4634146341463412,2.172593007559255,UNC13B;TCF7L2;BAD;ANKRD1;GHRL;GCK
positive regulation of cell cycle arrest (GO:0071158),6/82,0.22659177650802834,1,0,0,1.4634146341463412,2.172593007559255,PLK2;GML;UBC;GATA6;FOXO4;E2F8
positive regulation of cell-cell adhesion (GO:0022409),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,CITED2;GCNT2;BMP7
negative regulation of neurogenesis (GO:0050768),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,DISP3;NOTCH1;BMP7
neural tube closure (GO:0001843),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,DVL3;COBL;CELSR1
positive regulation of calcium ion transport (GO:0051928),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,CCR1;PDGFRB;ANK2
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,DLG1;SYNE4;MYO9A
regulation of interleukin-12 production (GO:0032655),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,TLR9;IL12B;TLR2
regulation of release of sequestered calcium ion into cytosol (GO:0051279),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,CXCL9;JPH2;JPH3;ANK2
positive regulation of cellular process (GO:0048522),30/519,0.2301189152527311,1,0,0,1.1560693641618496,1.6984498044291754,ANKLE1;NOTCH1;CITED2;DOT1L;DERL2;ACACB;BCLAF1;CCND2;CAPNS1;EPCAM;EXOSC9;RPS6KA1;GCNT2;TIMP1;PDGFRB;NTRK2;WWTR1;EGF;RHOG;VEGFC;LIFR;ACSL3;DKK1;POU3F2;MT3;EHD1;SFRP2;CDK3;ITGB1BP1;EIF4G2
regulation of GTPase activity (GO:0043087),12/188,0.23222186782704862,1,0,0,1.276595744680851,1.8639089839969563,ARHGAP21;NTRK2;SNX18;RASGRF1;DVL3;ITGB1BP1;RGS8;CCL18;ARHGAP35;RAPGEF3;CCL16;NDEL1
cellular response to metal ion (GO:0071248),7/100,0.2335936861063974,1,0,0,1.4000000000000001,2.035840879866453,CRHBP;MAPK9;MAPK8;NCF1;MT1M;BRAF;MT3
purine ribonucleotide metabolic process (GO:0009150),5/66,0.23381942521025603,1,0,0,1.5151515151515151,2.201827497975576,BAD;GMPR2;GMPR;BPNT1;PDE6B
negative regulation of epithelial cell proliferation (GO:0050680),5/66,0.23381942521025603,1,0,0,1.5151515151515151,2.201827497975576,DUSP10;SFRP2;PTPRM;GHRL;RUNX3
negative regulation of signaling (GO:0023057),6/83,0.23481354624178025,1,0,0,1.4457831325301203,2.0948869879664898,EPHB6;PDGFRB;NTRK2;ERBB3;PCSK9;BRAF
establishment of protein localization to membrane (GO:0090150),6/83,0.23481354624178025,1,0,0,1.4457831325301203,2.0948869879664898,MACF1;SYS1;NCF1;CHM;BRAF;SYNE3
positive regulation of peptidyl-serine phosphorylation (GO:0033138),6/83,0.23481354624178025,1,0,0,1.4457831325301203,2.0948869879664898,LATS1;OPRD1;SFRP2;BRAF;RAPGEF3;IFNA21
spermatogenesis (GO:0007283),10/153,0.2362142323082741,1,0,0,1.3071895424836601,1.8862955839307176,SPAG9;NLRP14;PTTG1;DEFB118;CCDC136;DMC1;YBX2;CATSPERZ;TCFL5;BRDT
negative regulation of viral genome replication (GO:0045071),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,IFITM1;MX1;IFNL3;SRPK1
regulation of interleukin-8 production (GO:0032677),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,TLR9;BPI;TLR2
negative regulation of cellular metabolic process (GO:0031324),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,PCSK9;PTX3;MT3
ventricular cardiac muscle tissue morphogenesis (GO:0055010),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,NOTCH1;NOG;TNNI3
regulation of axon extension (GO:0030516),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,MACF1;SEMA3G;MT3
positive regulation of chemokine production (GO:0032722),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,CD74;TLR9;TLR2
intrinsic apoptotic signaling pathway (GO:0097193),7/101,0.24110527590989309,1,0,0,1.3861386138613863,1.9718121345751627,BAD;ZMAT4;ARL6IP5;CUL1;TRIB3;CD24;BBC3
male gamete generation (GO:0048232),10/154,0.24225595112447437,1,0,0,1.2987012987012985,1.8412473538541556,SPAG9;NLRP14;PTTG1;DEFB118;CCDC136;DMC1;YBX2;CATSPERZ;TCFL5;BRDT
negative regulation of protein serine/threonine kinase activity (GO:0071901),5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,LATS1;HEXIM1;BMP7;CDK5RAP3;DUSP7
regulation of gluconeogenesis (GO:0006111),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,SOGA1;GCK
negative regulation of phosphate metabolic process (GO:0045936),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,DYNLL1;BMP7
positive regulation of heart contraction (GO:0045823),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,APELA;NPPA
regulation of heterotypic cell-cell adhesion (GO:0034114),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,GCNT2;BMP7
positive regulation of mononuclear cell migration (GO:0071677),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,CCR1;CREB3
cellular response to zinc ion (GO:0071294),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,MT1M;MT3
endocardial cushion development (GO:0003197),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,NOTCH1;NOG
positive regulation of toll-like receptor signaling pathway (GO:0034123),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,TLR9;TLR2
folic acid metabolic process (GO:0046655),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,FPGS;SLC25A32
calcium ion transport into cytosol (GO:0060402),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,JPH2;JPH3
aspartate family amino acid catabolic process (GO:0009068),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,SDSL;AASS
positive regulation of epithelial cell differentiation (GO:0030858),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,BAD;RFX3
protein heterotetramerization (GO:0051290),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,CD74;CPSF7
mitochondrial membrane organization (GO:0007006),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,CHCHD3;BAD
regulation of catenin import into nucleus (GO:0035412),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,WWTR1;EGF
positive regulation of actin filament polymerization (GO:0030838),4/51,0.2504443908625444,1,0,0,1.5686274509803921,2.171793530456325,CDC42EP5;RHOG;WASHC2C;WASL
regulation of cellular amine metabolic process (GO:0033238),4/51,0.2504443908625444,1,0,0,1.5686274509803921,2.171793530456325,PSMA4;PSMD11;PSMD14;PSMA2
regulation of cellular amino acid metabolic process (GO:0006521),4/51,0.2504443908625444,1,0,0,1.5686274509803921,2.171793530456325,PSMA4;PSMD11;PSMD14;PSMA2
DNA replication (GO:0006260),8/120,0.2519691354453672,1,0,0,1.3333333333333333,1.8379315698176057,DUT;EGF;TREX1;TOP3A;REV1;POLL;TNFAIP1;RAD9B
cholesterol metabolic process (GO:0008203),5/68,0.25266492029805,1,0,0,1.4705882352941175,2.023075137913094,NPC1L1;LCAT;CEL;HSD17B7;MT3
positive regulation of GTPase activity (GO:0043547),12/192,0.2540277465811737,1,0,0,1.25,1.7128897242764174,ARHGAP21;ARHGAP42;SNX18;TBC1D3L;RASGRF1;RHOG;DVL3;RGS8;CCL18;RAPGEF3;CCL16;NDEL1
positive regulation of NIK/NF-kappaB signaling (GO:1901224),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,PTP4A3;PDCD4;CD14
negative regulation of cell-substrate adhesion (GO:0010812),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,NOTCH1;GCNT2;ITGB1BP1
regulation of endothelial cell apoptotic process (GO:2000351),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,PDCD4;TNFAIP3;NFE2L2
negative regulation of protein complex assembly (GO:0031333),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,OPRD1;DKK1;NOP53
regulation of synapse assembly (GO:0051963),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,GHRL;RAB17;TLR2
carboxylic acid transmembrane transport (GO:1905039),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,SLC36A1;SLC38A6;SLC25A32
negative regulation of tumor necrosis factor production (GO:0032720),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,TNFAIP3;BPI;GHRL
regulation of cardiac muscle contraction (GO:0055117),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,NPPA;TNNI3;ANK2
carbohydrate catabolic process (GO:0016052),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,PKLR;GCK;DERA
negative regulation of cell migration (GO:0030336),8/121,0.25904531858348734,1,0,0,1.322314049586777,1.7861186874223587,IFITM1;TMEFF2;SFRP2;DUSP10;CITED2;NOG;ITGB1BP1;TIMP1
regulation of peptidyl-serine phosphorylation (GO:0033135),6/86,0.25999953625691774,1,0,0,1.3953488372093021,1.8796401371099152,LATS1;OPRD1;SFRP2;BRAF;DKK1;RAPGEF3
regulation of calcium ion transport (GO:0051924),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,CAMK2B;CCR1;EGF;ANK2
regulation of DNA binding (GO:0051101),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,CDT1;MAPK8;EGF;DOT1L
regulation of innate immune response (GO:0045088),5/69,0.26222604197239524,1,0,0,1.4492753623188406,1.9399252051607478,ERAP1;TNFAIP3;TRAFD1;BIRC2;IFNA21
negative regulation of angiogenesis (GO:0016525),5/69,0.26222604197239524,1,0,0,1.4492753623188406,1.9399252051607478,ATF2;PTPRM;GHRL;FOXO4;GTF2I
negative regulation of innate immune response (GO:0045824),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,TNFAIP3;TRAFD1
Golgi to endosome transport (GO:0006895),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,SYS1;KIF16B
negative regulation of intracellular protein transport (GO:0090317),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,INSIG1;ITGB1BP1
negative regulation of actin filament bundle assembly (GO:0032232),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,TMEFF2;ARHGAP28
"wound healing, spreading of cells (GO:0044319)",2/20,0.2641503607881601,1,0,0,2,2.66247357905395,TMEFF2;ARHGAP35
error-prone translesion synthesis (GO:0042276),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,UBC;REV1
neuromuscular junction development (GO:0007528),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,UNC13B;ZC4H2
regulation of calcium ion transmembrane transport (GO:1903169),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,NPPA;ANK2
glial cell development (GO:0021782),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,MT3;TLR2
regulation of response to cytokine stimulus (GO:0060759),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,LIFR;CD24
steroid hormone mediated signaling pathway (GO:0043401),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,ABHD2;BMP7
vesicle cytoskeletal trafficking (GO:0099518),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,WASL;NDEL1
cellular response to steroid hormone stimulus (GO:0071383),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,ABHD2;BMP7
regulation of transport (GO:0051049),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,DISP3;TRIB3
negative regulation of membrane potential (GO:0045837),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ARL6IP5
pyrimidine-containing compound biosynthetic process (GO:0072528),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,UMPS
vocal learning (GO:0042297),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NRXN2
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NOTCH1
transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FRS2
positive regulation of growth hormone secretion (GO:0060124),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GHRL
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EXOSC9
positive regulation of deacetylase activity (GO:0090045),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MAPK8
galactosylceramide metabolic process (GO:0006681),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GALC
vitamin K metabolic process (GO:0042373),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CYP4F11
SCF complex assembly (GO:0010265),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CUL1
embryonic skeletal joint development (GO:0072498),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NOG
"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SRP9
lipoxin biosynthetic process (GO:2001301),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HPGD
T-helper 17 cell lineage commitment (GO:0072540),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BATF
striated muscle hypertrophy (GO:0014897),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TCAP
peripheral nervous system neuron development (GO:0048935),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RUNX3
spinal cord motor neuron differentiation (GO:0021522),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ZC4H2
regulation of superoxide metabolic process (GO:0090322),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BMP7
lipoprotein metabolic process (GO:0042157),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NPC1L1
regulation of dopamine metabolic process (GO:0042053),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ITGAM
negative regulation of oligodendrocyte differentiation (GO:0048715),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NOTCH1
negative regulation of necroptotic process (GO:0060546),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BIRC2
astral microtubule organization (GO:0030953),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DLG1
ventricular cardiac muscle cell development (GO:0055015),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HEY2
N-acetylneuraminate catabolic process (GO:0019262),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NPL
negative regulation of lymphocyte migration (GO:2000402),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,WASL
negative regulation of bone resorption (GO:0045779),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TNFAIP3
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EXOSC9
negative regulation of cytokinesis (GO:0032466),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,E2F8
negative regulation of protein targeting to membrane (GO:0090315),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ITGB1BP1
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TNFAIP3
negative regulation of muscle cell apoptotic process (GO:0010656),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BMP7
amino sugar catabolic process (GO:0046348),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NPL
positive regulation of protein acetylation (GO:1901985),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RAPGEF3
retinal ganglion cell axon guidance (GO:0031290),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PTPRM
positive regulation of mitochondrial membrane potential (GO:0010918),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BAD
iron ion import across plasma membrane (GO:0098711),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STEAP4
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NOG
monoamine transport (GO:0015844),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC18A1
hematopoietic stem cell differentiation (GO:0060218),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BATF
aortic valve development (GO:0003176),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NOTCH1
pyrimidine-containing compound transmembrane transport (GO:0072531),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC25A36
gap junction assembly (GO:0016264),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GJD3
positive regulation of memory T cell differentiation (GO:0043382),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL12B
centromeric sister chromatid cohesion (GO:0070601),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MEIKIN
regulation of glucokinase activity (GO:0033131),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BAD
regulation of cellular response to oxidative stress (GO:1900407),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BMP7
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ITGB1BP1
regulation of phosphatidylinositol biosynthetic process (GO:0010511),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HTR2C
aromatic compound catabolic process (GO:0019439),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ACAA1
antigen processing and presentation of endogenous peptide antigen (GO:0002483),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ERAP1
regulation of NK T cell activation (GO:0051133),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL12B
regulation of protein K63-linked ubiquitination (GO:1900044),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BIRC2
embryonic skeletal joint morphogenesis (GO:0060272),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NOG
regulation of protein localization to cell cortex (GO:1904776),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GNAI1
lymphoid progenitor cell differentiation (GO:0002320),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BATF
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CD74
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DUT
aortic valve morphogenesis (GO:0003180),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NOTCH1
growth hormone secretion (GO:0030252),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GHRL
negative regulation of amino acid transport (GO:0051956),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ARL6IP5
regulation of hyaluronan biosynthetic process (GO:1900125),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EGF
positive regulation of microtubule motor activity (GO:2000576),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DYNLL1
purine ribonucleoside monophosphate catabolic process (GO:0009169),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NUDT4
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CCR5
neurotransmitter loading into synaptic vesicle (GO:0098700),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC18A1
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BAD
protein geranylgeranylation (GO:0018344),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CHM
regulation of transforming growth factor beta2 production (GO:0032909),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GATA6
"retrograde transport, vesicle recycling within Golgi (GO:0000301)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SYS1
vesicle fusion with Golgi apparatus (GO:0048280),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,VTI1A
folic acid-containing compound biosynthetic process (GO:0009396),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FPGS
positive regulation of microglial cell activation (GO:1903980),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ITGAM
positive regulation of cholesterol storage (GO:0010886),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EHD1
positive regulation of cardiac muscle contraction (GO:0060452),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NPPA
ventricular compact myocardium morphogenesis (GO:0003223),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NOG
regulation of respiratory system process (GO:0044065),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TSHZ3
regulation of male gonad development (GO:2000018),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CITED2
SREBP signaling pathway (GO:0032933),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,INSIG1
GDP-mannose metabolic process (GO:0019673),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MPI
positive regulation of activation of Janus kinase activity (GO:0010536),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL12B
plasma membrane fusion (GO:0045026),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MYMK
regulation of T-helper 17 cell lineage commitment (GO:2000328),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL12B
polyphosphate metabolic process (GO:0006797),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRUNE1
positive regulation of sodium ion transmembrane transport (GO:1902307),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GLRX
positive regulation of clathrin-dependent endocytosis (GO:2000370),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,WASL
imitative learning (GO:0098596),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NRXN2
positive regulation of kidney development (GO:0090184),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NOG
morphogenesis of an endothelium (GO:0003159),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CCM2
glomerulus vasculature development (GO:0072012),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PECAM1
regulation of natural killer cell proliferation (GO:0032817),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL12B
maintenance of protein location in extracellular region (GO:0071694),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,LTBP1
venous blood vessel morphogenesis (GO:0048845),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NOTCH1
positive regulation of trophoblast cell migration (GO:1901165),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,APELA
collecting duct development (GO:0072044),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PKD1
astrocyte differentiation (GO:0048708),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MT3
tRNA catabolic process (GO:0016078),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EXOSC9
negative regulation of glial cell proliferation (GO:0060253),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NOTCH1
L-amino acid import (GO:0043092),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC1A1
neutrophil extravasation (GO:0072672),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PECAM1
endoplasmic reticulum membrane organization (GO:0090158),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STX18
positive regulation of cell differentiation (GO:0045597),12/194,0.26519672492956997,1,0,0,1.2371134020618557,1.6420000455868393,SPAG9;WWTR1;MAPK9;IFITM1;SFRP2;NOTCH1;RARRES2;RPS6KA1;PLA2G2A;GCNT2;BMP7;AAMDC
negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),9/140,0.2670012236522016,1,0,0,1.2857142857142856,1.6977883340897255,NLRP14;TCF7L2;NLRX1;TLR9;TNFAIP3;RBCK1;BMP7;TAF3;CDK5RAP3
apoptotic process (GO:0006915),14/231,0.2672701409403699,1,0,0,1.2121212121212122,1.5993883251494772,PLAG1;BAD;GML;MX1;TNFAIP1;BBC3;BCLAF1;ERBB3;PDCD4;TNFSF9;CD14;IKBKG;IER3;TLR2
regulation of potassium ion transport (GO:0043266),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,DLG1;KCNIP2;ANK2
actin polymerization or depolymerization (GO:0008154),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,COBL;GHRL;WASL
regulation of response to DNA damage stimulus (GO:2001020),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,BCLAF1;ANKLE1;IER3
cardiac muscle contraction (GO:0060048),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,TNNT1;TCAP;TNNI3
negative regulation of blood coagulation (GO:0030195),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,CPB2;SERPINB2;SERPINE2
regulation of cysteine-type endopeptidase activity (GO:2000116),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,MT3;BIRC2;BBC3
nervous system development (GO:0007399),26/455,0.26816392595554384,1,0,0,1.1428571428571428,1.504179224512278,BARHL2;PCDHGB6;ZC4H2;CPNE6;PCSK9;NRXN2;MSI1;CELSR1;KALRN;PKD1;DMBX1;ERBB3;ST8SIA4;NDN;BPNT1;ARNT2;PROP1;RBFOX3;PCDH8;NOG;CRIM1;POU3F2;PCDHGA9;DLG1;CSPG5;ZNF358
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),5/70,0.2718688550208947,1,0,0,1.4285714285714284,1.860622113738027,CUL1;SPOPL;KLHL11;FBXO7;SPSB4
regulation of angiogenesis (GO:0045765),11/177,0.272241280054801,1,0,0,1.2429378531073447,1.6171448605107661,ATF2;APELA;SFRP2;GATA6;TNFAIP3;PTPRM;VEGFC;GHRL;FOXO4;RAPGEF3;GTF2I
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),4/53,0.272750159994601,1,0,0,1.5094339622641508,1.9610551964847422,PDGFRB;NTRK2;NCF1;ERBB3
embryonic organ development (GO:0048568),4/53,0.272750159994601,1,0,0,1.5094339622641508,1.9610551964847422,APELA;RARRES2;HEY2;COBL
tumor necrosis factor-mediated signaling pathway (GO:0033209),8/123,0.27337366492441967,1,0,0,1.3008130081300813,1.6870447917730367,PSMD11;PSMA4;PSMD14;TNFRSF13B;PSMA2;UBC;TNFSF9;BIRC2
cellular response to lipid (GO:0071396),11/178,0.27823085805843045,1,0,0,1.2359550561797752,1.581162352534778,CRHBP;BRINP2;MAPK8;PABPN1;INSIG1;ANKRD1;PDCD4;TNFAIP3;CD14;CCR5;GNAI1
defense response to Gram-negative bacterium (GO:0050829),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,DEFB118;RARRES2;TLR9;IL12B;SPACA7
positive regulation of growth (GO:0045927),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,SFRP2;EXOSC9;RPS6KA1;DERL2;EIF4G2
sodium-independent organic anion transport (GO:0043252),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,SLC22A24;SLC22A25;SLCO6A1
positive regulation of receptor activity (GO:2000273),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,JPH2;NCF1;EGF
establishment of protein localization to vacuole (GO:0072666),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,VTI1A;VPS28
regulation of interleukin-17 production (GO:0032660),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,IL12B;PRKCQ
cortical actin cytoskeleton organization (GO:0030866),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,DLG1;WASL
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,ANK2;TNNI3
sterol transport (GO:0015918),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,NPC1L1;LCAT
cellular protein complex localization (GO:0034629),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,DLG1;EXOC8
zinc II ion transport (GO:0006829),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,SLC39A8;MT3
positive regulation of translational initiation (GO:0045948),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,YTHDF1;DAZ3
protein O-linked glycosylation via threonine (GO:0018243),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,GALNT7;GALNT15
regulation of macrophage activation (GO:0043030),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CD74;BPI
positive regulation of BMP signaling pathway (GO:0030513),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,NOTCH1;GATA6
cellular response to alkaloid (GO:0071312),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CRHBP;BAD
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,HEXIM1;LATS1
cellular response to copper ion (GO:0071280),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,MT1M;MT3
lipid catabolic process (GO:0016042),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,MT3;CES3
ERK1 and ERK2 cascade (GO:0070371),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,EGF;MT3
"synaptic transmission, glutamatergic (GO:0035249)",2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,UNC13B;GRID1
RNA modification (GO:0009451),4/54,0.2840279876642483,1,0,0,1.4814814814814814,1.8647148112043361,TYW5;TRMT1;FTSJ1;TARBP1
regulation of neuron apoptotic process (GO:0043523),6/89,0.2858516905884061,1,0,0,1.348314606741573,1.6884703375813395,NTRK2;ERBB3;AGAP2;PCSK9;MT3;RETREG1
positive regulation of intracellular signal transduction (GO:1902533),27/479,0.2868975018255393,1,0,0,1.127348643006263,1.4076416331815311,EPHB6;CXCL9;NCF1;LITAF;BCLAF1;ERBB3;UBC;GCNT2;IKBKG;CD14;CDK5RAP3;HEXIM1;PDGFRB;NTRK2;CD74;TCF7L2;EGF;BAD;PLK2;FRS2;PTP4A3;PDCD4;TLR9;ITGB1BP1;RBCK1;CCDC22;BIRC2
regulation of neuron death (GO:1901214),5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,ITGAM;PCSK9;GPR75;IKBKG;DKK1
regulation of JNK cascade (GO:0046328),6/90,0.29459151170537495,1,0,0,1.3333333333333333,1.6295541177562636,DUSP10;NCF1;GADD45B;MINK1;TLR9;MAPK8IP3
regulation of cellular catabolic process (GO:0031329),4/55,0.2953729340320737,1,0,0,1.4545454545454544,1.773842236930121,PIP4K2A;RAB39B;PIP4K2B;SOGA1
fat cell differentiation (GO:0045444),4/55,0.2953729340320737,1,0,0,1.4545454545454544,1.773842236930121,TCF7L2;STEAP4;ERAP1;SDF4
positive regulation of neuron death (GO:1901216),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,ITGAM;PCSK9;DKK1
muscle filament sliding (GO:0030049),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,TNNT1;TCAP;TNNI3
actin-myosin filament sliding (GO:0033275),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,TNNT1;TCAP;TNNI3
monocarboxylic acid metabolic process (GO:0032787),7/108,0.29558593657898286,1,0,0,1.296296296296296,1.5799203089302307,VNN2;BSG;CELSR1;ALKBH7;ACAA1;CYP4F11;ACACB
positive regulation of protein modification process (GO:0031401),10/163,0.2988597106982444,1,0,0,1.2269938650306749,1.4819398904135106,CD74;NTRK2;CCND2;RARRES2;CNEP1R1;P2RY1;ASPSCR1;DVL3;MT3;RAPGEF3
nucleic acid phosphodiester bond hydrolysis (GO:0090305),5/73,0.30120905235381457,1,0,0,1.36986301369863,1.6437681222088858,ANKLE1;PDE12;UBC;RAD9B;FAN1
chloride transport (GO:0006821),5/73,0.30120905235381457,1,0,0,1.36986301369863,1.6437681222088858,GABRB2;SLC1A1;CLCNKA;GABRE;GABRG1
positive regulation of multicellular organism growth (GO:0040018),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GHRL
skeletal muscle myosin thick filament assembly (GO:0030241),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TCAP
membrane raft polarization (GO:0001766),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MAL2
positive regulation of dendritic spine morphogenesis (GO:0061003),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CAMK2B
smooth muscle cell migration (GO:0014909),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PDGFRB
"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EXOSC9
negative regulation of leukocyte migration (GO:0002686),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,WASL
cellular response to interferon-alpha (GO:0035457),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PDE12
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CD14
postsynaptic density assembly (GO:0097107),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NRXN2
exonucleolytic trimming involved in rRNA processing (GO:0000459),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EXOSC9
regulation of endocytic recycling (GO:2001135),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EHD1
fat-soluble vitamin catabolic process (GO:0042363),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CYP4F11
regulation of extracellular matrix organization (GO:1903053),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NOTCH1
regulation of DNA endoreduplication (GO:0032875),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,E2F8
regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ATF2
dorsal aorta development (GO:0035907),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HEY2
cellular response to laminar fluid shear stress (GO:0071499),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NFE2L2
regulation of lymphocyte migration (GO:2000401),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,WASL
vesicle transport along actin filament (GO:0030050),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,WASL
regulation of low-density lipoprotein particle clearance (GO:0010988),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PCSK9
cytoplasmic sequestering of NF-kappaB (GO:0007253),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCDC22
leukocyte aggregation (GO:0070486),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BMP7
release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCR5
left/right pattern formation (GO:0060972),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CITED2
sequestering of extracellular ligand from receptor (GO:0035581),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,LTBP1
retrograde axonal transport (GO:0008090),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NEFL
positive regulation of autophagy of mitochondrion (GO:1903599),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FBXO7
membrane raft distribution (GO:0031580),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MAL2
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,APELA
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NOTCH1
negative regulation of synapse organization (GO:1905809),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TLR2
L-alanine transport (GO:0015808),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC36A1
regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TLR9
tRNA 3'-end processing (GO:0042780),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TRNT1
central nervous system neuron axonogenesis (GO:0021955),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ARHGAP35
activation of MAPKKK activity (GO:0000185),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GADD45B
chitin metabolic process (GO:0006030),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CHI3L2
strand invasion (GO:0042148),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DMC1
positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031659),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PKD1
negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PDGFRB
formation of translation preinitiation complex (GO:0001731),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EIF4H
positive regulation of protein deubiquitination (GO:1903003),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NOP53
regulation of memory T cell differentiation (GO:0043380),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL12B
regulation of smooth muscle cell differentiation (GO:0051150),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FOXO4
positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NFE2L2
chromatin-mediated maintenance of transcription (GO:0048096),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,KMT2B
response to type I interferon (GO:0034340),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MX1
positive regulation of killing of cells of other organism (GO:0051712),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PGLYRP1
establishment of protein localization to peroxisome (GO:0072663),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PEX1
morphogenesis of a polarized epithelium (GO:0001738),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CELSR1
positive regulation of lymphocyte apoptotic process (GO:0070230),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PDCD1
positive regulation of macrophage migration (GO:1905523),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RARRES2
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NPPA
positive regulation of NK T cell activation (GO:0051135),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL12B
membrane fusion involved in viral entry into host cell (GO:0039663),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCR5
regulation of high voltage-gated calcium channel activity (GO:1901841),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NPPA
protein deglutamylation (GO:0035608),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,AGBL5
negative regulation of membrane protein ectodomain proteolysis (GO:0051045),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TIMP1
zinc II ion transmembrane import (GO:0071578),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC39A8
negative regulation of macrophage activation (GO:0043031),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BPI
regulation of meiotic nuclear division (GO:0040020),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,WEE2
positive regulation of striated muscle contraction (GO:0045989),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NPPA
regulation of toll-like receptor 3 signaling pathway (GO:0034139),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TNFAIP3
regulation of establishment of protein localization (GO:0070201),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PTP4A3
cellular response to histamine (GO:0071420),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GABRB2
pharyngeal arch artery morphogenesis (GO:0061626),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NOG
regulation of growth hormone secretion (GO:0060123),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GHRL
fusion of virus membrane with host plasma membrane (GO:0019064),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCR5
dorsal aorta morphogenesis (GO:0035912),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HEY2
regulation of NADP metabolic process (GO:1902031),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CELSR1
cell differentiation in spinal cord (GO:0021515),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ZC4H2
copper ion import (GO:0015677),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,STEAP4
xenobiotic catabolic process (GO:0042178),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ACAA1
positive regulation of isomerase activity (GO:0010912),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ITGAM
SA node cell action potential (GO:0086015),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ANK2
regulation of activation of Janus kinase activity (GO:0010533),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL12B
positive regulation of macrophage chemotaxis (GO:0010759),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RARRES2
regulation of microglial cell activation (GO:1903978),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ITGAM
cleavage furrow formation (GO:0036089),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SNX18
"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DKK1
amino acid import across plasma membrane (GO:0089718),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC1A1
chitin catabolic process (GO:0006032),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CHI3L2
myoblast fusion (GO:0007520),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MYMK
store-operated calcium entry (GO:0002115),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ORAI2
T-helper 1 type immune response (GO:0042088),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL12B
metanephric nephron tubule development (GO:0072234),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PKD1
neuron fate specification (GO:0048665),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,POU3F2
folic acid transport (GO:0015884),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC25A32
"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PRKCQ
long-chain fatty acid import (GO:0044539),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ACSL3
microglial cell activation (GO:0001774),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ITGAM
cellular response to gonadotropin stimulus (GO:0071371),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NOTCH1
regulation of calcium ion import (GO:0090279),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,PDGFRB;EGF
NAD biosynthetic process (GO:0009435),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,NNMT;NADSYN1
cellular response to nerve growth factor stimulus (GO:1990090),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,EHD1;NTRK2
positive regulation of protein targeting to membrane (GO:0090314),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,ITGAM;ITGB1BP1
lymphocyte activation involved in immune response (GO:0002285),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,CD1C;IFNA21
hematopoietic progenitor cell differentiation (GO:0002244),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,TNFRSF13B;BATF
nuclear transport (GO:0051169),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,NXT1;ANP32E
regulation of DNA biosynthetic process (GO:2000278),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,PDGFRB;ANKRD1
cytosolic calcium ion transport (GO:0060401),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,JPH2;JPH3
positive regulation of interleukin-10 production (GO:0032733),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,TLR9;IL12B
negative regulation of sprouting angiogenesis (GO:1903671),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,NOTCH1;ITGB1BP1
protein O-linked glycosylation via serine (GO:0018242),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GALNT7;GALNT15
regulation of ERBB signaling pathway (GO:1901184),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,ERBB3;EGF
negative regulation of nervous system development (GO:0051961),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,NOTCH1;TLR2
regulation of monocyte chemotaxis (GO:0090025),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,CCR1;CREB3
circulatory system development (GO:0072359),7/109,0.3035915104348741,1,0,0,1.2844036697247707,1.5311019042060257,APELA;NOTCH1;ERBB3;CITED2;GATA6;TNNI3;PKD1
negative regulation of protein kinase activity (GO:0006469),7/109,0.3035915104348741,1,0,0,1.2844036697247707,1.5311019042060257,WWTR1;DUSP10;TRIB3;ITGB1BP1;DUSP26;NYX;CDK5RAP3
Wnt signaling pathway (GO:0016055),7/109,0.3035915104348741,1,0,0,1.2844036697247707,1.5311019042060257,TCF7L2;SFRP2;EGF;UBC;CUL1;DVL3;CD24
protein deubiquitination (GO:0016579),15/257,0.3058111081294603,1,0,0,1.1673151750972761,1.383020616336801,INO80C;OTUB2;PSMD11;USP27X;USP5;PSMD14;TNFAIP3;FOXO4;ATXN3L;PSMA4;PSMA2;UBC;IKBKG;NFRKB;BIRC2
positive regulation of protein transport (GO:0051222),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,UNC13B;ANKRD1;ACSL3;VPS28
phosphatidylinositol-mediated signaling (GO:0048015),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,PDGFRB;ERBB3;PTAFR;PI4KB
negative regulation of cellular catabolic process (GO:0031330),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,TIMP1;MT3;CDK5RAP3;EIF4G2
positive regulation of macromolecule metabolic process (GO:0010604),16/276,0.3070815212987012,1,0,0,1.1594202898550725,1.3688603187887696,ATAD1;ATF2;NTRK2;CITED2;EGF;NOG;PCSK9;ANK2;BRAF;DKK1;MT3;MAPK9;MAPK8;TLR9;TLR2;NFE2L2
negative regulation of protein catabolic process (GO:0042177),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,AGAP2;TIMP1;CDK5RAP3
ERBB2 signaling pathway (GO:0038128),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,ERBB3;EGF;UBC
purine ribonucleoside monophosphate metabolic process (GO:0009167),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,BAD;GMPR2;PDE6B
positive regulation of fat cell differentiation (GO:0045600),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,SFRP2;RARRES2;AAMDC
inositol lipid-mediated signaling (GO:0048017),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,PDGFRB;PTAFR;PI4KB
Golgi to plasma membrane transport (GO:0006893),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,MACF1;SYS1;CCDC22
DNA biosynthetic process (GO:0071897),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,TOP3A;POLL;PALB2
regulation of mRNA stability (GO:0043488),8/128,0.3100735275977645,1,0,0,1.25,1.4636822797847617,PSMD11;PSMA4;YTHDF2;PSMD14;PDE12;PSMA2;EXOSC9;UBC
negative regulation of cytokine production (GO:0001818),7/110,0.3116404927590689,1,0,0,1.2727272727272725,1.4838791193422005,NLRX1;UBC;TLR9;PDCD4;IL12B;TNFAIP3;BPI
cellular response to peptide hormone stimulus (GO:0071375),7/110,0.3116404927590689,1,0,0,1.2727272727272725,1.4838791193422005,CRHBP;PKLR;PCSK9;TRIB3;GNG11;GCK;GNG13
positive regulation of cellular metabolic process (GO:0031325),6/92,0.31222205200130426,1,0,0,1.3043478260869563,1.5183138771942595,PDGFRB;ATAD1;EGF;PCSK9;ACACB;MT3
cell cycle G1/S phase transition (GO:0044843),6/92,0.31222205200130426,1,0,0,1.3043478260869563,1.5183138771942595,LATS1;CDT1;CCNH;PLK2;CDK3;CUL1
defense response to bacterium (GO:0042742),14/241,0.32045313248699003,1,0,0,1.1618257261410787,1.3221800366191223,WFDC12;GSDMC;DEFB129;DEFB118;RARRES2;DEFB115;PLA2G2A;DEFB110;TLR9;IL12B;PGLYRP1;RPL39;SPACA7;TLR2
mitotic G2/M transition checkpoint (GO:0044818),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,NOP53;CDK5RAP3
"nucleotide-excision repair, DNA gap filling (GO:0006297)",2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,LIG1;UBC
glycolytic process (GO:0006096),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,PKLR;GCK
vitamin transport (GO:0051180),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,SLC23A1;SLC25A32
metanephros development (GO:0001656),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,PKD1;BMP7
membrane assembly (GO:0071709),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,NRXN2;CEL
peroxisome organization (GO:0007031),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,PEX10;PEX1
cellular response to ammonium ion (GO:0071242),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,GABRB2;CRHBP
apoptotic nuclear changes (GO:0030262),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,CECR2;CDK5RAP3
regulation of interleukin-8 secretion (GO:2000482),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,CD14;TLR2
folic acid-containing compound metabolic process (GO:0006760),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,FPGS;SLC25A32
histone H3-K4 methylation (GO:0051568),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,KMT2B;DPY30
negative regulation of axonogenesis (GO:0050771),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,SEMA3G;MT3
divalent inorganic cation homeostasis (GO:0072507),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,JPH2;MT3
negative regulation of transcription factor import into nucleus (GO:0042992),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,PKD1;BMP7
positive regulation of ion transmembrane transporter activity (GO:0032414),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,GLRX;ANK2
negative regulation of axon extension (GO:0030517),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,SEMA3G;MT3
negative regulation of phosphorylation (GO:0042326),5/75,0.32103520904984706,1,0,0,1.3333333333333333,1.5149393018047932,WWTR1;PDE12;DYNLL1;BMP7;CDK5RAP3
regulation of defense response (GO:0031347),5/75,0.32103520904984706,1,0,0,1.3333333333333333,1.5149393018047932,NLRP14;NLRX1;ERAP1;TNFAIP3;BIRC2
proteolysis involved in cellular protein catabolic process (GO:0051603),6/93,0.32110195783620454,1,0,0,1.2903225806451613,1.465802039518082,UBL4A;TINAGL1;PSMA4;PSMA2;UBC;TNFAIP3
regulated exocytosis (GO:0045055),9/148,0.32185346752169186,1,0,0,1.2162162162162162,1.3787743461346562,CRHBP;ITIH3;EGF;RARRES2;PECAM1;SDF4;VEGFC;TIMP1;MANF
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),12/204,0.32323153903260027,1,0,0,1.176470588235294,1.328689851124352,NLRP14;CD74;NLRX1;PLK2;UBC;TLR9;TNFAIP3;RBCK1;IKBKG;CCDC22;LITAF;BIRC2
positive regulation of Ras protein signal transduction (GO:0046579),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,GPR17;NOTCH1;RASGRF1
protein modification by small protein removal (GO:0070646),15/261,0.32673794968754316,1,0,0,1.1494252873563218,1.2857434557028515,INO80C;OTUB2;PSMD11;USP27X;USP5;PSMD14;TNFAIP3;FOXO4;ATXN3L;PSMA4;PSMA2;UBC;IKBKG;NFRKB;BIRC2
heart development (GO:0007507),9/149,0.3288746551668815,1,0,0,1.2080536912751678,1.3434506433973514,APELA;NOTCH1;ERBB3;CITED2;GATA6;TCAP;TNNI3;BMP7;PKD1
post-Golgi vesicle-mediated transport (GO:0006892),4/58,0.3296936338803053,1,0,0,1.379310344827586,1.5304709488498607,SYS1;KIF16B;VTI1A;CCDC22
positive regulation of kinase activity (GO:0033674),7/113,0.3360072922265982,1,0,0,1.238938053097345,1.3512136129900216,EPHB6;PDGFRB;CD74;NTRK2;ERBB3;MMD;MAPRE3
protein insertion into mitochondrial membrane (GO:0051204),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BAD
regulation of DNA methylation (GO:0044030),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DPPA3
exocyst localization (GO:0051601),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EXOC8
positive regulation of tissue remodeling (GO:0034105),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,IL12B
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NPPA
ribosomal large subunit export from nucleus (GO:0000055),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NOP53
defense response to protozoan (GO:0042832),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BATF
DNA recombinase assembly (GO:0000730),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DMC1
integrin activation (GO:0033622),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ITGB1BP1
cellular response to forskolin (GO:1904322),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GNAI1
negative regulation of interleukin-1 production (GO:0032692),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GHRL
aorta development (GO:0035904),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PDGFRB
phenol-containing compound biosynthetic process (GO:0046189),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TYRP1
T-helper 17 cell differentiation (GO:0072539),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BATF
negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TNFAIP3
negative regulation of platelet aggregation (GO:0090331),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SERPINE2
translocation of molecules into host (GO:0044417),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DDX39B
lagging strand elongation (GO:0006273),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LIG1
positive regulation of chromatin binding (GO:0035563),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CDT1
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CDT1
DNA repair complex assembly (GO:0090735),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DMC1
coronary vasculature morphogenesis (GO:0060977),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NOTCH1
cellular cation homeostasis (GO:0030003),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MT3
establishment of Golgi localization (GO:0051683),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ARHGAP21
transepithelial transport (GO:0070633),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SLC23A1
imidazole-containing compound catabolic process (GO:0052805),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,UROC1
protein localization to microtubule (GO:0035372),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CHAMP1
benzene-containing compound metabolic process (GO:0042537),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ACAA1
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD14
spleen development (GO:0048536),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CITED2
response to forskolin (GO:1904321),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GNAI1
glycerolipid biosynthetic process (GO:0045017),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CPNE6
multi-ciliated epithelial cell differentiation (GO:1903251),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MCIDAS
positive regulation of cAMP-mediated signaling (GO:0043950),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CXCL9
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,JPH2
T-helper cell lineage commitment (GO:0002295),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BATF
atrial cardiac muscle cell to AV node cell signaling (GO:0086026),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ANK2
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MT3
positive regulation of catenin import into nucleus (GO:0035413),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EGF
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PATL1
glycosyl compound metabolic process (GO:1901657),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LCTL
regulation of toll-like receptor 2 signaling pathway (GO:0034135),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TNFAIP3
lung epithelium development (GO:0060428),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PKD1
kynurenine metabolic process (GO:0070189),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TDO2
protein localization to microtubule cytoskeleton (GO:0072698),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CHAMP1
histidine catabolic process (GO:0006548),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,UROC1
angiogenesis involved in wound healing (GO:0060055),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MCAM
B cell mediated immunity (GO:0019724),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD74
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,VPS28
double-strand break repair via synthesis-dependent strand annealing (GO:0045003),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DMC1
positive regulation of regulatory T cell differentiation (GO:0045591),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DUSP10
positive regulation of monocyte differentiation (GO:0045657),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD74
histidine metabolic process (GO:0006547),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,UROC1
cardiac muscle hypertrophy (GO:0003300),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TCAP
ketone body biosynthetic process (GO:0046951),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BDH1
cGMP-mediated signaling (GO:0019934),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KCNC2
regulation of lipid transport (GO:0032368),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DISP3
ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NOTCH1
leptin-mediated signaling pathway (GO:0033210),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MT3
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ATF2
actin filament network formation (GO:0051639),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,COBL
peroxisomal transport (GO:0043574),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PEX1
negative regulation of bone remodeling (GO:0046851),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TNFAIP3
regulation of smooth muscle cell apoptotic process (GO:0034391),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,IL12B
acid secretion (GO:0046717),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GHRL
mitochondrial tRNA modification (GO:0070900),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MTO1
positive regulation of viral entry into host cell (GO:0046598),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD74
mammary gland epithelial cell differentiation (GO:0060644),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LATS1
U4 snRNA 3'-end processing (GO:0034475),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EXOSC9
regulation of dopamine receptor signaling pathway (GO:0060159),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RGS8
immunoglobulin mediated immune response (GO:0016064),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD74
histone H3-K36 demethylation (GO:0070544),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KDM7A
viral mRNA export from host cell nucleus (GO:0046784),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DDX39B
regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CITED2
response to leptin (GO:0044321),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GCK
pantothenate metabolic process (GO:0015939),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,VNN2
positive regulation of non-canonical Wnt signaling pathway (GO:2000052),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DKK1
regulation of cellular metabolic process (GO:0031323),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,KIF16B;ACACB;DKK1
regulation of protein localization (GO:0032880),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,MAPK8;MMD;DVL3
cellular lipid catabolic process (GO:0044242),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CEL;MT3
histone mRNA metabolic process (GO:0008334),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,SNRPD3;SNRPB
Golgi to plasma membrane protein transport (GO:0043001),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,MACF1;SYS1
response to dsRNA (GO:0043331),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PDE12;IFNA21
ATP generation from ADP (GO:0006757),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PKLR;GCK
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,TRIB3;BBC3
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,HEXIM1;LATS1
regulation of epidermal growth factor-activated receptor activity (GO:0007176),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,NCF1;EGF
sensory perception of pain (GO:0019233),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,OPRD1;RETREG1
eosinophil chemotaxis (GO:0048245),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CCL18;CCL16
regulation of chemotaxis (GO:0050920),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PDGFRB;RARRES2
negative regulation of oxidative stress-induced cell death (GO:1903202),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,FBXO7;NFE2L2
negative regulation of endothelial cell apoptotic process (GO:2000352),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,TNFAIP3;NFE2L2
eosinophil migration (GO:0072677),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CCL18;CCL16
limb development (GO:0060173),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,NOG;DKK1
regulation of neuronal synaptic plasticity (GO:0048168),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CAMK2B;SYP
regulation of cardiac muscle cell action potential (GO:0098901),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,DLG1;ANK2
transition metal ion homeostasis (GO:0055076),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,MT3;ATOX1
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CD74;SFRP2
cGMP biosynthetic process (GO:0006182),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,NPPA;HTR2C
water-soluble vitamin metabolic process (GO:0006767),5/77,0.34100404859306127,1,0,0,1.2987012987012985,1.397221985795033,VNN2;SLC23A1;FPGS;SLC25A32;ACACB
regulation of protein metabolic process (GO:0051246),4/59,0.3411916398273588,1,0,0,1.3559322033898304,1.458048767361736,MAPK8;IL12B;SPOPL;KLHL11
dicarboxylic acid metabolic process (GO:0043648),4/59,0.3411916398273588,1,0,0,1.3559322033898304,1.458048767361736,FH;FPGS;SLC25A32;CELSR1
peptidyl-serine modification (GO:0018209),10/170,0.34499465048375516,1,0,0,1.176470588235294,1.2520310210766845,LATS1;CAMK2B;GALNT7;MAPK9;MAPK8;GALNT15;MAST3;PLK2;PRKCQ;PKD1
cellular response to cytokine stimulus (GO:0071345),25/456,0.3459660298663927,1,0,0,1.0964912280701753,1.1638318950890818,OPRD1;ITGAM;PTAFR;IL22RA2;CRHBP;MAPK8;UBC;ANKRD1;NDN;IL12B;TIMP1;CCL18;CCR5;IFNL3;CCL16;IFNA21;CCR1;POU2F1;IL11RA;LIFR;NYX;BATF;IL22RA1;PDE12;NFE2L2
protein localization to nucleus (GO:0034504),6/96,0.3479363200566363,1,0,0,1.25,1.3196697553688395,POM121L2;NXT1;CNEP1R1;BMP7;NOP53;TAF3
negative regulation of cell communication (GO:0010648),5/78,0.3510237868632946,1,0,0,1.282051282051282,1.3421811397066412,EPHB6;PDGFRB;NTRK2;ERBB3;BRAF
negative regulation of inflammatory response (GO:0050728),5/78,0.3510237868632946,1,0,0,1.282051282051282,1.3421811397066412,NLRP14;NLRX1;PDCD4;TNFAIP3;GHRL
determination of left/right symmetry (GO:0007368),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,NOTCH1;CITED2;RFX3
cellular response to oxidative stress (GO:0034599),7/115,0.35239484145081534,1,0,0,1.2173913043478262,1.269742811049461,MAPK9;PRDX5;MAPK8;NCF1;NOX4;MT3;NFE2L2
"regulation of mRNA splicing, via spliceosome (GO:0048024)",4/60,0.3527005497730227,1,0,0,1.3333333333333333,1.3895145106479536,RBFOX3;RBM8A;SRSF4;SRPK1
regulation of stress fiber assembly (GO:0051492),4/60,0.3527005497730227,1,0,0,1.3333333333333333,1.3895145106479536,TMEFF2;ITGB1BP1;ARHGAP28;RAPGEF3
positive regulation of neuron projection development (GO:0010976),6/97,0.3569285827398046,1,0,0,1.2371134020618557,1.2744984316239885,CAMK2B;NTRK2;CPNE6;COBL;BMP7;ARHGAP35
negative regulation of cell motility (GO:2000146),6/97,0.3569285827398046,1,0,0,1.2371134020618557,1.2744984316239885,IFITM1;TMEFF2;SFRP2;DUSP10;CITED2;NOG
protein localization to organelle (GO:0033365),6/97,0.3569285827398046,1,0,0,1.2371134020618557,1.2744984316239885,EHD1;OBSCN;CNEP1R1;ANK2;BMP7;UBAC2
glycolytic process through glucose-6-phosphate (GO:0061620),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PKLR;GCK
negative regulation of wound healing (GO:0061045),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,DUSP10;SERPINE2
canonical glycolysis (GO:0061621),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PKLR;GCK
glucose catabolic process to pyruvate (GO:0061718),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PKLR;GCK
response to copper ion (GO:0046688),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,MT1M;MT3
"protein import into nucleus, translocation (GO:0000060)",2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,OPRD1;MT3
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,LATS1;CCDC22
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,JPH2;JPH3
prostaglandin metabolic process (GO:0006693),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CD74;HPGD
positive regulation of nuclear division (GO:0051785),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PDGFRB;EGF
regulation of interleukin-10 production (GO:0032653),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,TLR9;IL12B
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CD74;ANKRD1
response to alcohol (GO:0097305),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SDF4;CCR5
monocarboxylic acid catabolic process (GO:0072329),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CEL;ACAA1
cellular response to vascular endothelial growth factor stimulus (GO:0035924),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,NOTCH1;ITGB1BP1
regulation of potassium ion transmembrane transporter activity (GO:1901016),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,DLG1;ANK2
negative regulation of epithelial to mesenchymal transition (GO:0010719),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SFRP2;NOG
regulation of nervous system development (GO:0051960),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PRUNE1;RAB17
peptidyl-tyrosine dephosphorylation (GO:0035335),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,DUSP10;DUSP7
positive regulation of calcium ion transmembrane transport (GO:1904427),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CXCL9;ANK2
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,EGF;BMP7
positive regulation of hydrolase activity (GO:0051345),10/172,0.3583996304747495,1,0,0,1.1627906976744184,1.193147242934103,ARHGAP21;MAPK8;SNX18;RASGRF1;DVL3;RGS8;CCL18;RAPGEF3;CCL16;NDEL1
endosomal transport (GO:0016197),13/229,0.3593599084724989,1,0,0,1.1353711790393013,1.1619739045994106,SPAG9;TINAGL1;SYS1;WASHC2C;DPY30;EHD1;SNX18;HEATR5A;KIF16B;UBC;VTI1A;RAB17;VPS28
regulation of cellular ketone metabolic process (GO:0010565),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,PSMA4;PSMD11;PSMD14;PSMA2
striated muscle contraction (GO:0006941),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,ARHGEF11;TNNT1;TCAP;TNNI3
positive regulation of interferon-gamma production (GO:0032729),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,TLR9;IL12B;CD14
regulation of B cell proliferation (GO:0030888),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,CD74;TNFRSF13B;TLR9
negative regulation of ERBB signaling pathway (GO:1901185),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,ERBB3;EGF;UBC
male gonad development (GO:0008584),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,KLHL26;NCOA4;GATA6
development of primary male sexual characteristics (GO:0046546),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,KLHL26;NCOA4;GATA6
response to hydrogen peroxide (GO:0042542),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,TNFAIP3;APTX;NFE2L2
positive regulation of protein localization to plasma membrane (GO:1903078),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,DLG1;RHOG;ACSL3
positive regulation of neuron differentiation (GO:0045666),6/98,0.3659360545830404,1,0,0,1.2244897959183672,1.2309755205294757,CAMK2B;NTRK2;BRINP2;MMD;ZC4H2;ARHGAP35
activation of MAPK activity (GO:0000187),7/117,0.36885988926259045,1,0,0,1.1965811965811965,1.1933963891623318,SPAG9;MADD;UBC;GHRL;IKBKG;MAPK8IP3;DUSP7
negative regulation of interleukin-17 production (GO:0032700),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IL12B
type B pancreatic cell differentiation (GO:0003309),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RFX3
very-low-density lipoprotein particle remodeling (GO:0034372),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,LCAT
removal of superoxide radicals (GO:0019430),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MT3
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901838),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NOL11
alanine transport (GO:0032328),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC36A1
RNA destabilization (GO:0050779),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,YTHDF2
negative regulation of cytokine production involved in inflammatory response (GO:1900016),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PDCD4
dynamin family protein polymerization involved in membrane fission (GO:0003373),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MX1
negative regulation of phagocytosis (GO:0050765),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TLR2
L-fucose metabolic process (GO:0042354),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FUT1
regulation of protein acetylation (GO:1901983),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RAPGEF3
positive regulation of production of molecular mediator of immune response (GO:0002702),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TLR9
regulation of macrophage cytokine production (GO:0010935),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CD74
positive regulation of protein maturation (GO:1903319),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TNP1
negative regulation of response to reactive oxygen species (GO:1901032),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NFE2L2
regulation of interleukin-6 biosynthetic process (GO:0045408),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GHRL
regulation of organ growth (GO:0046620),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,LATS1
neuronal ion channel clustering (GO:0045161),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,KCNIP2
positive regulation of triglyceride biosynthetic process (GO:0010867),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CNEP1R1
anoikis (GO:0043276),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IKBKG
negative regulation of T cell apoptotic process (GO:0070233),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PRKCQ
regulation of T-helper 1 type immune response (GO:0002825),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IL12B
negative regulation of mitotic nuclear division (GO:0045839),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BMP7
negative regulation of catenin import into nucleus (GO:0035414),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,WWTR1
potassium ion export (GO:0071435),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,KCNIP2
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NFE2L2
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IL12B
homocysteine metabolic process (GO:0050667),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NOX4
embryonic forelimb morphogenesis (GO:0035115),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ZNF358
positive regulation of synapse maturation (GO:0090129),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CAMK2B
L-fucose catabolic process (GO:0042355),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FUT1
indolalkylamine catabolic process (GO:0046218),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TDO2
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PDGFRB
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BATF
maintenance of protein localization in endoplasmic reticulum (GO:0035437),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,INSIG1
sphingoid biosynthetic process (GO:0046520),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SPTLC3
L-ascorbic acid metabolic process (GO:0019852),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC23A1
epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RFX3
nicotinamide nucleotide biosynthetic process (GO:0019359),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NADSYN1
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NOP53
columnar/cuboidal epithelial cell differentiation (GO:0002065),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GATA6
positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IL12B
"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,EXOSC9
regulation of striated muscle tissue development (GO:0016202),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MEGF10
podosome assembly (GO:0071800),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NCF1
glycine transport (GO:0015816),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC36A1
regulation of Rac protein signal transduction (GO:0035020),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RASGRF1
interleukin-23-mediated signaling pathway (GO:0038155),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IL12B
mitochondrial protein processing (GO:0034982),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PMPCA
positive regulation of ribosome biogenesis (GO:0090070),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TRMT112
membrane disruption in other organism (GO:0051673),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DEFB118
atrioventricular valve development (GO:0003171),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NOTCH1
regulation of sequestering of calcium ion (GO:0051282),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ANK2
regulation of natural killer cell activation (GO:0032814),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IL12B
positive regulation of cell activation (GO:0050867),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RPS6KA1
regulation of organ morphogenesis (GO:2000027),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CITED2
positive regulation of rRNA processing (GO:2000234),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TRMT112
negative regulation of lymphocyte apoptotic process (GO:0070229),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PRKCQ
cellular response to superoxide (GO:0071451),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MT3
positive regulation of myeloid leukocyte mediated immunity (GO:0002888),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ITGAM
postsynaptic density organization (GO:0097106),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NRXN2
regulation of cell-cell adhesion mediated by cadherin (GO:2000047),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,EPCAM
regulation of leukocyte activation (GO:0002694),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CD74
fucose catabolic process (GO:0019317),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FUT1
protein autoprocessing (GO:0016540),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PCSK9
protein hexamerization (GO:0034214),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PANX1
regulation of oxidative phosphorylation (GO:0002082),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PDE12
regulation of flagellated sperm motility (GO:1901317),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TEX101
regulation of homotypic cell-cell adhesion (GO:0034110),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PRKCQ
mitral valve morphogenesis (GO:0003183),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NOTCH1
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MX1
axonal transport of mitochondrion (GO:0019896),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NEFL
nuclear RNA surveillance (GO:0071027),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,EXOSC9
lipoprotein biosynthetic process (GO:0042158),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,WIPI2
serine family amino acid catabolic process (GO:0009071),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SDSL
"negative regulation of synaptic transmission, glutamatergic (GO:0051967)",1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ATAD1
DNA topological change (GO:0006265),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TOP3A
regulation of glycoprotein biosynthetic process (GO:0010559),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MT3
vitamin transmembrane transport (GO:0035461),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC25A32
positive regulation of stress-activated MAPK cascade (GO:0032874),5/80,0.37109875658286956,1,0,0,1.25,1.239108826933398,NCF1;GADD45B;MINK1;ARL6IP5;TLR9
negative regulation of defense response (GO:0031348),5/80,0.37109875658286956,1,0,0,1.25,1.239108826933398,NLRP14;NLRX1;TNFAIP3;TRAFD1;GHRL
ion transport (GO:0006811),16/289,0.37383302582281325,1,0,0,1.107266435986159,1.089490420791735,SLC36A1;SLC24A2;GABRB2;SLC1A1;CLCNKA;SLC1A7;GABRG1;CALHM6;PANX1;SCNN1A;UBC;SLC17A5;VDAC2;ATP13A5;GABRE;TRPM3
positive regulation of catabolic process (GO:0009896),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,FZR1;PLK2;TNFAIP3;VPS28
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,CREB3;SFRP2;NDUFS3;NFE2L2
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,PLK2;GML;UBC;E2F8
bile acid biosynthetic process (GO:0006699),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,OSBPL3;CYP8B1
apoptotic cell clearance (GO:0043277),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,MEGF10;RHOG
regulation of transcription regulatory region DNA binding (GO:2000677),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,DOT1L;HEY2
positive regulation of interferon-beta production (GO:0032728),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,TLR9;TLR2
positive regulation of cAMP metabolic process (GO:0030816),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,CXCL9;RAPGEF3
regulation of cardiac muscle cell contraction (GO:0086004),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,DLG1;ANK2
regulation of microtubule-based process (GO:0032886),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,MACF1;KLHL42
T cell activation involved in immune response (GO:0002286),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,CD1C;IFNA21
positive regulation of release of cytochrome c from mitochondria (GO:0090200),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,BAD;BBC3
strand displacement (GO:0000732),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,TOP3A;PALB2
GPI anchor metabolic process (GO:0006505),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,PGAP3;PIGP
RNA biosynthetic process (GO:0032774),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,SMN1;TTF1
positive regulation of protein serine/threonine kinase activity (GO:0071902),7/118,0.37711178989119853,1,0,0,1.1864406779661016,1.1570330972966532,PDGFRB;CCND2;CCNH;EGF;MAPRE3;CCNL1;CD24
regulation of canonical Wnt signaling pathway (GO:0060828),12/213,0.37765962919247165,1,0,0,1.1267605633802817,1.0971965531094479,LATS1;WWTR1;TCF7L2;SFRP2;PSMA4;PSMD11;PSMD14;PSMA2;NOG;UBC;DVL3;DKK1
positive regulation of transferase activity (GO:0051347),8/137,0.3782278714972952,1,0,0,1.167883211678832,1.1354842982136466,EPHB6;PDGFRB;CD74;NTRK2;PABPN1;ERBB3;PRKCQ;TRIB3
lymphocyte chemotaxis (GO:0048247),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,CXCL9;CCL18;CCL16
negative regulation of immune system process (GO:0002683),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,NLRP14;NLRX1;TLR9
positive regulation of macroautophagy (GO:0016239),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,PIP4K2A;PIP4K2B;IKBKG
positive regulation of interleukin-8 production (GO:0032757),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,TLR9;CD14;TLR2
negative regulation of type I interferon production (GO:0032480),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,NLRX1;UBC;TNFAIP3
heart contraction (GO:0060047),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,TNNT1;TCAP;TNNI3
positive regulation of actin filament bundle assembly (GO:0032233),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,SYNPO2L;ITGB1BP1;RAPGEF3
regulation of apoptotic process (GO:0042981),43/815,0.3791041395700734,1,0,0,1.0552147239263803,1.0234995458464005,EPHB6;USP27X;CITED2;RASGRF2;GATA6;PCSK9;CHM;KALRN;BBC3;MAPK9;PRDX5;BCLAF1;MAPK8;CCND2;ERBB3;RPS6KA1;UBC;ARL6IP5;ANKRD1;AAMDC;PDGFRB;ARHGEF11;UNC13B;NTRK2;CD74;ARHGEF12;GADD45B;BAD;PLK2;MINK1;BRAF;MT3;BMP7;DKK1;GZMK;LATS1;SFRP2;OBSCN;MADD;ANP32E;GHRL;NOP53;BIRC2
negative regulation of cell death (GO:0060548),5/81,0.3811403952771392,1,0,0,1.2345679012345678,1.1908487409762,DUS2;PDE12;IKBKG;MT3;BMP7
positive regulation of binding (GO:0051099),5/81,0.3811403952771392,1,0,0,1.2345679012345678,1.1908487409762,CDT1;TCF7L2;EGF;TRIB3;PKD1
regulation of proteolysis (GO:0030162),4/63,0.38719146599357773,1,0,0,1.2698412698412698,1.204871065559935,SERPINE2;BAD;SPOPL;KLHL11
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),4/63,0.38719146599357773,1,0,0,1.2698412698412698,1.204871065559935,PLK2;GML;UBC;E2F8
regulation of cell cycle (GO:0051726),12/215,0.38991643248973035,1,0,0,1.1162790697674418,1.0513371220310108,MCIDAS;GADD45B;HPGD;CITED2;MINK1;MADD;PDCD4;RUNX3;BMP7;NOP53;CDK5RAP3;BIRC2
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",5/82,0.39117601725719064,1,0,0,1.2195121951219512,1.1446312783908745,PLK2;GML;UBC;E2F8;BATF
positive regulation of cell cycle (GO:0045787),5/82,0.39117601725719064,1,0,0,1.2195121951219512,1.1446312783908745,CCND2;CITED2;CCNH;MAPRE3;CCNL1
nicotinamide nucleotide metabolic process (GO:0046496),3/45,0.3924009183942127,1,0,0,1.3333333333333333,1.2472949477860094,PKLR;NADSYN1;GCK
metal ion homeostasis (GO:0055065),3/45,0.3924009183942127,1,0,0,1.3333333333333333,1.2472949477860094,JPH2;SCNN1A;MT3
neuron differentiation (GO:0030182),8/139,0.39355473032009886,1,0,0,1.1510791366906474,1.0734217379560849,MAPK9;NTRK2;MAPK8;TDP2;PCSK9;RUNX3;POU3F2;MANF
enzyme linked receptor protein signaling pathway (GO:0007167),7/120,0.39363540297261096,1,0,0,1.1666666666666665,1.0877185331509394,CNKSR1;CD8B;ERBB3;NPPA;GUCA1B;LIFR;FRS2
peptidyl-glutamic acid modification (GO:0018200),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,AGBL5;F9
endocytic recycling (GO:0032456),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,EHD1;RAB17
negative regulation of osteoblast differentiation (GO:0045668),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,NOTCH1;NOG
regulation of protein targeting to membrane (GO:0090313),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,ITGAM;ITGB1BP1
protein targeting to vacuole (GO:0006623),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,NCOA4;VTI1A
cellular response to oxygen-containing compound (GO:1901701),15/274,0.3966882830957562,1,0,0,1.094890510948905,1.0123406801059442,NCF1;INSIG1;TNFAIP3;CRHBP;MAPK9;PRDX5;BRINP2;MAPK8;PABPN1;ANKRD1;PDCD4;CD14;CCR5;RAPGEF3;TLR2
positive regulation of cell adhesion (GO:0045785),4/64,0.39864450306553323,1,0,0,1.25,1.1496065362528942,SFRP2;CITED2;IL12B;DUSP26
positive regulation of Wnt signaling pathway (GO:0030177),8/140,0.4012246378411757,1,0,0,1.1428571428571428,1.04369578789494,MACF1;SFRP2;PSMD11;PSMA4;PSMD14;PSMA2;UBC;TLR2
induction of positive chemotaxis (GO:0050930),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,VEGFC
regulation of response to stress (GO:0080134),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CRHBP
glomerular filtration (GO:0003094),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MCAM
regulation of phospholipase C activity (GO:1900274),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PDGFRB
regulation of synapse maturation (GO:0090128),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CAMK2B
negative regulation of cellular protein catabolic process (GO:1903363),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CDK5RAP3
male meiosis I (GO:0007141),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,BRDT
endothelium development (GO:0003158),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PECAM1
negative regulation of sodium ion transmembrane transport (GO:1902306),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PCSK9
dorsal/ventral axis specification (GO:0009950),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EGF
positive regulation of calcium ion import (GO:0090280),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PDGFRB
glucosamine-containing compound catabolic process (GO:1901072),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CHI3L2
regulation of cellular respiration (GO:0043457),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NOP53
negative regulation of oxidative stress-induced neuron death (GO:1903204),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,FBXO7
presynaptic membrane assembly (GO:0097105),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CEL
N-acetylneuraminate metabolic process (GO:0006054),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NPL
skeletal muscle thin filament assembly (GO:0030240),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TCAP
glycine metabolic process (GO:0006544),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC25A32
pyroptosis (GO:0070269),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GSDMC
response to laminar fluid shear stress (GO:0034616),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NFE2L2
regulation of actin filament-based movement (GO:1903115),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ANK2
positive regulation of glucose import in response to insulin stimulus (GO:2001275),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RARRES2
negative regulation of inclusion body assembly (GO:0090084),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SACS
regulation of protein exit from endoplasmic reticulum (GO:0070861),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,INSIG1
"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,POP7
"regulation of DNA-templated transcription, initiation (GO:2000142)",1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,BCLAF1
astrocyte development (GO:0014002),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MT3
tryptophan metabolic process (GO:0006568),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TDO2
DNA dealkylation involved in DNA repair (GO:0006307),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ASCC1
T cell chemotaxis (GO:0010818),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CXCL9
positive regulation of natural killer cell activation (GO:0032816),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IL12B
positive regulation of T cell apoptotic process (GO:0070234),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PDCD1
negative regulation of B cell proliferation (GO:0030889),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TNFRSF13B
negative regulation of reproductive process (GO:2000242),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TIMP1
regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IL12B
protein localization to synapse (GO:0035418),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NRXN2
positive regulation of reproductive process (GO:2000243),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,APELA
nuclear mRNA surveillance (GO:0071028),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EXOSC9
myeloid dendritic cell differentiation (GO:0043011),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,BATF
DNA dealkylation (GO:0035510),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ASCC1
detection of bacterium (GO:0016045),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PGLYRP1
ectoderm development (GO:0007398),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ITGAM
regulation of DNA damage checkpoint (GO:2000001),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DDX39B
negative regulation of protein maturation (GO:1903318),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SERPINE2
positive regulation of smooth muscle cell migration (GO:0014911),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PDGFRB
intraciliary retrograde transport (GO:0035721),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IFT43
negative regulation of stem cell differentiation (GO:2000737),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NOTCH1
negative regulation by host of viral process (GO:0044793),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PTX3
neuron projection fasciculation (GO:0106030),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ARHGAP35
actin filament-based transport (GO:0099515),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,WASL
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CITED2
ganglioside biosynthetic process (GO:0001574),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ST8SIA4
negative regulation of sodium ion transmembrane transporter activity (GO:2000650),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PCSK9
negative regulation of embryonic development (GO:0045992),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SFRP2
UV protection (GO:0009650),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SDF4
regulation of immunoglobulin production (GO:0002637),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TLR9
very-low-density lipoprotein particle assembly (GO:0034379),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ACSL3
negative regulation of homotypic cell-cell adhesion (GO:0034111),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SERPINE2
"complement activation, lectin pathway (GO:0001867)",1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,COLEC10
endothelial tube morphogenesis (GO:0061154),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCM2
response to histamine (GO:0034776),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GABRB2
medium-chain fatty acid metabolic process (GO:0051791),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ABHD2
sequestering of actin monomers (GO:0042989),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TMSB4Y
tryptophan catabolic process (GO:0006569),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TDO2
regulation of plasminogen activation (GO:0010755),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SERPINE2
forelimb morphogenesis (GO:0035136),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ZNF358
ketone body metabolic process (GO:1902224),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,BDH1
protein prenylation (GO:0018342),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CHM
Golgi organization (GO:0007030),7/121,0.40189970418865884,1,0,0,1.1570247933884297,1.054689090068788,ARHGAP21;RAB30;LMAN2L;GOLGA6D;GORASP2;VTI1A;SYNE1
regulation of cell differentiation (GO:0045595),7/121,0.40189970418865884,1,0,0,1.1570247933884297,1.054689090068788,MEGF10;RPS6KA1;HEY2;CD24;RUNX3;BIRC2;TCFL5
interleukin-12-mediated signaling pathway (GO:0035722),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,SERPINB2;PDCD4;IL12B
positive regulation of protein localization to cell periphery (GO:1904377),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,DLG1;RHOG;GNAI1
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,TNFAIP3;SPOPL;VPS28
cartilage development (GO:0051216),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,GHRL;PKD1;RUNX3
cellular response to interleukin-12 (GO:0071349),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,SERPINB2;PDCD4;IL12B
positive regulation of ion transport (GO:0043270),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,CCR1;DLG1;ANK2
positive regulation of protein phosphorylation (GO:0001934),22/412,0.4063351744176455,1,0,0,1.0679611650485437,0.9617811630385504,EPHB6;OPRD1;PDGFRB;NTRK2;CD74;CCNH;MMD;EGF;RARRES2;BRAF;MT3;BMP7;LATS1;SFRP2;CCND2;ERBB3;P2RY1;TLR9;DVL3;MAPRE3;CCNL1;RAPGEF3
protein localization to membrane (GO:0072657),9/160,0.4073910770526227,1,0,0,1.125,1.0102293873083648,DLG1;PACS1;BSG;P2RY1;NRXN2;ANK2;BRAF;ITGB1BP1;SYNE3
DNA synthesis involved in DNA repair (GO:0000731),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,TOP3A;UBC;REV1;PALB2
negative regulation of cell adhesion (GO:0007162),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,NOTCH1;ERBB3;GCNT2;ITGB1BP1
regulation of cell cycle G2/M phase transition (GO:1902749),5/84,0.41120390033692134,1,0,0,1.1904761904761902,1.0579358090845326,CDK3;CNTRL;DYNLL1;TUBG1;HAUS1
cellular response to hydrogen peroxide (GO:0070301),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,TNFAIP3;NFE2L2
RNA phosphodiester bond hydrolysis (GO:0090501),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,POP7;PDE12
regulation of mRNA processing (GO:0050684),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,PABPN1;SRPK1
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway (GO:0051482),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,GPR17;HTR2C
organelle fission (GO:0048285),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,MX1;TUBG1
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,WWTR1;BMP7
negative regulation of JNK cascade (GO:0046329),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,DUSP10;PDCD4
cGMP metabolic process (GO:0046068),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,NPPA;HTR2C
protein export from nucleus (GO:0006611),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,ANKLE1;PKD1
primary neural tube formation (GO:0014020),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,COBL;CELSR1
bicellular tight junction assembly (GO:0070830),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,PATJ;DLG1
regulation of cell migration (GO:0030334),17/316,0.41345862616848394,1,0,0,1.0759493670886076,0.9502761431448388,CCR1;PDGFRB;SPAG9;MACF1;IFITM1;NOTCH1;SERPINE2;CITED2;EGF;NOG;MINK1;SEMA3G;TMEFF2;SFRP2;DUSP10;TRIP6;GCNT2
"transcription, DNA-templated (GO:0006351)",19/356,0.4183155465582686,1,0,0,1.0674157303370786,0.9302733409178734,CCNH;GATA6;NRL;YBX2;FOXO4;TTF1;RUNX3;ILF2;GFI1B;PTTG1;TRIP11;ELOB;SMN1;NFRKB;POLR3K;TAF3;GTF2I;NFE2L2;TCFL5
cellular calcium ion homeostasis (GO:0006874),7/123,0.4184152232009605,1,0,0,1.1382113821138211,0.9917019313802579,CCR1;SLC24A2;HTR2C;ATP13A5;ANK2;TNNI3;PDE6B
response to glucose (GO:0009749),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,UNC13B;TCF7L2;GCK
regulation of intrinsic apoptotic signaling pathway (GO:2001242),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,BCLAF1;BAD;NDUFS3
negative regulation of cellular biosynthetic process (GO:0031327),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,TRIB3;SOGA1;GCK
regulation of type I interferon production (GO:0032479),5/85,0.42118396120911705,1,0,0,1.176470588235294,1.0172771508801166,NLRX1;TREX1;UBC;TNFAIP3;POLR3K
post-translational protein modification (GO:0043687),19/357,0.4231553198369333,1,0,0,1.0644257703081232,0.9154231730069721,PSMD11;PSMD14;CUL1;CHM;PCSK9;KLHL11;KLHL13;LTBP1;SUMF1;KLHL42;PSMA4;KBTBD6;PSMA2;ELOB;TIMP1;CCDC22;FBXO7;CHGB;SPSB4
anterograde trans-synaptic signaling (GO:0098916),13/240,0.4239711734951957,1,0,0,1.0833333333333333,0.9295972975261219,UNC13B;OPRD1;GABRB2;KCNIP2;CPNE6;MINK1;SLC1A1;HTR2C;NRXN2;GABRG1;DLG1;PNOC;GABRE
Fc-epsilon receptor signaling pathway (GO:0038095),10/182,0.42610696760779215,1,0,0,1.0989010989010988,0.9374339192985021,MAPK9;MAPK8;PSMD11;PSMA4;PSMD14;PSMA2;UBC;CUL1;PRKCQ;IKBKG
platelet degranulation (GO:0002576),7/124,0.42665940706055616,1,0,0,1.129032258064516,0.9616749321100159,ITIH3;EGF;RARRES2;PECAM1;VEGFC;TIMP1;MANF
negative regulation of macromolecule metabolic process (GO:0010605),7/124,0.42665940706055616,1,0,0,1.129032258064516,0.9616749321100159,CCR1;OPRD1;SFRP2;NOTCH1;CITED2;HEY2;PCSK9
mitotic cell cycle phase transition (GO:0044772),12/221,0.4268281136170111,1,0,0,1.085972850678733,0.9245689314229618,LATS1;CDT1;CCNH;PPME1;PLK2;CDK3;CNTRL;UBC;CUL1;TUBG1;DYNLL1;HAUS1
regulation of protein kinase B signaling (GO:0051896),9/163,0.4289504847985568,1,0,0,1.1042944785276072,0.9346900712747971,PDGFRB;TCF7L2;ERBB3;EGF;GCNT2;FRS2;TRIB3;ITGB1BP1;NOP53
G1/S transition of mitotic cell cycle (GO:0000082),6/105,0.4290058391536542,1,0,0,1.1428571428571428,0.9671825703611097,LATS1;CDT1;CCNH;PLK2;CDK3;CUL1
mRNA export from nucleus (GO:0006406),6/105,0.4290058391536542,1,0,0,1.1428571428571428,0.9671825703611097,NXT1;DDX39B;RBM8A;PABPN1;SRSF4;SRSF11
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,CCNH;UBC
regulation of macrophage derived foam cell differentiation (GO:0010743),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,MAPK9;PLA2G2A
tube closure (GO:0060606),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,COBL;CELSR1
determination of bilateral symmetry (GO:0009855),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,NOTCH1;CITED2
cardiac muscle cell action potential (GO:0086001),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,KCNIP2;ANK2
vacuolar transport (GO:0007034),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,VTI1A;PCSK9
amino acid transmembrane transport (GO:0003333),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,SLC36A1;SLC38A6
transmembrane transport (GO:0055085),20/378,0.42988545839892717,1,0,0,1.0582010582010581,0.8933719381961023,SLC24A2;GABRB2;PSMD11;PSMD14;ABCA3;CLCNKA;ABCC11;GABRG1;CALHM6;SLC22A24;SLC22A25;PSMA4;PSMA2;UCP2;SCNN1A;UBC;LRRC8D;ATP13A5;GABRE;ABCG2
calcium ion transmembrane transport (GO:0070588),5/86,0.4311336138274714,1,0,0,1.1627906976744184,0.9782991023729873,SLC24A2;PMPCA;TRPM7;PKD1;TRPM3
isotype switching (GO:0045190),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BATF
positive regulation of endothelial cell apoptotic process (GO:2000353),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PDCD4
atrial septum morphogenesis (GO:0060413),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HEY2
negative regulation of leukocyte activation (GO:0002695),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BPI
regulation of tumor necrosis factor biosynthetic process (GO:0042534),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GHRL
intracellular protein transmembrane transport (GO:0065002),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SRP9
regulation of inclusion body assembly (GO:0090083),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SACS
regulation of leukocyte cell-cell adhesion (GO:1903037),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,IFNL3
positive regulation of superoxide anion generation (GO:0032930),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ITGAM
negative regulation of nuclear division (GO:0051784),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BMP7
immune response-regulating cell surface receptor signaling pathway (GO:0002768),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CD24
regulation of hydrogen peroxide-induced cell death (GO:1903205),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NFE2L2
protein localization to pre-autophagosomal structure (GO:0034497),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,WIPI2
negative regulation of bone mineralization (GO:0030502),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CCR1
positive regulation of leukocyte degranulation (GO:0043302),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ITGAM
mesonephros development (GO:0001823),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BMP7
carnitine shuttle (GO:0006853),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ACACB
pyrimidine nucleoside catabolic process (GO:0046135),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NT5C
Golgi ribbon formation (GO:0090161),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,VTI1A
negative regulation of fatty acid biosynthetic process (GO:0045717),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TRIB3
proteasome assembly (GO:0043248),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PSMD11
positive regulation of cytolysis (GO:0045919),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PGLYRP1
cellular response to sterol (GO:0036315),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,INSIG1
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ARL6IP5
cell-substrate junction assembly (GO:0007044),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,LAMA3
modulation by host of viral process (GO:0044788),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PTX3
low-density lipoprotein particle remodeling (GO:0034374),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PLA2G2A
biotin metabolic process (GO:0006768),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ACACB
regulation of ventricular cardiac muscle cell action potential (GO:0098911),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,DLG1
somite development (GO:0061053),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SFRP2
purine nucleobase metabolic process (GO:0006144),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PRTFDC1
"synaptic transmission, dopaminergic (GO:0001963)",1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CRHBP
positive regulation of myoblast fusion (GO:1901741),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,EHD1
calcium ion regulated exocytosis (GO:0017156),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SDF4
rRNA base methylation (GO:0070475),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TRMT112
organic cyclic compound catabolic process (GO:1901361),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ACAA1
negative regulation of peptide secretion (GO:0002792),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CD74
negative regulation of myotube differentiation (GO:0010832),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NOTCH1
renal filtration (GO:0097205),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MCAM
positive regulation of actin filament depolymerization (GO:0030836),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,WASHC2C
regulation of short-term neuronal synaptic plasticity (GO:0048172),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SYP
transcytosis (GO:0045056),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RAB17
regulation of chromatin binding (GO:0035561),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CDT1
negative regulation of cell division (GO:0051782),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,E2F8
cochlea morphogenesis (GO:0090103),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,POU3F4
rhodopsin mediated signaling pathway (GO:0016056),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PDE6B
cytoplasmic mRNA processing body assembly (GO:0033962),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PATL1
fatty acid transmembrane transport (GO:1902001),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ACACB
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CD74
photoreceptor cell development (GO:0042461),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NRL
heart process (GO:0003015),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TNNI3
negative regulation of chemotaxis (GO:0050922),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NOTCH1
inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BIRC2
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GLRX
hemidesmosome assembly (GO:0031581),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,LAMA3
carbohydrate derivative catabolic process (GO:1901136),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,DERA
presynaptic membrane organization (GO:0097090),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CEL
protein carboxylation (GO:0018214),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,F9
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,APELA
peptidyl-glutamic acid carboxylation (GO:0017187),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,F9
urate metabolic process (GO:0046415),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ABCG2
cardiac muscle cell membrane repolarization (GO:0099622),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,KCNIP2
membrane repolarization during action potential (GO:0086011),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,KCNIP2
spinal cord development (GO:0021510),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PKD1
"mRNA splicing, via spliceosome (GO:0000398)",14/261,0.43256781589264026,1,0,0,1.0727969348659003,0.8990211733412427,CPSF7;RBM8A;PLRG1;SRPK1;PRPF6;DDX39B;PABPN1;SRSF4;SNRPD3;GEMIN7;SMN1;SMNDC1;SRSF11;SNRPB
positive regulation of synaptic transmission (GO:0050806),4/67,0.4327475179328833,1,0,0,1.1940298507462686,1.0001203826990046,UNC13B;SLC24A2;TSHZ3;PLK2
positive regulation of autophagy (GO:0010508),4/67,0.4327475179328833,1,0,0,1.1940298507462686,1.0001203826990046,BAD;PLK2;IKBKG;FBXO7
Fc receptor signaling pathway (GO:0038093),10/183,0.43289109433144524,1,0,0,1.0928961748633879,0.9150481932904313,MAPK9;MAPK8;PSMD11;PSMA4;PSMD14;PSMA2;UBC;CUL1;PRKCQ;IKBKG
cytoplasmic microtubule organization (GO:0031122),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,ATAD1;DLG1;SLAIN2
glycoprotein metabolic process (GO:0009100),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,ST8SIA4;MAN1B1;GAL3ST4
interstrand cross-link repair (GO:0036297),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,UBC;FANCA;FAN1
pattern recognition receptor signaling pathway (GO:0002221),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,TLR9;CD14;TLR2
positive regulation of chemotaxis (GO:0050921),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,PDGFRB;CXCL9;RARRES2
amino acid transport (GO:0006865),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,SLC36A1;SLC6A15;SLC38A6
cellular response to mechanical stimulus (GO:0071260),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,MAPK8;BAD;ANKRD1
protein dephosphorylation (GO:0006470),7/125,0.4348899664469206,1,0,0,1.1199999999999999,0.9325816982581239,DUSP2;DUSP10;PTPRM;RPRD1A;PTPRH;DUSP26;DUSP7
negative regulation of multicellular organismal process (GO:0051241),7/125,0.4348899664469206,1,0,0,1.1199999999999999,0.9325816982581239,CRHBP;SFRP2;NOTCH1;DUSP10;TNNT1;TIMP1;DKK1
regulation of autophagy (GO:0010506),11/203,0.4362426845468669,1,0,0,1.083743842364532,0.8990268295649474,MAPK8;CAPNS1;EXOC8;BAD;PLK2;PIP4K2A;RAB39B;PIP4K2B;SOGA1;MT3;EIF4G2
fatty acid metabolic process (GO:0006631),6/106,0.43796290568349927,1,0,0,1.1320754716981132,0.9346653536744506,ACSM3;HPGD;CEL;ALKBH7;ACAA1;CYP4F11
peptidyl-serine phosphorylation (GO:0018105),8/145,0.4395232982954594,1,0,0,1.103448275862069,0.9071057129387737,LATS1;CAMK2B;MAPK9;MAPK8;MAST3;PLK2;PRKCQ;PKD1
ubiquitin-dependent protein catabolic process (GO:0006511),18/341,0.4408910980692834,1,0,0,1.0557184750733137,0.8645884333910757,PSMD11;PSMD14;CUL1;KLHL11;TNFAIP3;TNFAIP1;KLHL42;PSMA4;UBE2R2;PSMA2;UBC;SPOPL;RBCK1;FBXO7;VPS28;BIRC2;SPSB4;NFE2L2
positive regulation of cellular component biogenesis (GO:0044089),5/87,0.44104723204673524,1,0,0,1.1494252873563218,0.9409233415212925,CDT1;SYNPO2L;STX18;GHRL;BMP7
regulation of epithelial to mesenchymal transition (GO:0010717),4/68,0.44400267624141365,1,0,0,1.176470588235294,0.9552055164674429,WWTR1;SFRP2;NOTCH1;GCNT2
monocarboxylic acid biosynthetic process (GO:0072330),4/68,0.44400267624141365,1,0,0,1.176470588235294,0.9552055164674429,ACSM3;OSBPL3;CSPG5;CYP8B1
response to interferon-gamma (GO:0034341),4/68,0.44400267624141365,1,0,0,1.176470588235294,0.9552055164674429,IFITM1;PDE12;CCL18;CCL16
regulation of endopeptidase activity (GO:0052548),4/68,0.44400267624141365,1,0,0,1.176470588235294,0.9552055164674429,SERPINB2;SERPINE2;TIMP1;BIRC2
regulation of actin filament polymerization (GO:0030833),4/68,0.44400267624141365,1,0,0,1.176470588235294,0.9552055164674429,LATS1;CDC42EP5;RHOG;ARHGAP28
negative regulation of signal transduction (GO:0009968),15/283,0.4459213536724002,1,0,0,1.0600706713780919,0.8561265154438287,EPHB6;PDGFRB;NTRK2;YTHDF2;EGF;TNFAIP3;BRAF;RPGRIP1L;DKK1;CRHBP;SFRP2;ERBB3;UBC;TLR9;PRKCQ
protein heterooligomerization (GO:0051291),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,CD74;CPSF7;KCNC2
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,DEFB118;PGLYRP1;RPL39
regulation of megakaryocyte differentiation (GO:0045652),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,KMT2B;DPY30;PRKCQ
positive regulation of response to DNA damage stimulus (GO:2001022),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,BCLAF1;ANKLE1;ANKRD1
gonad development (GO:0008406),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,KLHL26;NCOA4;GATA6
ribosomal large subunit assembly (GO:0000027),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,NOP53;MDN1
negative regulation of stress-activated MAPK cascade (GO:0032873),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,DLG1;DUSP10
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,NOTCH1;ITGB1BP1
regulation of defense response to virus by host (GO:0050691),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,TNFAIP3;IL12B
negative regulation of endothelial cell proliferation (GO:0001937),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,PTPRM;GHRL
hippo signaling (GO:0035329),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,LATS1;WWTR1
connective tissue development (GO:0061448),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,GHRL;PKD1
cellular response to cAMP (GO:0071320),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,CRHBP;RAPGEF3
cellular response to drug (GO:0035690),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,CRHBP;MT3
activation of protein kinase B activity (GO:0032148),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,ITGB1BP1;MT3
activation of JUN kinase activity (GO:0007257),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,SPAG9;MAPK8IP3
regulation of cell adhesion mediated by integrin (GO:0033628),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,SFRP2;ITGB1BP1
regulation of cation transmembrane transport (GO:1904062),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,DLG1;KCNIP2
ATP-dependent chromatin remodeling (GO:0043044),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,CECR2;ANP32E
positive regulation of B cell proliferation (GO:0030890),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,CD74;TLR9
regulation of protein secretion (GO:0050708),6/107,0.44689369780524896,1,0,0,1.1214953271028036,0.903291056261686,UNC13B;KCNC2;ANKRD1;RFX3;RAPGEF3;GCK
divalent metal ion transport (GO:0070838),5/88,0.4509193850280069,1,0,0,1.1363636363636362,0.9050757984351353,PANX1;CCR1;SLC39A8;CCR5;MT3
positive regulation of protein kinase B signaling (GO:0051897),7/127,0.45129692526290477,1,0,0,1.1023622047244093,0.8770722042008007,PDGFRB;TCF7L2;ERBB3;EGF;GCNT2;FRS2;ITGB1BP1
negative regulation of response to stimulus (GO:0048585),7/127,0.45129692526290477,1,0,0,1.1023622047244093,0.8770722042008007,EPHB6;PDGFRB;NLRP14;NTRK2;NLRX1;ERBB3;BRAF
regulation of osteoblast differentiation (GO:0045667),4/69,0.45518892642326336,1,0,0,1.1594202898550725,0.9125133023815558,IFITM1;NOTCH1;NOG;BMP7
wound healing (GO:0042060),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,MACF1;ERBB3;NOG
negative regulation of protein ubiquitination (GO:0031397),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,TNFAIP3;SPOPL;VPS28
rRNA 3'-end processing (GO:0031125),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EXOSC9
cardiac right ventricle morphogenesis (GO:0003215),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HEY2
regulation of vasculogenesis (GO:2001212),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HEY2
regulation of myoblast fusion (GO:1901739),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EHD1
axonal fasciculation (GO:0007413),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ARHGAP35
signal transduction involved in G2 DNA damage checkpoint (GO:0072425),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,FZR1
histone H3-K9 demethylation (GO:0033169),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,KDM7A
negative regulation of chondrocyte differentiation (GO:0032331),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CHADL
regulation of oligodendrocyte differentiation (GO:0048713),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NOTCH1
negative regulation of protein oligomerization (GO:0032460),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,OPRD1
regulation of DNA-dependent DNA replication (GO:0090329),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CDT1
ribose phosphate metabolic process (GO:0019693),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DERA
protein localization to kinetochore (GO:0034501),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CHAMP1
regulation of protein glycosylation (GO:0060049),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MT3
skeletal myofibril assembly (GO:0014866),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,TCAP
positive regulation of establishment of protein localization (GO:1904951),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PTP4A3
pentose-phosphate shunt (GO:0006098),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DERA
vesicle budding from membrane (GO:0006900),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,WASL
mitochondrial outer membrane permeabilization (GO:0097345),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BAD
carbohydrate derivative transport (GO:1901264),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SLC17A5
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CD74
regulation of cytokine biosynthetic process (GO:0042035),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,IL12B
cell differentiation in hindbrain (GO:0021533),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NOG
entry of bacterium into host cell (GO:0035635),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UBC
Golgi localization (GO:0051645),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ARHGAP21
regulation of cholesterol storage (GO:0010885),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EHD1
epithelial structure maintenance (GO:0010669),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,TLR9
serine family amino acid biosynthetic process (GO:0009070),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SERINC3
positive regulation of T-helper 1 type immune response (GO:0002827),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,IL12B
regulation of rRNA processing (GO:2000232),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,TRMT112
mitochondrion transport along microtubule (GO:0047497),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NEFL
lysine catabolic process (GO:0006554),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,AASS
pre-mRNA cleavage required for polyadenylation (GO:0098789),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CPSF7
cell wall macromolecule catabolic process (GO:0016998),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SPACA7
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ITGB1BP1
DNA ligation involved in DNA repair (GO:0051103),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,LIG1
positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NOG
somatic hypermutation of immunoglobulin genes (GO:0016446),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,POLL
eye photoreceptor cell development (GO:0042462),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NRL
spliceosomal tri-snRNP complex assembly (GO:0000244),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PRPF6
tRNA 5'-leader removal (GO:0001682),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,POP7
positive regulation of pseudopodium assembly (GO:0031274),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CDC42EP5
cellular response to fluid shear stress (GO:0071498),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NFE2L2
cytoplasmic translational initiation (GO:0002183),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EIF4H
regulation of skeletal muscle tissue development (GO:0048641),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MEGF10
lysine metabolic process (GO:0006553),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,AASS
activation of cysteine-type endopeptidase activity (GO:0097202),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BAD
kinetochore organization (GO:0051383),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CDT1
regulation of mononuclear cell migration (GO:0071675),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,RARRES2
regulation of pseudopodium assembly (GO:0031272),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CDC42EP5
negative regulation of vascular smooth muscle cell proliferation (GO:1904706),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PDCD4
ribosomal subunit export from nucleus (GO:0000054),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NOP53
cardiac muscle fiber development (GO:0048739),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,TCAP
negative regulation of ATP metabolic process (GO:1903579),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PDE12
regulation of blood vessel size (GO:0050880),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ITGB1BP1
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CD74
PERK-mediated unfolded protein response (GO:0036499),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NFE2L2
positive regulation of cyclase activity (GO:0031281),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MAPK8
prostanoid metabolic process (GO:0006692),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HPGD
dermatan sulfate biosynthetic process (GO:0030208),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CSPG5
negative regulation of myoblast differentiation (GO:0045662),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NOTCH1
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MT3
negative regulation of fatty acid metabolic process (GO:0045922),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,TRIB3
regulation of catabolic process (GO:0009894),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,RARRES2
eye photoreceptor cell differentiation (GO:0001754),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PROM1
positive regulation of cell proliferation (GO:0008284),22/424,0.46022063335192964,1,0,0,1.0377358490566038,0.8053341447580155,PDGFRB;NTRK2;WWTR1;CD74;NOTCH1;EGF;BAD;DOT1L;RHOG;DERL2;VEGFC;LIFR;POU3F2;DISP3;SFRP2;CCND2;CAPNS1;EPCAM;CDK3;GCNT2;ITGB1BP1;TIMP1
positive regulation of ubiquitin-protein transferase activity (GO:0051443),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,FZR1;TRIB3
negative regulation of blood vessel endothelial cell migration (GO:0043537),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,NOTCH1;ITGB1BP1
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,TNFAIP3;BPI
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,CXCL9;JPH2
organelle transport along microtubule (GO:0072384),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,ARHGAP21;NDEL1
regulation of protein export from nucleus (GO:0046825),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,TCF7L2;RAPGEF3
nucleobase-containing small molecule interconversion (GO:0015949),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,DUT;GLRX
termination of RNA polymerase I transcription (GO:0006363),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,CCNH;TTF1
proton transport (GO:0015992),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,SLC36A1;UCP2
vesicle-mediated transport to the plasma membrane (GO:0098876),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,WASHC2C;CCDC22
"positive regulation of transcription, DNA-templated (GO:0045893)",57/1120,0.4644325066138018,1,0,0,1.0178571428571428,0.7806343744964467,ATF2;NCF1;CCNH;CITED2;CITED4;NRL;LITAF;CD3D;PKD1;YY2;MCIDAS;HEY2;RPS6KA1;IKBKG;CCNL1;ARHGEF11;NCOA4;RHOG;RFX3;ILF2;RUNX3;CREB3;TOX2;SFRP2;NR5A2;PRPF6;DDX39B;TLR9;MAPRE3;ITGB1BP1;TLR2;ZNF350;NOTCH1;PLAG1;KMT2B;DOT1L;GATA6;FOXO4;NPAS3;BCLAF1;EPCAM;UBC;DVL3;AAMDC;E2F8;WWTR1;CD74;ARNT2;TCF7L2;POU2F1;EGF;CDX1;SS18L1;BMP7;MT3;TAF3;NFE2L2
regulation of cell motility (GO:2000145),6/109,0.4646603211324838,1,0,0,1.1009174311926606,0.8437966596577015,MACF1;SERPINE2;ERBB3;EGF;MINK1;TEX101
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,USP5;TRIB3;NOP53;NFE2L2
calcium-mediated signaling (GO:0019722),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,ANK2;TNNI3;CCR5;NUDT4
positive regulation of phosphorylation (GO:0042327),11/208,0.4683681021557312,1,0,0,1.0576923076923077,0.8022604077649453,EPHB6;PDGFRB;CD74;NTRK2;CCND2;ERBB3;EGF;RARRES2;P2RY1;DVL3;MT3
cell-matrix adhesion (GO:0007160),5/90,0.4705185605943169,1,0,0,1.111111111111111,0.8376887467502594,DEFB118;TRIP6;ZYX;ITGB1BP1;PKD1
protein tetramerization (GO:0051262),5/90,0.4705185605943169,1,0,0,1.111111111111111,0.8376887467502594,CD74;CPSF7;TDO2;ACACB;AASS
regulation of Ras protein signal transduction (GO:0046578),5/90,0.4705185605943169,1,0,0,1.111111111111111,0.8376887467502594,RASA4B;NOTCH1;RASGRF1;MADD;AGAP2
protein ubiquitination (GO:0016567),26/506,0.47177903125247966,1,0,0,1.0276679841897234,0.7720299796706346,PSMD11;PSMD14;CUL1;KLHL11;KLHL13;TNFAIP1;UBC;ELOB;FBXO7;UBL4A;USP5;KLHL26;RNF208;PEX10;KLHL4;KLHL42;PSMA4;KBTBD6;UBE2R2;PSMA2;SPOPL;RBCK1;CCDC22;BIRC2;SPSB4;NFE2L2
coenzyme metabolic process (GO:0006732),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,ACSM3;VNN2;FPGS
positive regulation of developmental growth (GO:0048639),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,MACF1;CPNE6;GHRL
DNA repair (GO:0006281),15/288,0.4732239343434198,1,0,0,1.0416666666666667,0.7793610087447198,LIG1;ASCC1;TREX1;TOP3A;DOT1L;FANCA;APTX;PALB2;TDP2;UBC;POLL;RAD9B;TNP1;NOP53;FAN1
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),6/110,0.4734883847029237,1,0,0,1.0909090909090908,0.8155940698683591,MAPK8;BAD;NMT1;DYNLL1;IFNL3;BBC3
cellular response to insulin stimulus (GO:0032869),6/110,0.4734883847029237,1,0,0,1.0909090909090908,0.8155940698683591,PKLR;PCSK9;TRIB3;FOXO4;SOGA1;GCK
protein localization to plasma membrane (GO:0072659),7/130,0.47572414988888423,1,0,0,1.0769230769230769,0.8000645797585316,MACF1;DLG1;SYS1;PACS1;BSG;P2RY1;ANK2
regulation of cell communication (GO:0010646),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,GRID1;ANK2;CEL;BIRC2
recombinational repair (GO:0000725),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,PSMD14;POLL;PALB2;FAN1
response to insulin (GO:0032868),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,PKLR;PCSK9;TRIB3;GCK
negative regulation of cell differentiation (GO:0045596),8/150,0.4774859646340916,1,0,0,1.0666666666666667,0.7885018804584587,ANKRD26;SFRP2;NOTCH1;CCDC85B;CHADL;NOG;PDCD4;TRIB3
chemical synaptic transmission (GO:0007268),15/289,0.4786650407120942,1,0,0,1.0380622837370241,0.7647967628604242,UNC13B;OPRD1;GABRB2;GRID1;KCNIP2;CPNE6;MINK1;SLC1A1;HTR2C;NRXN2;GABRG1;CRHBP;DLG1;PNOC;GABRE
dendrite morphogenesis (GO:0048813),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,MINK1;WASL
response to zinc ion (GO:0010043),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,MT1M;MT3
regulation of glutamate receptor signaling pathway (GO:1900449),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CRHBP;MINK1
phosphatidylcholine biosynthetic process (GO:0006656),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CHAT;LCAT
cellular response to glucagon stimulus (GO:0071377),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,GNG11;GNG13
central nervous system neuron differentiation (GO:0021953),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,NTRK2;ZC4H2
negative regulation of BMP signaling pathway (GO:0030514),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,NOTCH1;NOG
cyclic-nucleotide-mediated signaling (GO:0019935),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,RAPGEF3;NUDT4
regulation of potassium ion transmembrane transport (GO:1901379),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,DLG1;KCNIP2
negative regulation of receptor activity (GO:2000272),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CRHBP;PCSK9
GPI anchor biosynthetic process (GO:0006506),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,PGAP3;PIGP
regulation of cell-cell adhesion (GO:0022407),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CITED2;MINK1
mismatch repair (GO:0006298),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,LIG1;TREX1
regulation of protein catabolic process (GO:0042176),5/91,0.48023571472567267,1,0,0,1.0989010989010988,0.8060200255732013,FZR1;PLK2;AGAP2;TNFAIP3;VPS28
regulation of protein binding (GO:0043393),6/111,0.48227464232748546,1,0,0,1.0810810810810811,0.7883692214534975,TCF7L2;MAPK8;TRIB3;ITGB1BP1;DKK1;PKD1
plasma membrane bounded cell projection morphogenesis (GO:0120039),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,MINK1;RHOG;BMP7
DNA strand elongation (GO:0022616),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GINS3
dermatan sulfate metabolic process (GO:0030205),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CSPG5
regulation of interleukin-1 beta production (GO:0032651),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GHRL
signal transduction involved in DNA damage checkpoint (GO:0072422),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,FZR1
regulation of granulocyte chemotaxis (GO:0071622),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RARRES2
negative regulation of hemostasis (GO:1900047),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SERPINE2
mitochondrial genome maintenance (GO:0000002),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SLC25A36
regulation of lymphocyte activation (GO:0051249),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IFNL3
positive regulation of cardiac muscle cell proliferation (GO:0060045),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NOTCH1
atrial cardiac muscle cell action potential (GO:0086014),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ANK2
intestinal absorption (GO:0050892),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NPC1L1
regulation of superoxide anion generation (GO:0032928),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ITGAM
regulation of NMDA receptor activity (GO:2000310),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CRHBP
"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SRSF4
regulation of glucose import in response to insulin stimulus (GO:2001273),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RARRES2
maintenance of gastrointestinal epithelium (GO:0030277),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TLR9
striated muscle myosin thick filament assembly (GO:0071688),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TCAP
mRNA cleavage involved in mRNA processing (GO:0098787),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CPSF7
positive regulation of glycogen biosynthetic process (GO:0045725),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GCK
regulation of macromolecule biosynthetic process (GO:0010556),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL12B
positive regulation of T cell mediated cytotoxicity (GO:0001916),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL12B
regulation of triglyceride biosynthetic process (GO:0010866),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CNEP1R1
placenta development (GO:0001890),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,E2F8
positive regulation of actin nucleation (GO:0051127),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,WASL
alpha-linolenic acid metabolic process (GO:0036109),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ACAA1
regulation of cAMP metabolic process (GO:0030814),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CXCL9
cardiocyte differentiation (GO:0035051),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GATA6
poly(A)+ mRNA export from nucleus (GO:0016973),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PABPN1
response to UV-B (GO:0010224),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL12B
B cell activation involved in immune response (GO:0002312),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,BATF
toll-like receptor 9 signaling pathway (GO:0034162),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TLR9
neuron fate commitment (GO:0048663),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,POU3F2
establishment of chromosome localization (GO:0051303),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NDEL1
membrane repolarization (GO:0086009),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,KCNIP2
regulation of endothelial cell chemotaxis (GO:2001026),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NOTCH1
motile cilium assembly (GO:0044458),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MCIDAS
prostanoid biosynthetic process (GO:0046457),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CD74
cranial nerve development (GO:0021545),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ERBB3
positive regulation of ERAD pathway (GO:1904294),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NFE2L2
triglyceride-rich lipoprotein particle remodeling (GO:0034370),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,LCAT
secretion (GO:0046903),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GUCA1B
mammary gland epithelium development (GO:0061180),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,LATS1
nucleotide metabolic process (GO:0009117),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NUDT4
chondroitin sulfate catabolic process (GO:0030207),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CSPG5
positive regulation of alpha-beta T cell proliferation (GO:0046641),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL12B
regulation of cytolysis (GO:0042268),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,BAD
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,HEY2
negative regulation of cartilage development (GO:0061037),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CHADL
negative regulation of interleukin-10 production (GO:0032693),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL12B
detection of calcium ion (GO:0005513),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,KCNIP2
"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ZBTB8OS
Rho protein signal transduction (GO:0007266),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,ARHGEF11;CNKSR1;CDC42EP5;RHOG
regulation of epithelial cell proliferation (GO:0050678),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,DUSP10;SFRP2;BAD;RUNX3
cilium organization (GO:0044782),10/192,0.49347483222081845,1,0,0,1.0416666666666667,0.7357118957796307,CFAP61;EHD1;NOTCH1;IFT43;MCIDAS;TSGA10IP;IFT172;RFX3;RAB17;DYNLL1
inflammatory response (GO:0006954),13/252,0.4944560974084455,1,0,0,1.0317460317460316,0.7266555458225812,CXCL9;NLRX1;GPR68;CYP4F11;NLRP14;CRHBP;PRDX5;NOX4;PTX3;IKBKG;CCL18;NFRKB;CCL16
glycogen metabolic process (GO:0005977),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,STBD1;UBC
"chemical synaptic transmission, postsynaptic (GO:0099565)",2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,GABRE;GABRG1
oligosaccharide biosynthetic process (GO:0009312),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,GALNT7;GALNT15
entry into host cell (GO:0030260),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,UBC;CCR5
regulation of autophagosome assembly (GO:2000785),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,PIP4K2A;PIP4K2B
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,BCLAF1;BAD
regulation of postsynaptic membrane potential (GO:0060078),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,GABRE;GABRG1
positive regulation of catalytic activity (GO:0043085),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,MAPK8;MT3
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,EXOSC9;PATL1
carboxylic acid metabolic process (GO:0019752),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,SLC23A1;FPGS
transcription from RNA polymerase I promoter (GO:0006360),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,CCNH;TTF1
positive regulation of nucleocytoplasmic transport (GO:0046824),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,TCF7L2;RAPGEF3
positive regulation of Notch signaling pathway (GO:0045747),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,NOTCH1;ITGB1BP1
positive regulation of locomotion (GO:0040017),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,PDGFRB;RARRES2
cellular glucose homeostasis (GO:0001678),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,UNC13B;GCK
regulation of neurotransmitter receptor activity (GO:0099601),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,CRHBP;MINK1
canonical Wnt signaling pathway (GO:0060070),4/73,0.49910951364629225,1,0,0,1.095890410958904,0.7615668395449564,TCF7L2;SFRP2;EGF;DVL3
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),5/93,0.4994819883860412,1,0,0,1.075268817204301,0.7464341299256831,BAD;RPS6KA1;ARL6IP5;MT3;BBC3
positive regulation of canonical Wnt signaling pathway (GO:0090263),6/113,0.4997075653239782,1,0,0,1.0619469026548671,0.7367067833785346,SFRP2;PSMD11;PSMA4;PSMD14;PSMA2;UBC
regulation of signal transduction (GO:0009966),12/233,0.5002234181309964,1,0,0,1.0300429184549356,0.7135111870553266,EPHB6;PDGFRB;NTRK2;RGS3;ERBB3;BRAF;LIFR;ITGB1BP1;TIMP1;RFNG;CD24;BIRC2
axon development (GO:0061564),5/94,0.509002443009079,1,0,0,1.0638297872340425,0.7184068753385349,LRFN3;PLPPR4;TLR9;LRRC55;ARHGAP35
mitotic nuclear division (GO:0140014),4/74,0.5098528753630284,1,0,0,1.0810810810810811,0.7282519724998587,TUBG1;BIRC2;ZWINT;NDEL1
sensory perception (GO:0007600),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,OPRD1;PNOC;RETREG1
membrane fusion (GO:0061025),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,CHCHD3;MX1;MYMK
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NFE2L2
regulation of fibroblast migration (GO:0010762),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ITGB1BP1
branching involved in blood vessel morphogenesis (GO:0001569),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SFRP2
nucleoside salvage (GO:0043174),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PRTFDC1
positive regulation of neural precursor cell proliferation (GO:2000179),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,DISP3
positive regulation of cell adhesion mediated by integrin (GO:0033630),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SFRP2
regulation of Golgi organization (GO:1903358),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,STX18
intermediate filament organization (GO:0045109),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NEFL
negative regulation of receptor-mediated endocytosis (GO:0048261),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PCSK9
myeloid dendritic cell activation (GO:0001773),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,BATF
establishment of mitotic spindle orientation (GO:0000132),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NDEL1
regulation of nucleocytoplasmic transport (GO:0046822),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NUDT4
establishment or maintenance of actin cytoskeleton polarity (GO:0030950),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ARHGAP35
regulation of phosphate metabolic process (GO:0019220),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CD24
"retrograde transport, endosome to plasma membrane (GO:1990126)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,WASHC2C
pore complex assembly (GO:0046931),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,BAD
positive regulation of response to cytokine stimulus (GO:0060760),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CD74
negative regulation of interleukin-1 beta production (GO:0032691),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,GHRL
"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,UQCRFS1
negative regulation of Rho protein signal transduction (GO:0035024),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TNFAIP1
regulation of monocyte differentiation (GO:0045655),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CD74
modified amino acid transport (GO:0072337),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SLC25A32
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CD74
negative regulation of focal adhesion assembly (GO:0051895),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ITGB1BP1
pyrimidine-containing compound catabolic process (GO:0072529),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NT5C
pancreas development (GO:0031016),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TCF7L2
regulation of lymphocyte differentiation (GO:0045619),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TLR9
regulation of defense response to virus (GO:0050688),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TNFAIP3
hydrogen peroxide catabolic process (GO:0042744),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PRDX5
regulation of neural precursor cell proliferation (GO:2000177),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,DISP3
cellular protein complex disassembly (GO:0043624),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TRMT112
negative regulation of biomineral tissue development (GO:0070168),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CCR1
positive regulation of glycogen metabolic process (GO:0070875),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,GCK
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PKD1
response to ethanol (GO:0045471),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SDF4
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ANK2
monosaccharide transport (GO:0015749),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SLC23A1
cAMP biosynthetic process (GO:0006171),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TAAR1
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ANKRD1
Golgi to vacuole transport (GO:0006896),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,VTI1A
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CREB3
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,IL12B
fatty acid transport (GO:0015908),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,LCN12
cellular response to nitrogen compound (GO:1901699),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PDE12
"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ZBTB8OS
purine nucleotide catabolic process (GO:0006195),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NT5C
positive regulation of purine nucleotide metabolic process (GO:1900544),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CXCL9
positive regulation of heart rate (GO:0010460),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NPPA
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CDT1
purine-containing compound catabolic process (GO:0072523),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NT5C
epithelial tube morphogenesis (GO:0060562),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,CCM2;PKD1
embryonic limb morphogenesis (GO:0030326),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,NOG;ZNF358
response to peptide (GO:1901652),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,QRFPR;GNAI1
negative regulation of endothelial cell migration (GO:0010596),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,NOTCH1;PTPRM
endoplasmic reticulum organization (GO:0007029),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,LMAN2L;STX18
positive regulation of cell development (GO:0010720),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,BAD;RFX3
response to glucagon (GO:0033762),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,GNG11;GNG13
regulation of interferon-beta production (GO:0032648),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,TLR9;TLR2
regulation of gene expression (GO:0010468),52/1037,0.5125684668320631,1,0,0,1.0028929604628736,0.6702544092543148,ATF2;CITED2;NRL;ZNF728;PTTG2;HEY2;ZNF689;ZNF19;ZNF282;NOG;RFX3;ANK2;DKK1;RUNX3;TOX2;PTP4A3;SFRP2;NR5A2;DDX39B;TLR9;PRKCQ;ZNF358;TOX;TLR2;OPRD1;ZNF792;NLRX1;ZNF350;NOTCH1;FOXO4;MAPK9;MAPK8;GCNT2;ZNF225;APBB3;TCFL5;CCR1;NTRK2;WWTR1;ARNT2;TCF7L2;EGF;ASCC1;BRAF;MT3;SRPK1;NLRP14;CDK3;ZNF699;ZNF611;NFE2L2;BRDT
response to lipopolysaccharide (GO:0032496),8/155,0.5147966059985056,1,0,0,1.032258064516129,0.6854022153666004,CXCL9;MAPK8;PABPN1;ANKRD1;PDCD4;TNFAIP3;CD14;CCR5
cellular response to organic cyclic compound (GO:0071407),7/135,0.5157499226195729,1,0,0,1.037037037037037,0.6866567317716777,CRHBP;GABRB2;PDE12;BAD;INSIG1;RAPGEF3;GNAI1
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",12/236,0.5182651275741422,1,0,0,1.0169491525423728,0.6684084796971648,CPSF7;PRPF6;DDX39B;RBM8A;PABPN1;SRSF4;SNRPD3;GEMIN7;PLRG1;SMNDC1;SRSF11;SNRPB
regulation of heart contraction (GO:0008016),5/95,0.5184489993734346,1,0,0,1.0526315789473684,0.6914880189626921,APELA;KCNIP2;NPPA;ANK2;TNNI3
regulation of actin cytoskeleton organization (GO:0032956),4/75,0.520490485053102,1,0,0,1.0666666666666667,0.6965159162578138,PDGFRB;ARHGAP28;ARHGAP35;RAPGEF3
gland development (GO:0048732),4/75,0.520490485053102,1,0,0,1.0666666666666667,0.6965159162578138,CITED2;PCSK9;COBL;ARHGAP35
positive regulation of cysteine-type endopeptidase activity (GO:2001056),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,BAD;ARL6IP5;BBC3
Notch signaling pathway (GO:0007219),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,NOTCH1;HEY2;UBC
cellular response to interferon-gamma (GO:0071346),6/116,0.5254581276778527,1,0,0,1.0344827586206895,0.6656739028524064,CAMK2B;PDE12;PTAFR;HLA-DRA;CCL18;CCL16
neutrophil degranulation (GO:0043312),24/479,0.5259864526432697,1,0,0,1.0020876826722338,0.6438211159988143,ITGAM;TMEM63A;PSMD11;CALML5;PSMD14;PTAFR;RHOG;RETN;DYNLL1;ABCA13;ILF2;AP2A2;FCAR;DERA;PSMA2;STBD1;PECAM1;DSG1;BPI;PTX3;CD14;PGLYRP1;ACAA1;TLR2
positive regulation of protein metabolic process (GO:0051247),5/96,0.5278178232072942,1,0,0,1.0416666666666667,0.6656292568931363,FZR1;MAPK8;PLK2;TNFAIP3;VPS28
ciliary basal body-plasma membrane docking (GO:0097711),5/96,0.5278178232072942,1,0,0,1.0416666666666667,0.6656292568931363,CNTRL;RPGRIP1L;TUBG1;DYNLL1;HAUS1
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,EXOSC9;PATL1
positive regulation of peptide secretion (GO:0002793),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,UNC13B;ANKRD1
negative regulation of protein kinase B signaling (GO:0051898),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,TRIB3;NOP53
regulation of microtubule polymerization (GO:0031113),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,PRUNE1;SLAIN2
negative regulation of epithelial cell migration (GO:0010633),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,DUSP10;PTPRM
apical junction assembly (GO:0043297),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,PATJ;DLG1
cholesterol biosynthetic process (GO:0006695),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,NPC1L1;HSD17B7
membrane protein proteolysis (GO:0033619),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,ERAP1;PRKCQ
flagellated sperm motility (GO:0030317),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,CATSPERZ;TNP1
positive regulation of osteoblast differentiation (GO:0045669),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,IFITM1;BMP7
protein kinase B signaling (GO:0043491),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,FOXO4;MT3
double-strand break repair via homologous recombination (GO:0000724),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,PSMD14;POLL;PALB2;FAN1
transforming growth factor beta receptor signaling pathway (GO:0007179),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,HPGD;UBC;GCNT2;ZYX
cellular defense response (GO:0006968),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,CXCL9;NCF1;CCR5
regulation of BMP signaling pathway (GO:0030510),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,NOTCH1;NOG;GATA6
cellular iron ion homeostasis (GO:0006879),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,UBC;CUL1;ABCG2
myotube differentiation (GO:0014902),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MYMK
myeloid cell development (GO:0061515),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TLR2
positive regulation of alpha-beta T cell activation (GO:0046635),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,IL12B
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NNMT
membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,KCNIP2
regulation of branching involved in ureteric bud morphogenesis (GO:0090189),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NOG
regulation of mRNA metabolic process (GO:1903311),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SRPK1
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ACAA1
apoptotic DNA fragmentation (GO:0006309),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CECR2
negative regulation of adherens junction organization (GO:1903392),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ITGB1BP1
regulation of B cell differentiation (GO:0045577),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TLR9
epithelial cilium movement (GO:0003351),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RFX3
embryonic axis specification (GO:0000578),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,COBL
positive regulation of mesonephros development (GO:0061213),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NOG
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PDGFRB
pyrimidine nucleoside biosynthetic process (GO:0046134),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,UMPS
"phototransduction, visible light (GO:0007603)",1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PDE6B
positive regulation of CREB transcription factor activity (GO:0032793),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,OPRD1
L-alpha-amino acid transmembrane transport (GO:1902475),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC1A1
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ARL6IP5
"protein localization to chromosome, centromeric region (GO:0071459)",1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CHAMP1
lipoxygenase pathway (GO:0019372),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HPGD
positive regulation of potassium ion transmembrane transport (GO:1901381),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ANK2
regulation of interleukin-4 production (GO:0032673),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PRKCQ
ventricular cardiac muscle cell action potential (GO:0086005),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ANK2
unsaturated fatty acid biosynthetic process (GO:0006636),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HPGD
intracellular lipid transport (GO:0032365),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ACACB
negative regulation of coagulation (GO:0050819),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SERPINE2
regulation of centriole replication (GO:0046599),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PLK2
presynapse assembly (GO:0099054),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CEL
dermatan sulfate proteoglycan biosynthetic process (GO:0050651),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CSPG5
negative regulation of interleukin-2 production (GO:0032703),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TNFAIP3
regulation of clathrin-dependent endocytosis (GO:2000369),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,WASL
regulation of cell-substrate junction assembly (GO:0090109),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MACF1
nitric oxide mediated signal transduction (GO:0007263),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,KCNC2
positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PDGFRB
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ETFA
response to cholesterol (GO:0070723),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CCR5
ganglioside metabolic process (GO:0001573),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ST8SIA4
regulation of delayed rectifier potassium channel activity (GO:1902259),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NPPA
vasculature development (GO:0001944),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PDGFRB
regulation of macrophage chemotaxis (GO:0010758),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RARRES2
negative regulation of signal transduction by p53 class mediator (GO:1901797),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CD74
negative regulation of axon extension involved in axon guidance (GO:0048843),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SEMA3G
positive regulation of cellular response to insulin stimulus (GO:1900078),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RARRES2
amide transport (GO:0042886),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC25A32
cofactor transport (GO:0051181),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC25A32
body fluid secretion (GO:0007589),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GUCA1B
negative regulation of platelet activation (GO:0010544),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SERPINE2
positive regulation of interleukin-4 production (GO:0032753),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PRKCQ
filopodium assembly (GO:0046847),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RAB17
microtubule depolymerization (GO:0007019),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NCKAP5L
protein O-linked fucosylation (GO:0036066),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RFNG
negative regulation of mRNA processing (GO:0050686),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SRSF4
negative regulation of protein processing (GO:0010955),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SERPINE2
regulation of RNA export from nucleus (GO:0046831),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NUDT4
regulation of lymphocyte proliferation (GO:0050670),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,IL12B
regulation of T cell mediated cytotoxicity (GO:0001914),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,IL12B
regulation of peptide secretion (GO:0002791),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CD74
negative regulation of anoikis (GO:2000811),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NOTCH1
cell morphogenesis involved in neuron differentiation (GO:0048667),5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,LRFN3;PLPPR4;MINK1;TLR9;LRRC55
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,CD74;HLA-DMA;HLA-DRA;DYNLL1;AP2A2
response to tumor necrosis factor (GO:0034612),5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,CRHBP;ANKRD1;CCL18;CCL16;NFE2L2
antigen processing and presentation of exogenous peptide antigen (GO:0002478),5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,CD74;HLA-DMA;HLA-DRA;DYNLL1;AP2A2
ion transmembrane transport (GO:0034220),11/219,0.5376682698087102,1,0,0,1.004566210045662,0.6233469028772605,SLC24A2;GABRB2;KCNIP2;SCNN1A;UBC;CLCNKA;LRRC8D;ATP13A5;GABRE;GABRG1;CALHM6
regulation of signal transduction by p53 class mediator (GO:1901796),7/138,0.5392352041131376,1,0,0,1.0144927536231885,0.6265542063646131,HEXIM1;UBC;TOP3A;RAD9B;NOP53;TAF3;CDK5RAP3
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),4/77,0.541429111359833,1,0,0,1.0389610389610389,0.6374474106254083,NOTCH1;NOG;UBC;DKK1
plasma membrane bounded cell projection organization (GO:0120036),6/118,0.5423234836595405,1,0,0,1.0169491525423728,0.6222636836506547,CFAP61;EHD1;TSGA10IP;RASGRF1;PTPRM;MANF
cytosolic transport (GO:0016482),6/118,0.5423234836595405,1,0,0,1.0169491525423728,0.6222636836506547,SPAG9;SYS1;HEATR5A;KIF16B;VTI1A;WASHC2C
neutrophil activation involved in immune response (GO:0002283),24/483,0.5427846009403516,1,0,0,0.9937888198757763,0.6072474246946159,ITGAM;TMEM63A;PSMD11;CALML5;PSMD14;PTAFR;RHOG;RETN;DYNLL1;ABCA13;ILF2;AP2A2;FCAR;DERA;PSMA2;STBD1;PECAM1;DSG1;BPI;PTX3;CD14;PGLYRP1;ACAA1;TLR2
carbohydrate biosynthetic process (GO:0016051),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,GALNT7;GALNT15
regulation of muscle cell differentiation (GO:0051147),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,SPAG9;MEGF10
natural killer cell activation (GO:0030101),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,IL12B;IFNA21
endoderm formation (GO:0001706),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,DUSP2;LAMA3
regulation of filopodium assembly (GO:0051489),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,WASL;RAB17
mRNA catabolic process (GO:0006402),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,PDE12;EXOSC9
vesicle-mediated transport in synapse (GO:0099003),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,UNC13B;C2CD4B
zymogen activation (GO:0031638),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,F9;BAD
regulation of cell morphogenesis involved in differentiation (GO:0010769),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,WASHC2C;ARHGAP35
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,TCF7L2;PDE6B
secondary alcohol biosynthetic process (GO:1902653),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,NPC1L1;HSD17B7
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),5/98,0.5463079186398003,1,0,0,1.0204081632653061,0.616910723108701,CD74;HLA-DMA;HLA-DRA;DYNLL1;AP2A2
response to molecule of bacterial origin (GO:0002237),5/98,0.5463079186398003,1,0,0,1.0204081632653061,0.616910723108701,CXCL9;TLR9;TNFAIP3;CD14;CD24
regulation of primary metabolic process (GO:0080090),7/139,0.546960679882136,1,0,0,1.0071942446043165,0.6077192138852752,PSMD11;PSMA4;PSMD14;SIN3B;PSMA2;ANKRD1;TRIB3
positive regulation of cell death (GO:0010942),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,ITGAM;DKK1;MT3
regulation of neurogenesis (GO:0050767),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,NOTCH1;PRUNE1;CDK5RAP3
cellular respiration (GO:0045333),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,NDUFS3;ETFA;SDHAF4
sensory perception of smell (GO:0007608),12/241,0.5478946475793864,1,0,0,0.9958506224066389,0.5991756940670975,OR5M11;OR2G6;OR13C9;OR2C1;OR2W3;OR14I1;OR2H1;OR5L1;OR2M2;OR5D16;OR6C2;OR10A3
negative regulation of nucleic acid-templated transcription (GO:1903507),22/444,0.5489292037258071,1,0,0,0.990990990990991,0.594382325067679,HEXIM1;TCF7L2;ZNF350;NOTCH1;POU2F1;TSHZ3;ZNF282;CITED2;GATA6;RFX3;UBP1;MT3;BMP7;ARHGAP35;DMBX1;BCLAF1;SFRP2;CCDC85B;HEY2;PDCD4;TRIB3;TNP1
regulation of neuron projection development (GO:0010975),6/119,0.5506572107989453,1,0,0,1.0084033613445378,0.6016565903086142,CAMK2B;NTRK2;RAB17;FBXO7;ARHGAP35;NDEL1
regulation of phosphorylation (GO:0042325),6/119,0.5506572107989453,1,0,0,1.0084033613445378,0.6016565903086142,EGF;CD24;DYNLL1;BMP7;NOP53;GCK
RNA export from nucleus (GO:0006405),6/119,0.5506572107989453,1,0,0,1.0084033613445378,0.6016565903086142,POM121L2;NXT1;DDX39B;RBM8A;SRSF4;SRSF11
fibroblast growth factor receptor signaling pathway (GO:0008543),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,KIF16B;NOG;UBC;FRS2
regulation of cell growth (GO:0001558),10/201,0.5523179780186385,1,0,0,0.9950248756218906,0.5906779616132228,ARHGEF11;SFRP2;CCDC85B;EXOSC9;RPS6KA1;NDUFS3;DERL2;PRKCQ;MT3;EIF4G2
base-excision repair (GO:0006284),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,LIG1;POLL
protein peptidyl-prolyl isomerization (GO:0000413),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,FKBP7;PPIAL4F
regulation of regulated secretory pathway (GO:1903305),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,C2CD4B;SYT6
regulation of sodium ion transmembrane transporter activity (GO:2000649),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,PCSK9;GLRX
positive regulation of axonogenesis (GO:0050772),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,MACF1;NTRK2
regulation of peptidyl-threonine phosphorylation (GO:0010799),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,EGF;BMP7
regulation of osteoclast differentiation (GO:0045670),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,CCR1;IL12B
positive regulation of stress fiber assembly (GO:0051496),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,ITGB1BP1;RAPGEF3
negative regulation of Ras protein signal transduction (GO:0046580),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,RASA4B;TNFAIP1
regulation of metal ion transport (GO:0010959),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,CAMK2B;ANK2
macromolecular complex assembly (GO:0065003),6/120,0.558921512029944,1,0,0,1,0.5817462235027698,CD74;FANCA;TCAP;ELOB;WASL;MDN1
actin filament organization (GO:0007015),6/120,0.558921512029944,1,0,0,1,0.5817462235027698,DLG1;RHOG;COBL;TCAP;GHRL;WASL
negative regulation of growth (GO:0045926),6/120,0.558921512029944,1,0,0,1,0.5817462235027698,SFRP2;NOTCH1;CCDC85B;MT1M;NDUFS3;MT3
neutrophil mediated immunity (GO:0002446),24/487,0.5594149167429713,1,0,0,0.9856262833675564,0.5725146608215005,ITGAM;TMEM63A;PSMD11;CALML5;PSMD14;PTAFR;RHOG;RETN;DYNLL1;ABCA13;ILF2;AP2A2;FCAR;DERA;PSMA2;STBD1;PECAM1;DSG1;BPI;PTX3;CD14;PGLYRP1;ACAA1;TLR2
response to light stimulus (GO:0009416),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,MAPK8;OPN3;REV1
integrin-mediated signaling pathway (GO:0007229),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,ZYX;ITGB1BP1;CCM2
neutrophil migration (GO:1990266),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,PECAM1;CCL18;CCL16
peptidyl-threonine dephosphorylation (GO:0035970),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,DUSP10
positive regulation of epithelial cell apoptotic process (GO:1904037),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PDCD4
regulation of actin nucleation (GO:0051125),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,WASL
positive regulation of secretion (GO:0051047),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ACSL3
positive regulation of cardiac muscle tissue growth (GO:0055023),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NOTCH1
cellular response to dsRNA (GO:0071359),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PDE12
regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TNFAIP3
embryonic digit morphogenesis (GO:0042733),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NOG
phosphatidylinositol acyl-chain remodeling (GO:0036149),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PLA2G2A
histone H2A acetylation (GO:0043968),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,EP400
negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,HEY2
neuron apoptotic process (GO:0051402),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ERBB3
positive regulation of myotube differentiation (GO:0010831),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,EHD1
dendritic spine morphogenesis (GO:0060997),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,WASL
negative regulation of DNA recombination (GO:0045910),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ZSCAN4
positive regulation of cilium assembly (GO:0045724),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ARHGAP35
T cell migration (GO:0072678),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CXCL9
positive regulation of triglyceride metabolic process (GO:0090208),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CNEP1R1
regulation of SMAD protein import into nucleus (GO:0060390),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,WWTR1
positive regulation of cyclic nucleotide metabolic process (GO:0030801),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CXCL9
genitalia development (GO:0048806),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PKD1
negative regulation of peptide hormone secretion (GO:0090278),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CRHBP
odontogenesis of dentin-containing tooth (GO:0042475),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ANKRD11
G-protein coupled acetylcholine receptor signaling pathway (GO:0007213),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,RGS8
regulation of stem cell proliferation (GO:0072091),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,EPCAM
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CCND2
mitochondrial fusion (GO:0008053),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CHCHD3
detection of visible light (GO:0009584),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PDE6B
endoplasmic reticulum to cytosol transport (GO:1903513),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,DERL2
positive regulation of positive chemotaxis (GO:0050927),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,VEGFC
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SFRP2
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,BCLAF1
cell-cell junction assembly (GO:0007043),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,PATJ;DLG1;GJD3;DSG1
regulation of transcription from RNA polymerase II promoter (GO:0006357),73/1478,0.5628316478309718,1,0,0,0.9878213802435724,0.5677747597121576,ATF2;BARHL2;CCNH;CITED2;CITED4;UBP1;NRL;TTF1;LITAF;CD3D;PKD1;ARHGAP35;YY2;CHCHD3;MCIDAS;SIN3B;HEY2;RPS6KA1;ANKRD1;IKBKG;CCNL1;GTF2I;NOG;RFX3;DUSP26;POU3F2;DKK1;RUNX3;CREB3;TOX2;SFRP2;NR5A2;ETV3L;PRPF6;TLR9;TRIB3;ITGB1BP1;TLR2;ZBED9;ZNF350;NOTCH1;TSHZ3;PLAG1;DOT1L;GATA6;FOXO4;NPAS3;EPCAM;UBC;RPRD1A;AAMDC;E2F8;TCEAL9;TCFL5;HEXIM1;FOXB2;WWTR1;ARNT2;TCF7L2;POU2F1;CDX1;SS18L1;ELP2;BMP7;TARBP1;BATF;GFI1B;DLG1;TBX10;PDCD4;NOP53;TAF3;NFE2L2
cellular response to transforming growth factor beta stimulus (GO:0071560),5/100,0.5644459548061124,1,0,0,1,0.5719106399118082,HPGD;UBC;ANKRD1;GCNT2;ZYX
regulation of lipid metabolic process (GO:0019216),5/100,0.5644459548061124,1,0,0,1,0.5719106399118082,DISP3;SIN3B;RARRES2;ANKRD1;TRIB3
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),5/100,0.5644459548061124,1,0,0,1,0.5719106399118082,NXT1;DDX39B;RBM8A;SRSF4;SRSF11
cell junction assembly (GO:0034329),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,DSG1;MYO9A;LIMS2
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,NOG;DKK1;BMP7
spindle assembly (GO:0051225),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,GOLGA6D;TUBG1;BIRC2;HAUS1
ERBB signaling pathway (GO:0038127),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,ERBB3;KIF16B;EGF;UBC
regulation of hydrolase activity (GO:0051336),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,NTRK2;ITGB1BP1;ARHGAP35;CDK5RAP3
neuron projection morphogenesis (GO:0048812),8/163,0.5724547815603112,1,0,0,0.9815950920245399,0.5475548769053109,LRFN3;PLPPR4;MINK1;RHOG;TLR9;WASL;LRRC55;BMP7
mitochondrion disassembly (GO:0061726),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,WIPI2;FBXO7
homotypic cell-cell adhesion (GO:0034109),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,MEGF10;MEGF11
positive regulation of innate immune response (GO:0045089),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,TLR9;TLR2
regulation of ossification (GO:0030278),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,NOTCH1;DKK1
regulation of protein ubiquitination (GO:0031396),5/101,0.5733754172932677,1,0,0,0.9900990099009901,0.5507075230503586,LATS1;TNFAIP3;SPOPL;CDK5RAP3;VPS28
regulation of kinase activity (GO:0043549),5/101,0.5733754172932677,1,0,0,0.9900990099009901,0.5507075230503586,EPHB6;PDGFRB;CD74;NTRK2;ERBB3
vesicle-mediated transport (GO:0016192),20/410,0.5781846907866909,1,0,0,0.975609756097561,0.534499441089679,SPAG9;CPNE6;AGAP2;RHOG;RAB39B;WASHC2C;C2CD4B;WASL;SYP;MAPK8IP3;KALRN;SYT6;EHD1;CECR2;SNX18;HEATR5A;AP1G2;KIF16B;VTI1A;RAB17
negative regulation of cell cycle process (GO:0010948),4/81,0.5818428728182232,1,0,0,0.9876543209876543,0.5348689833845679,CDT1;FOXO4;BMP7;E2F8
positive regulation of protein catabolic process (GO:0045732),4/81,0.5818428728182232,1,0,0,0.9876543209876543,0.5348689833845679,FZR1;PLK2;TNFAIP3;VPS28
positive regulation of protein processing (GO:0010954),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TNP1
regulation of cellular protein catabolic process (GO:1903362),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CDK5RAP3
regulation of multicellular organism growth (GO:0040014),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,GHRL
high-density lipoprotein particle remodeling (GO:0034375),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,LCAT
regulation of tissue remodeling (GO:0034103),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,IL12B
reverse cholesterol transport (GO:0043691),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,LCAT
negative regulation of axon guidance (GO:1902668),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SEMA3G
ureteric bud development (GO:0001657),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,BMP7
glycosphingolipid biosynthetic process (GO:0006688),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ST8SIA4
preassembly of GPI anchor in ER membrane (GO:0016254),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PIGP
regulation of lipid catabolic process (GO:0050994),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RARRES2
negative regulation of lipid biosynthetic process (GO:0051055),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TRIB3
gastrulation (GO:0007369),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,APELA
positive regulation of dendrite extension (GO:1903861),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CPNE6
pigment granule transport (GO:0051904),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RAB17
negative regulation of cell development (GO:0010721),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NOTCH1
negative regulation of reactive oxygen species metabolic process (GO:2000378),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,MT3
positive regulation of stem cell proliferation (GO:2000648),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,EPCAM
negative regulation of intracellular transport (GO:0032387),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,INSIG1
positive regulation of cellular protein catabolic process (GO:1903364),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PCSK9
3'-UTR-mediated mRNA stabilization (GO:0070935),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,DAZ3
rRNA catabolic process (GO:0016075),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,EXOSC9
embryo development ending in birth or egg hatching (GO:0009792),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NR5A2
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,IL12B
positive regulation of macrophage activation (GO:0043032),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ITGAM
long-term memory (GO:0007616),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RASGRF1
macrophage activation (GO:0042116),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ITGAM
virion assembly (GO:0019068),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,UBC
defense response to fungus (GO:0050832),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RARRES2
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ANK2
serine family amino acid metabolic process (GO:0009069),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SLC25A32
purine-containing compound metabolic process (GO:0072521),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ABCG2
positive regulation of telomere capping (GO:1904355),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PRKCQ
melanosome transport (GO:0032402),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RAB17
positive regulation of cation transmembrane transport (GO:1904064),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ANK2
platelet-derived growth factor receptor signaling pathway (GO:0048008),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PDGFRB
positive regulation of transcription of Notch receptor target (GO:0007221),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NOTCH1
membrane depolarization during cardiac muscle cell action potential (GO:0086012),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ANK2
cell chemotaxis (GO:0060326),3/60,0.5828910435264506,1,0,0,1,0.5397549994176116,PDGFRB;RHOG;PRKCQ
positive regulation of protein binding (GO:0032092),3/60,0.5828910435264506,1,0,0,1,0.5397549994176116,TCF7L2;TRIB3;PKD1
cellular protein modification process (GO:0006464),49/1001,0.5837274650542439,1,0,0,0.979020979020979,0.5270276253901379,MPI;PCSK9;PTPRM;CHM;PTPRH;SERP2;DUSP10;RPS6KA1;PRKG2;ELOB;TIMP1;FBXO7;CHGB;DUSP2;MINK1;CEL;WIPI2;DUSP26;RUNX3;DUSP7;SUMF1;KLHL42;LATS1;PSMA4;PSMA2;CAMK2B;PSMD11;PSMD14;RPN1;CUL1;KLHL11;GLRX;KLHL13;FUT1;LTBP1;MAPK9;MAPK8;LCE3B;ST8SIA4;GCNT2;UBL4A;PLK2;BRAF;MT3;SRPK1;KBTBD6;CDK3;CCDC22;SPSB4
positive regulation of signal transduction (GO:0009967),10/206,0.583848066481467,1,0,0,0.9708737864077669,0.5224412525591288,UNC13B;MACF1;CD74;NOTCH1;CITED2;TLR9;GHRL;ITGB1BP1;MT3;TLR2
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),7/144,0.5847203579347515,1,0,0,0.9722222222222222,0.521715412033393,HPGD;UBC;NOG;GCNT2;ZYX;PDCD4;BMP7
signal transduction by p53 class mediator (GO:0072331),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,ZMAT4;BATF
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,MADD;TNFAIP3
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,RBM8A;RBFOX3
regulation of proteasomal protein catabolic process (GO:0061136),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,PSMD14;PKD1
clathrin-dependent endocytosis (GO:0072583),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,C2CD4B;AP2A2
positive regulation of reactive oxygen species metabolic process (GO:2000379),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,PDGFRB;ITGAM
alpha-amino acid catabolic process (GO:1901606),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,TDO2;UROC1
acyl-CoA metabolic process (GO:0006637),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,ACSM3;ACACB
regulation of coenzyme metabolic process (GO:0051196),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,CELSR1;GCK
positive regulation of angiogenesis (GO:0045766),5/103,0.5909417872320486,1,0,0,0.9708737864077669,0.5107162768822324,APELA;SFRP2;GATA6;VEGFC;RAPGEF3
protein import into nucleus (GO:0006606),5/103,0.5909417872320486,1,0,0,0.9708737864077669,0.5107162768822324,OPRD1;POM121L2;NXT1;EGF;MT3
"retrograde transport, endosome to Golgi (GO:0042147)",4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,SPAG9;HEATR5A;VTI1A;WASHC2C
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,NOTCH1;CITED2;GATA6;BMP7
ephrin receptor signaling pathway (GO:0048013),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,EPHB6;WASL;AP2A2;KALRN
negative regulation of binding (GO:0051100),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,MAPK8;ITGB1BP1;ARHGAP28;DKK1
positive regulation of T cell proliferation (GO:0042102),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,IL12B;TNFSF9;CD24
mRNA transport (GO:0051028),5/104,0.599573857726415,1,0,0,0.9615384615384616,0.49186164733317733,NXT1;DDX39B;RBM8A;SRSF4;SRSF11
positive regulation of vasculature development (GO:1904018),5/104,0.599573857726415,1,0,0,0.9615384615384616,0.49186164733317733,APELA;SFRP2;GATA6;VEGFC;RAPGEF3
neuron projection development (GO:0031175),8/167,0.6000926173801865,1,0,0,0.9580838323353293,0.4892658906618576,EHD1;RASGRF1;MINK1;RHOG;PTPRM;WASL;BMP7;MANF
negative regulation of transport (GO:0051051),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,ERBB3;EGF
"nucleotide-excision repair, DNA incision (GO:0033683)",2/40,0.60119891797304,1,0,0,1,0.5088294208836465,UBC;FAN1
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,EGF;UBC
regulation of protein dephosphorylation (GO:0035304),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,PPP1R14B;CNEP1R1
autophagy of mitochondrion (GO:0000422),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,WIPI2;FBXO7
positive regulation of mitotic nuclear division (GO:0045840),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,PDGFRB;EGF
response to cAMP (GO:0051591),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,CRHBP;RAPGEF3
sterol biosynthetic process (GO:0016126),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,NPC1L1;HSD17B7
peptidyl-proline modification (GO:0018208),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,FKBP7;PPIAL4F
regulation of release of cytochrome c from mitochondria (GO:0090199),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,BAD;BBC3
regulation of intracellular transport (GO:0032386),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,RINT1;NDEL1
positive regulation of cytokine biosynthetic process (GO:0042108),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,TLR9;IL12B
JAK-STAT cascade (GO:0007259),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,EGF;PKD1
positive regulation of protein ubiquitination (GO:0031398),4/83,0.6012622374752512,1,0,0,0.963855421686747,0.4903364861494962,TRIB3;CCDC22;CDK5RAP3;BIRC2
negative regulation of endopeptidase activity (GO:0010951),4/83,0.6012622374752512,1,0,0,0.963855421686747,0.4903364861494962,SERPINB2;SERPINE2;TIMP1;MT3
glucan catabolic process (GO:0009251),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,STBD1
regulation of adherens junction organization (GO:1903391),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,MACF1
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ACSL3
establishment of melanosome localization (GO:0032401),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,RAB17
"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TSHZ3
organelle fusion (GO:0048284),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CHCHD3
mitotic recombination (GO:0006312),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DMC1
receptor localization to synapse (GO:0097120),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DLG1
regulation of spindle organization (GO:0090224),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GNAI1
actin filament polymerization (GO:0030041),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,COBL
anion transmembrane transport (GO:0098656),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,LRRC8D
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,IFNA21
glucan biosynthetic process (GO:0009250),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,UBC
release of cytochrome c from mitochondria (GO:0001836),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,BBC3
maintenance of protein localization in organelle (GO:0072595),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TAF3
anterior/posterior axis specification (GO:0009948),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CDX1
leukotriene biosynthetic process (GO:0019370),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,MGST3
establishment of mitotic spindle localization (GO:0040001),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,NDEL1
establishment or maintenance of apical/basal cell polarity (GO:0035088),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DLG1
negative regulation of RNA splicing (GO:0033119),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SRSF4
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,VPS28
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,NFE2L2
prostaglandin biosynthetic process (GO:0001516),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CD74
outer dynein arm assembly (GO:0036158),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CCDC183
"retrograde protein transport, ER to cytosol (GO:0030970)",1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DERL2
tRNA metabolic process (GO:0006399),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,POP7
negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DKK1
glycogen catabolic process (GO:0005980),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,STBD1
phosphatidylglycerol acyl-chain remodeling (GO:0036148),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PLA2G2A
glycogen biosynthetic process (GO:0005978),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,UBC
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,NFE2L2
DNA conformation change (GO:0071103),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TOP3A
positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,IFNA21
regulation of epithelial cell differentiation (GO:0030856),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CD24
positive regulation of carbohydrate metabolic process (GO:0045913),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,EGF
glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DERA
cell-substrate adherens junction assembly (GO:0007045),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TRIP6
regulation of dendrite extension (GO:1903859),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CPNE6
regulation of smooth muscle cell migration (GO:0014910),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PDGFRB
mRNA destabilization (GO:0061157),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,YTHDF2
positive regulation of morphogenesis of an epithelium (GO:1905332),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,NOG
DNA ligation (GO:0006266),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,LIG1
focal adhesion assembly (GO:0048041),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TRIP6
positive regulation of type I interferon production (GO:0032481),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,TLR9;POLR3K;TLR2
regulation of actin filament-based process (GO:0032970),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,PDGFRB;ARHGAP28;ARHGAP35
cellular amide metabolic process (GO:0043603),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,VNN2;FPGS;ACACB
cellular protein catabolic process (GO:0044257),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,TINAGL1;PCSK9;AP2A2
negative regulation of peptidase activity (GO:0010466),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,SERPINB2;SERPINE2;TIMP1
positive regulation of supramolecular fiber organization (GO:1902905),4/84,0.61076514771337,1,0,0,0.9523809523809523,0.4695645403132304,SYNPO2L;CDC42EP5;RHOG;SLAIN2
activation of GTPase activity (GO:0090630),4/84,0.61076514771337,1,0,0,0.9523809523809523,0.4695645403132304,ARHGAP42;TBC1D3L;RASGRF1;RHOG
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),41/848,0.6124270527635636,1,0,0,0.9669811320754718,0.47413545020228753,ATF2;ZNF350;NOTCH1;CCNH;PLAG1;CITED2;INSIG1;DOT1L;CITED4;NRL;FOXO4;LITAF;CD3D;PKD1;NPAS3;YY2;MCIDAS;EPCAM;HEY2;RPS6KA1;UBC;IKBKG;CCNL1;AAMDC;E2F8;WWTR1;ARNT2;TCF7L2;POU2F1;CDX1;SS18L1;RFX3;CREB3;TOX2;SFRP2;NR5A2;PRPF6;TLR9;ITGB1BP1;NFE2L2;TLR2
regulation of calcium-mediated signaling (GO:0050848),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,JPH2;JPH3
peptide transport (GO:0015833),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,LMAN2L;ITGB1BP1
regulation of stress-activated MAPK cascade (GO:0032872),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,ARL6IP5;MAPK8IP3
regulation of substrate adhesion-dependent cell spreading (GO:1900024),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,WASHC2C;ITGB1BP1
monocyte chemotaxis (GO:0002548),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,CCL18;CCL16
negative regulation of proteolysis (GO:0045861),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,SERPINE2;TIMP1
kidney development (GO:0001822),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,PCSK9;PKD1;BMP7
carbohydrate homeostasis (GO:0033500),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,TCF7L2;BAD;GCK
iron ion homeostasis (GO:0055072),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,UBC;CUL1;ABCG2
positive regulation of cell projection organization (GO:0031346),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,CAMK2B;NTRK2;ARHGAP35
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,PDE12;EXOSC9;PATL1
positive regulation of cellular component organization (GO:0051130),5/106,0.6165249871762161,1,0,0,0.9433962264150944,0.4562796476411569,CAMK2B;CDT1;GHRL;BMP7;RAPGEF3
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),4/85,0.6201271748700885,1,0,0,0.9411764705882353,0.4497230129121684,CD74;SFRP2;IL12B;IL22RA2
positive regulation of NF-kappaB transcription factor activity (GO:0051092),6/128,0.6222697663749293,1,0,0,0.9375,0.4447327240020074,UBC;TLR9;PRKCQ;RBCK1;IKBKG;TLR2
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CITED2
negative regulation of lymphocyte activation (GO:0051250),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TNFAIP3
error-free translesion synthesis (GO:0070987),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,UBC
negative regulation of cell junction assembly (GO:1901889),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ITGB1BP1
cellular polysaccharide catabolic process (GO:0044247),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,STBD1
protein targeting to lysosome (GO:0006622),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,NCOA4
NADP metabolic process (GO:0006739),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,DERA
acetylcholine receptor signaling pathway (GO:0095500),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RGS8
positive regulation of STAT cascade (GO:1904894),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,NOTCH1
protein exit from endoplasmic reticulum (GO:0032527),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,DERL2
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,EXOSC9
vesicle transport along microtubule (GO:0047496),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,NDEL1
endothelial cell development (GO:0001885),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RAPGEF3
acylglycerol biosynthetic process (GO:0046463),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MOGAT2
regulation of myotube differentiation (GO:0010830),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,NOTCH1
Rac protein signal transduction (GO:0016601),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RHOG
purine ribonucleoside bisphosphate metabolic process (GO:0034035),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,BPNT1
positive regulation of lipid storage (GO:0010884),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,EHD1
nucleosome disassembly (GO:0006337),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TNP1
chromatin disassembly (GO:0031498),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TNP1
leukotriene metabolic process (GO:0006691),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MGST3
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ERBB3
positive regulation of interferon-alpha production (GO:0032727),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TLR9
purine ribonucleotide catabolic process (GO:0009154),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,NUDT4
macromolecule biosynthetic process (GO:0009059),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,EIF4G2
positive regulation of immunoglobulin production (GO:0002639),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TLR9
nucleotide-sugar biosynthetic process (GO:0009226),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MPI
regulation of platelet activation (GO:0010543),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PRKCQ
positive regulation of phospholipase activity (GO:0010518),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PDGFRB
innate immune response in mucosa (GO:0002227),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RPL39
triglyceride biosynthetic process (GO:0019432),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MOGAT2
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CITED2
response to interferon-beta (GO:0035456),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,IFITM1
positive regulation of neuron apoptotic process (GO:0043525),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PCSK9
positive regulation of axon extension (GO:0045773),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MACF1
positive regulation of cell cycle process (GO:0090068),5/107,0.6248402405451496,1,0,0,0.9345794392523363,0.43949465144730016,PDGFRB;EGF;GATA6;FOXO4;E2F8
positive regulation of protein polymerization (GO:0032273),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,CDC42EP5;RHOG;SLAIN2
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,PECAM1;PTPRM;PKD1
cellular response to calcium ion (GO:0071277),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,CRHBP;BRAF
cellular response to radiation (GO:0071478),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,OPN3;RAD9B
glycolipid biosynthetic process (GO:0009247),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,PGAP3;PIGP
regulation of ion transmembrane transporter activity (GO:0032412),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,KCNIP2;ANK2
translesion synthesis (GO:0019985),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,UBC;REV1
nucleotide-excision repair (GO:0006289),5/108,0.6330463554564062,1,0,0,0.9259259259259258,0.4233441001393671,LIG1;CCNH;UBC;POLL;FAN1
regulation of cytokine production (GO:0001817),5/108,0.6330463554564062,1,0,0,0.9259259259259258,0.4233441001393671,NLRP14;NLRX1;TREX1;UBC;IL12B
negative regulation of apoptotic process (GO:0043066),23/485,0.6340586211739988,1,0,0,0.9484536082474226,0.43212861555439325,EPHB6;PDGFRB;NTRK2;CD74;NOTCH1;CITED2;PLK2;GATA6;AGAP2;BRAF;DKK1;MT3;POU3F4;PRDX5;MAPK8;CCND2;ERBB3;RPS6KA1;UBC;GHRL;RETREG1;BIRC2;AAMDC
protein glycosylation (GO:0006486),6/130,0.6372700870903559,1,0,0,0.9230769230769231,0.41590312126152085,SERP2;GALNT7;MPI;ST8SIA4;GCNT2;FUT1
O-glycan processing (GO:0016266),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,GALNT7;MUCL1;GALNT15
glycolipid metabolic process (GO:0006664),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,GALC;PGAP3;SUMF1
cellular response to type I interferon (GO:0071357),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,IFITM1;MX1;IFNA21
regulation of myeloid cell differentiation (GO:0045637),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,KMT2B;DPY30;PRKCQ
type I interferon signaling pathway (GO:0060337),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,IFITM1;MX1;IFNA21
fatty acid catabolic process (GO:0009062),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,ABHD2;CEL;ACAA1
mitotic metaphase plate congression (GO:0007080),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,CDT1;CHAMP1
negative regulation of protein metabolic process (GO:0051248),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,AGAP2;PTX3
protein transmembrane import into intracellular organelle (GO:0044743),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,PEX10;PEX1
negative regulation of DNA metabolic process (GO:0051053),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,DPPA3;ANKRD1
positive regulation of interleukin-6 production (GO:0032755),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,TLR9;TLR2
substantia nigra development (GO:0021762),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,NDUFS3;DYNLL1
branching morphogenesis of an epithelial tube (GO:0048754),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,SFRP2;PKD1
regulation of multicellular organismal development (GO:2000026),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,NOG;CD24
regulation of interferon-gamma production (GO:0032649),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,IL12B;CD14
cell projection assembly (GO:0030031),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RHOG
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CREB3
hydrogen peroxide metabolic process (GO:0042743),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PRDX5
proteoglycan metabolic process (GO:0006029),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GAL3ST4
natural killer cell activation involved in immune response (GO:0002323),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,IFNA21
positive regulation of dendritic spine development (GO:0060999),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CAMK2B
negative regulation of macromolecule biosynthetic process (GO:0010558),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TMEFF2
regulation of regulatory T cell differentiation (GO:0045589),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DUSP10
viral budding via host ESCRT complex (GO:0039702),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,VPS28
embryonic digestive tract development (GO:0048566),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RARRES2
response to progesterone (GO:0032570),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ABHD2
"regulation of DNA-templated transcription, elongation (GO:0032784)",1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DDX39B
purine nucleotide metabolic process (GO:0006163),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NT5C
autophagy of nucleus (GO:0044804),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,WIPI2
regulation of anoikis (GO:2000209),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NOTCH1
regulation of cell development (GO:0060284),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PRUNE1
regulation of glycogen biosynthetic process (GO:0005979),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GCK
organelle disassembly (GO:1903008),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RETREG1
aromatic amino acid family catabolic process (GO:0009074),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TDO2
covalent chromatin modification (GO:0016569),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,MT3
dorsal/ventral pattern formation (GO:0009953),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NOG
melanosome localization (GO:0032400),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RAB17
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NOG
chondroitin sulfate biosynthetic process (GO:0030206),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CSPG5
cellular response to estradiol stimulus (GO:0071392),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CRHBP
dopaminergic neuron differentiation (GO:0071542),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,MANF
protein stabilization (GO:0050821),7/152,0.6417021441357289,1,0,0,0.9210526315789472,0.4086075302976567,USP27X;CCNH;DVL3;DSG1;ANK2;MT3;NOP53
T cell activation (GO:0042110),4/88,0.6473496582204271,1,0,0,0.9090909090909091,0.39533518222257213,CD8B;CD1C;CD3D;IFNA21
ribosomal small subunit biogenesis (GO:0042274),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,SRFBP1;NOL11
regulation of focal adhesion assembly (GO:0051893),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,MACF1;ITGB1BP1
sprouting angiogenesis (GO:0002040),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,ITGB1BP1;E2F8
regulation of T cell activation (GO:0050863),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,PRKCQ;IFNL3
positive regulation of intracellular transport (GO:0032388),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,EHD1;STX18
positive regulation of transport (GO:0051050),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,BRAF;ACSL3
microtubule cytoskeleton organization involved in mitosis (GO:1902850),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,PLK2;TUBG1
"regulation of transcription, DNA-templated (GO:0006355)",77/1598,0.6532561089683414,1,0,0,0.9637046307884856,0.41033196206176187,ATF2;BARHL2;NCF1;CITED2;CITED4;UBP1;TTF1;LITAF;ARHGAP35;DMBX1;YY2;ZNF728;PTTG2;HEY2;RPS6KA1;ANKRD1;ZNF689;GTF2I;ARHGEF11;ZNF19;ZNF282;NCOA4;RHOG;RFX3;POU3F2;ILF2;RUNX3;TOX2;PTP4A3;SFRP2;NR5A2;ETV3L;TRIB3;PRKCQ;MAPRE3;ZNF358;TOX;ZBED9;ZNF792;ZNF350;NOTCH1;TSHZ3;GATA6;FOXO4;NPAS3;BCLAF1;CCDC85B;DVL3;ZNF225;APBB3;TCEAL9;TCFL5;HEXIM1;FOXB2;WWTR1;CD74;CDT1;ARNT2;TCF7L2;POU2F1;EGF;ASCC1;CDX1;SS18L1;ELP2;BMP7;MT3;TARBP1;BATF;TBX10;PDCD4;ZNF699;ZNF611;TNP1;TAF3;NFE2L2;BRDT
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,RPS29;RPL39;SRP9;RPL19
peptidyl-threonine modification (GO:0018210),4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,CAMK2B;GALNT7;MAPK8;GALNT15
negative regulation of protein binding (GO:0032091),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,MAPK8;ITGB1BP1;DKK1
regulation of cardiac conduction (GO:1903779),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,NPPA;ANK2;TNNI3
regulation of protein phosphorylation (GO:0001932),12/261,0.6585582788214799,1,0,0,0.9195402298850575,0.38409403156639316,WWTR1;CD74;NTRK2;CCND2;RARRES2;P2RY1;DVL3;CD24;MT3;BMP7;NOP53;CDK5RAP3
negative regulation of programmed cell death (GO:0043069),19/408,0.65863210696751,1,0,0,0.9313725490196079,0.3889320116695856,EPHB6;PDGFRB;NTRK2;CD74;CITED2;PLK2;GATA6;BRAF;DKK1;MT3;PRDX5;MAPK8;CCND2;ERBB3;RPS6KA1;UBC;GHRL;BIRC2;AAMDC
protein targeting (GO:0006605),6/133,0.6590954237799057,1,0,0,0.9022556390977443,0.3761386051870259,SYS1;NCF1;VTI1A;CHM;PEX1;FBXO7
positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,NOL11
dendritic cell differentiation (GO:0097028),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,BATF
positive regulation of leukocyte cell-cell adhesion (GO:1903039),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PRKCQ
cellular response to hexose stimulus (GO:0071331),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,UNC13B
energy reserve metabolic process (GO:0006112),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,MT3
histone lysine demethylation (GO:0070076),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,KDM7A
establishment of spindle orientation (GO:0051294),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,NDEL1
ventricular cardiac muscle tissue development (GO:0003229),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,TNNI3
negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PCSK9
positive regulation of T cell mediated immunity (GO:0002711),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,IL12B
mitochondrial fission (GO:0000266),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,MX1
negative regulation of cytokine biosynthetic process (GO:0042036),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GHRL
negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,RPGRIP1L
embryonic skeletal system morphogenesis (GO:0048704),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,NOG
establishment of endothelial barrier (GO:0061028),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,RAPGEF3
branched-chain amino acid catabolic process (GO:0009083),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,BCKDHB
regulation of interleukin-2 production (GO:0032663),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,TNFAIP3
response to nicotine (GO:0035094),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,BAD
negative regulation of viral process (GO:0048525),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PTX3
positive regulation of defense response to virus by host (GO:0002230),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,IL12B
protein-DNA complex disassembly (GO:0032986),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,TNP1
positive regulation of lipid metabolic process (GO:0045834),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,DISP3
mitochondrial calcium ion transmembrane transport (GO:0006851),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PMPCA
embryonic skeletal system development (GO:0048706),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,NOG
phosphatidylserine acyl-chain remodeling (GO:0036150),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PLA2G2A
glutamate metabolic process (GO:0006536),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,FPGS
mRNA processing (GO:0006397),13/283,0.6629473582844175,1,0,0,0.9187279151943463,0.37765201313307,CPSF7;RBM8A;CCNH;PLRG1;PRPF6;DDX39B;PABPN1;SRSF4;SNRPD3;GEMIN7;SMNDC1;SRSF11;SNRPB
protein polyubiquitination (GO:0000209),13/283,0.6629473582844175,1,0,0,0.9187279151943463,0.37765201313307,PSMD11;PSMD14;CUL1;TNFAIP3;KLHL42;FZR1;PSMA4;UBE2R2;PSMA2;UBC;RBCK1;FBXO7;BIRC2
nucleus organization (GO:0006997),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,ANKLE1;SYNE1
"regulation of synaptic transmission, glutamatergic (GO:0051966)",2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,ATAD1;TSHZ3
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,RPS6KA1;MT3;BIRC2
negative regulation of protein phosphorylation (GO:0001933),8/178,0.6711220124733558,1,0,0,0.898876404494382,0.3584757948492,WWTR1;SFRP2;NOG;TRIB3;ITGB1BP1;NYX;DKK1;CDK5RAP3
mitochondrial transport (GO:0006839),6/135,0.6731831840991095,1,0,0,0.8888888888888888,0.3517669298080437,BAD;UCP2;SLC25A32;FBXO7;SLC25A11;SLC25A36
lipid transport (GO:0006869),4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,ABCA11P;NPC1L1;ABCA3;ABCA13
negative regulation of kinase activity (GO:0033673),4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,WWTR1;ITGB1BP1;TRIB3;NYX
protein-DNA complex assembly (GO:0065004),4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,CCNH;DMC1;UBC;ANP32E
regulation of calcium ion transport into cytosol (GO:0010522),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ANK2
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,MT3
protein localization to cilium (GO:0061512),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,EHD1
glutathione derivative biosynthetic process (GO:1901687),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,MGST3
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CCDC22
early endosome to late endosome transport (GO:0045022),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,KIF16B
outflow tract septum morphogenesis (GO:0003148),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,GATA6
negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CREB3
peripheral nervous system development (GO:0007422),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ERBB3
regulation of transcription from RNA polymerase III promoter (GO:0006359),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PRDX5
sulfur amino acid metabolic process (GO:0000096),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,NOX4
"DNA catabolic process, endonucleolytic (GO:0000737)",1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CECR2
negative regulation of actin filament polymerization (GO:0030837),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,TMSB4Y
protein localization to cell surface (GO:0034394),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ANK2
rRNA modification (GO:0000154),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,TRMT112
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,UBC
regulation of cytokine production involved in inflammatory response (GO:1900015),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PDCD4
STAT cascade (GO:0097696),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PKD1
branched-chain amino acid metabolic process (GO:0009081),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,BCKDHB
beta-catenin destruction complex disassembly (GO:1904886),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,DVL3
regulation of membrane protein ectodomain proteolysis (GO:0051043),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,TIMP1
negative regulation of protein import into nucleus (GO:0042308),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,WWTR1
protein complex localization (GO:0031503),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,DLG1
viral genome replication (GO:0019079),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,UBP1
inner ear morphogenesis (GO:0042472),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,POU3F4
ncRNA catabolic process (GO:0034661),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,EXOSC9
glutathione derivative metabolic process (GO:1901685),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,MGST3
positive regulation of phosphatase activity (GO:0010922),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PDGFRB
maturation of SSU-rRNA (GO:0030490),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,SRFBP1;NOL11
regulation of cellular component movement (GO:0051270),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,ERBB3;EGF
negative regulation of autophagy (GO:0010507),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,MT3;EIF4G2
positive regulation of cell motility (GO:2000147),8/179,0.677184898085746,1,0,0,0.8938547486033519,0.34843435038653225,PDGFRB;CCR1;SPAG9;NOTCH1;EGF;TRIP6;SEMA3G;GCNT2
positive regulation of neurogenesis (GO:0050769),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,BRINP2;MMD;ZC4H2
Rab protein signal transduction (GO:0032482),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,RAB30;RAB39B;RAB17
neuropeptide signaling pathway (GO:0007218),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,OPRD1;NPPA;PNOC
interferon-gamma-mediated signaling pathway (GO:0060333),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,CAMK2B;PTAFR;HLA-DRA
muscle contraction (GO:0006936),6/137,0.6868931771447399,1,0,0,0.8759124087591241,0.3289721085839843,ARHGEF11;PABPN1;TNNT1;KCNIP2;TCAP;TNNI3
regulation of cytosolic calcium ion concentration (GO:0051480),6/137,0.6868931771447399,1,0,0,0.8759124087591241,0.3289721085839843,CCR1;P2RY1;PDE6B;GHRL;CD24;CCR5
cilium assembly (GO:0060271),13/288,0.6870684737462829,1,0,0,0.9027777777777777,0.3388317481813433,NOTCH1;IFT172;RFX3;RPGRIP1L;TUBG1;DYNLL1;HAUS1;EHD1;IFT43;MCIDAS;CNTRL;TRIP11;RAB17
negative regulation of cell growth (GO:0030308),5/115,0.687326064513291,1,0,0,0.8695652173913043,0.32604041610621337,SFRP2;CCDC85B;NDUFS3;SEMA3G;MT3
polyol metabolic process (GO:0019751),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,INPP5J;NUDT4
regulation of organelle assembly (GO:1902115),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,PLK2;STX18
postreplication repair (GO:0006301),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,UBC;REV1
fatty acid biosynthetic process (GO:0006633),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,ACSM3;ABHD2
inositol phosphate metabolic process (GO:0043647),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,INPP5J;NUDT4
cotranslational protein targeting to membrane (GO:0006613),4/93,0.6897669196744971,1,0,0,0.8602150537634409,0.3194851922842808,RPS29;RPL39;SRP9;RPL19
regulation of MAPK cascade (GO:0043408),9/203,0.6910425757023396,1,0,0,0.8866995073891626,0.32768321009203705,EPHB6;PDGFRB;CD74;NTRK2;ERBB3;TLR9;TRIB3;CD24;BMP7
regulation of axon extension involved in axon guidance (GO:0048841),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SEMA3G
regulation of protein oligomerization (GO:0032459),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,OPRD1
cholesterol efflux (GO:0033344),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,ABCG2
positive regulation of cell cycle G1/S phase transition (GO:1902808),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CCND2
microtubule polymerization or depolymerization (GO:0031109),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,NCKAP5L
positive regulation of ERBB signaling pathway (GO:1901186),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,UBC
regulation of telomere capping (GO:1904353),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,PRKCQ
cellular amino acid catabolic process (GO:0009063),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,BCKDHB
zinc II ion transmembrane transport (GO:0071577),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SLC39A8
glutamine family amino acid metabolic process (GO:0009064),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,FPGS
vesicle-mediated transport between endosomal compartments (GO:0098927),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,KIF16B
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,UBC
positive regulation of blood circulation (GO:1903524),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,APELA
regulation of dendritic spine morphogenesis (GO:0061001),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CAMK2B
rRNA methylation (GO:0031167),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,TRMT112
regulation of monooxygenase activity (GO:0032768),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,WASL
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,ANK2
regulation of microtubule cytoskeleton organization (GO:0070507),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SKA2
viral budding (GO:0046755),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,VPS28
NAD metabolic process (GO:0019674),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,NADSYN1
regulation of chondrocyte differentiation (GO:0032330),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CHADL
response to cytokine (GO:0034097),6/138,0.6936048973128792,1,0,0,0.8695652173913043,0.31813286332552565,IFITM1;MAPK8;MX1;TRAFD1;LIFR;TIMP1
transcription initiation from RNA polymerase II promoter (GO:0006367),7/160,0.6938770031397877,1,0,0,0.8749999999999999,0.3197779927015063,WWTR1;NOTCH1;NR5A2;CCNH;NPPA;TAF3;GTF2I
phosphatidylcholine metabolic process (GO:0046470),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,CHAT;PLA2G2A;LCAT
positive regulation of lymphocyte proliferation (GO:0050671),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,CD74;TLR9;IL12B
cellular response to fibroblast growth factor stimulus (GO:0044344),4/94,0.6978008887433855,1,0,0,0.8510638297872339,0.3062310439097954,KIF16B;UBC;FRS2;ITGB1BP1
regulation of nucleic acid-templated transcription (GO:1903506),28/607,0.6983931674782449,1,0,0,0.9225700164744646,0.3311777796743929,ATF2;ZNF792;ZNF350;NOTCH1;FOXO4;ZNF728;PTTG2;ZNF689;ZNF225;APBB3;TCFL5;WWTR1;ARNT2;TCF7L2;ZNF19;ZNF282;ASCC1;RFX3;RUNX3;PTP4A3;TOX2;NR5A2;PRKCQ;ZNF358;ZNF699;ZNF611;TOX;BRDT
protein K48-linked ubiquitination (GO:0070936),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,UBE2R2;TNFAIP3
regulation of cell cycle arrest (GO:0071156),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,GATA6;FOXO4
regulation of epithelial cell migration (GO:0010632),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,MACF1;DUSP10
cellular response to growth factor stimulus (GO:0071363),6/139,0.7002204199629493,1,0,0,0.8633093525179856,0.30764901396557814,EHD1;NTRK2;NOTCH1;ANKRD1;ITGB1BP1;BMP7
protein localization to cell periphery (GO:1990778),5/117,0.7017912619296536,1,0,0,0.8547008547008547,0.3026660400439901,DLG1;PACS1;BSG;P2RY1;ANK2
protein modification by small protein conjugation (GO:0032446),18/398,0.703326997898648,1,0,0,0.9045226130653267,0.31833167241504584,UBL4A;USP5;KLHL26;CUL1;PEX10;KLHL4;KLHL13;TNFAIP1;KLHL42;KBTBD6;UBE2R2;UBC;ELOB;CCDC22;FBXO7;CDK5RAP3;BIRC2;NFE2L2
negative regulation of cysteine-type endopeptidase activity (GO:2000117),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,CAST;RPS6KA1;MT3
transcription elongation from RNA polymerase II promoter (GO:0006368),4/95,0.7056844804748206,1,0,0,0.8421052631578947,0.2935469919093557,CCNH;ELP2;ELOB;TAF3
inorganic cation transmembrane transport (GO:0098662),6/140,0.7067393435253332,1,0,0,0.8571428571428571,0.29750859485229647,SLC24A2;SCNN1A;UCP2;TRPM7;PKD1;TRPM3
positive regulation of microtubule polymerization (GO:0031116),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SLAIN2
positive regulation of neutrophil chemotaxis (GO:0090023),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CD74
dendritic spine organization (GO:0097061),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,WASL
positive regulation of immune effector process (GO:0002699),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,IL12B
negative regulation of protein localization to membrane (GO:1905476),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,ITGB1BP1
regulation of chromosome organization (GO:0033044),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CDT1
ear morphogenesis (GO:0042471),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,NOG
negative regulation of sequestering of calcium ion (GO:0051283),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,HTR2C
regulation of actin filament bundle assembly (GO:0032231),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SYNPO2L
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,DDX39B
positive regulation of microtubule polymerization or depolymerization (GO:0031112),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SLAIN2
positive regulation of endopeptidase activity (GO:0010950),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,BBC3
regulation of AMPA receptor activity (GO:2000311),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,MINK1
cilium-dependent cell motility (GO:0060285),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RFX3
positive regulation of dephosphorylation (GO:0035306),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CNEP1R1
mucosal immune response (GO:0002385),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RPL39
fatty acid derivative biosynthetic process (GO:1901570),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,BDH1
mammary gland development (GO:0030879),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,ARHGAP35
proteoglycan biosynthetic process (GO:0030166),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,GAL3ST4
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,NOP53
cAMP metabolic process (GO:0046058),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,TAAR1
non-recombinational repair (GO:0000726),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,PSMD14;POLL
organic hydroxy compound biosynthetic process (GO:1901617),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,OSBPL3;CYP8B1
regulation of reactive oxygen species metabolic process (GO:2000377),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,PDGFRB;MT3
cilium movement (GO:0003341),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,CFAP61;CCDC183
double-strand break repair (GO:0006302),6/141,0.7131613497714089,1,0,0,0.8510638297872339,0.2877000741740847,PSMD14;TDP2;POLL;PALB2;APTX;FAN1
modification-dependent protein catabolic process (GO:0019941),6/141,0.7131613497714089,1,0,0,0.8510638297872339,0.2877000741740847,UBL4A;PSMD11;PSMD14;UBE2R2;UBC;FBXO7
epithelial cell differentiation (GO:0030855),4/96,0.7134178055156833,1,0,0,0.8333333333333333,0.28140670641508325,LATS1;MCIDAS;ACTL8;E2F8
transcription-coupled nucleotide-excision repair (GO:0006283),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,LIG1;CCNH;UBC
regulation of protein complex assembly (GO:0043254),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,LATS1;CDT1;NOP53
positive regulation of proteasomal protein catabolic process (GO:1901800),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,USP5;TRIB3;NOP53
positive regulation of macromolecule biosynthetic process (GO:0010557),6/142,0.7194862015133059,1,0,0,0.8450704225352113,0.2782123358209349,PDGFRB;YTHDF1;EGF;TLR9;GCK;TLR2
regulation of bone mineralization (GO:0030500),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,CCR1;BMP7
blood circulation (GO:0008015),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,ITGB1BP1;TNNI3
fatty acid beta-oxidation (GO:0006635),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,ETFA;ACAA1
double-strand break repair via nonhomologous end joining (GO:0006303),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,PSMD14;POLL
mRNA metabolic process (GO:0016071),4/97,0.7210011321847114,1,0,0,0.8247422680412371,0.269785213526288,SRSF4;SNRPD3;SRSF11;SNRPB
protein targeting to ER (GO:0045047),4/97,0.7210011321847114,1,0,0,0.8247422680412371,0.269785213526288,RPS29;RPL39;SRP9;RPL19
mitotic spindle organization (GO:0007052),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,PLK2;TUBG1;BIRC2
glucose homeostasis (GO:0042593),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,TCF7L2;BAD;GCK
signal peptide processing (GO:0006465),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,F9
regulation of centrosome duplication (GO:0010824),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PLK2
regulation of voltage-gated calcium channel activity (GO:1901385),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,NPPA
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PDGFRB
glial cell differentiation (GO:0010001),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ERBB3
cyclic nucleotide metabolic process (GO:0009187),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,NUDT4
peptide catabolic process (GO:0043171),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ERAP1
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CSPG5
positive regulation of filopodium assembly (GO:0051491),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,WASL
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,IL12B
positive regulation of glucose transport (GO:0010828),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,BRAF
positive regulation of interleukin-1 beta secretion (GO:0050718),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PANX1
negative regulation of cellular protein localization (GO:1903828),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CDT1
female gamete generation (GO:0007292),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,DMC1
regulation of apoptotic signaling pathway (GO:2001233),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,MADD
ncRNA 3'-end processing (GO:0043628),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TRNT1
negative regulation of insulin receptor signaling pathway (GO:0046627),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PRKCQ
long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ACSL3
positive regulation of neutrophil migration (GO:1902624),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CD74
peptide hormone secretion (GO:0030072),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GHRL
positive regulation of Rho protein signal transduction (GO:0035025),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GPR17
protein depolymerization (GO:0051261),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,NCKAP5L
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,BPNT1
regulation of vascular smooth muscle cell proliferation (GO:1904705),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PDCD4
signal transduction in response to DNA damage (GO:0042770),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,BATF
regulation of protein import into nucleus (GO:0042306),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,WWTR1
response to UV (GO:0009411),4/98,0.7284348779278988,1,0,0,0.8163265306122448,0.25865881578997496,MAPK8;REV1;IL12B;SDF4
purine ribonucleotide biosynthetic process (GO:0009152),3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,NPPA;HTR2C;TAAR1
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),23/512,0.7321018416119248,1,0,0,0.8984375,0.2801648389336166,HEXIM1;TCF7L2;ZNF350;NOTCH1;POU2F1;TSHZ3;ZNF282;CITED2;GATA6;RFX3;UBP1;MT3;BMP7;ARHGAP35;DMBX1;BCLAF1;SFRP2;CCDC85B;HEY2;PDCD4;ANKRD1;TRIB3;TNP1
activation of protein kinase activity (GO:0032147),10/233,0.7336283687351486,1,0,0,0.8583690987124463,0.26588213580322606,GADD45B;MINK1;MADD;UBC;FRS2;GHRL;ITGB1BP1;IKBKG;MT3;DUSP7
sodium ion homeostasis (GO:0055078),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,SCNN1A
positive regulation of glucose import (GO:0046326),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,RARRES2
positive regulation of synapse assembly (GO:0051965),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,GHRL
cytoskeleton-dependent intracellular transport (GO:0030705),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,DYNLL1
response to growth factor (GO:0070848),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,GATA6
monovalent inorganic cation homeostasis (GO:0055067),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,SCNN1A
positive regulation of granulocyte chemotaxis (GO:0071624),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CD74
response to ketone (GO:1901654),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,ABHD2
negative chemotaxis (GO:0050919),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,SEMA3G
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CDT1
negative regulation of cellular response to insulin stimulus (GO:1900077),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PRKCQ
regulation of muscle contraction (GO:0006937),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,TNNT1
phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PLA2G2A
cation transmembrane transport (GO:0098655),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,SLC36A1
snRNA 3'-end processing (GO:0034472),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,EXOSC9
positive regulation of apoptotic signaling pathway (GO:2001235),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,BCLAF1;BAD;BBC3
response to interleukin-1 (GO:0070555),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,ANKRD1;CCL18;CCL16
positive regulation of proteolysis (GO:0045862),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,BAD;TNP1
positive regulation of ossification (GO:0045778),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,IFITM1;BMP7
regulation of cell-matrix adhesion (GO:0001952),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,MACF1;MINK1
positive regulation of nervous system development (GO:0051962),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,CAMK2B;GHRL
positive regulation of mitotic cell cycle (GO:0045931),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,PDGFRB;EGF
positive regulation of secretion by cell (GO:1903532),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,UNC13B;ANKRD1
antigen receptor-mediated signaling pathway (GO:0050851),11/257,0.7433475644492396,1,0,0,0.8560311284046692,0.2538916063956462,PSMA4;PSMD11;PSMD14;PSMA2;UBC;CUL1;HLA-DRA;PRKCQ;RBCK1;IKBKG;CD3D
skeletal system development (GO:0001501),6/146,0.7438119980743109,1,0,0,0.821917808219178,0.24326052069129003,ANKRD11;NOG;GHRL;COL9A2;BMP7;PKD1
positive regulation of cytoskeleton organization (GO:0051495),3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,SYNPO2L;CDC42EP5;RHOG
organic anion transport (GO:0015711),5/124,0.7487088303457675,1,0,0,0.8064516129032258,0.23339122223979591,SLC22A24;SLC22A25;SLC23A1;SLCO6A1;ABCC11
regulation of protein kinase activity (GO:0045859),6/147,0.7496501617847804,1,0,0,0.8163265306122448,0.23522337324693435,WWTR1;MMD;TRIB3;ITGB1BP1;MAPRE3;NYX
protein processing (GO:0016485),4/101,0.7498448770134236,1,0,0,0.792079207920792,0.22803083128155077,F9;MMP16;PCSK9;PMPCA
phosphatidylcholine acyl-chain remodeling (GO:0036151),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PLA2G2A
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,LATS1
telomere maintenance via telomere lengthening (GO:0010833),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ZSCAN4
phosphatidylinositol phosphorylation (GO:0046854),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PI4KB
regulation of cilium assembly (GO:1902017),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ARHGAP35
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,SFRP2
positive regulation of lipid kinase activity (GO:0090218),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PDGFRB
response to hexose (GO:0009746),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,TCF7L2
leukocyte cell-cell adhesion (GO:0007159),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PECAM1
cristae formation (GO:0042407),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,CHCHD3
negative regulation of small GTPase mediated signal transduction (GO:0051058),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,RASA4B
regulation of protein localization to nucleus (GO:1900180),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,CDK5RAP3
transcription from RNA polymerase III promoter (GO:0006383),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,POLR3K
release of sequestered calcium ion into cytosol (GO:0051209),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,HTR2C
negative regulation of cell-matrix adhesion (GO:0001953),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ITGB1BP1
regulation of protein transport (GO:0051223),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,NDEL1
phosphatidylserine metabolic process (GO:0006658),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PLA2G2A
muscle fiber development (GO:0048747),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,TCAP
regulation of autophagy of mitochondrion (GO:1903146),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,FBXO7
regulation of protein localization to cell surface (GO:2000008),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,EGF
cellular response to glucose stimulus (GO:0071333),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,UNC13B
neutrophil chemotaxis (GO:0030593),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,CCL18;CCL16
regulation of calcium ion-dependent exocytosis (GO:0017158),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,C2CD4B;SYT6
RNA processing (GO:0006396),8/193,0.7546266204717633,1,0,0,0.8290155440414507,0.23339456537289388,PRPF6;DDX39B;PABPN1;SRSF4;SNRPD3;SRSF11;SRPK1;SNRPB
cell morphogenesis involved in differentiation (GO:0000904),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,YTHDF2;RADIL
protein targeting to mitochondrion (GO:0006626),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,PMPCA;FBXO7
intracellular transport of virus (GO:0075733),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,UBC;VPS28
positive regulation of immune response (GO:0050778),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,ITGAM;IL12B
positive regulation of response to stimulus (GO:0048584),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,BCLAF1;ANKLE1
transport of virus (GO:0046794),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,UBC;VPS28
glycosphingolipid metabolic process (GO:0006687),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,GALC;SUMF1
sensory perception of chemical stimulus (GO:0007606),14/327,0.7616599464074388,1,0,0,0.856269113149847,0.2331236222884696,OR2G6;OR2C1;OR6K3;OR4K5;OR14I1;OR2H1;OR5L1;OR2M2;OR5M11;OR13C9;OR2W3;OR5D16;OR6C2;OR10A3
regulation of vasculature development (GO:1901342),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,HEY2
negative regulation of endocytosis (GO:0045806),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,TLR2
cellular response to ketone (GO:1901655),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,GNAI1
hydrogen ion transmembrane transport (GO:1902600),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,UCP2
negative regulation of homeostatic process (GO:0032845),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,TNFAIP3
carboxylic acid catabolic process (GO:0046395),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,NPL
negative regulation of proteasomal protein catabolic process (GO:1901799),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,NOP53
positive regulation of phosphate metabolic process (GO:0045937),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,EGF
positive regulation of sprouting angiogenesis (GO:1903672),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,APELA
chondrocyte differentiation (GO:0002062),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,RUNX3
protein K11-linked ubiquitination (GO:0070979),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,FZR1
positive regulation of phospholipid metabolic process (GO:1903727),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PDGFRB
cardiac muscle cell action potential involved in contraction (GO:0086002),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,ANK2
positive regulation of calcium-mediated signaling (GO:0050850),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,JPH2
neural crest cell migration (GO:0001755),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,SEMA3G
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,ERAP1
regulation of fatty acid biosynthetic process (GO:0042304),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,TRIB3
positive regulation of lipid biosynthetic process (GO:0046889),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CNEP1R1
positive regulation of fibroblast proliferation (GO:0048146),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CD74
transcription elongation from RNA polymerase I promoter (GO:0006362),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CCNH
nucleosome organization (GO:0034728),3/79,0.7625315297227274,1,0,0,0.7594936708860759,0.2059074082780564,ANP32E;TNP1;BRDT
regulation of endothelial cell proliferation (GO:0001936),3/79,0.7625315297227274,1,0,0,0.7594936708860759,0.2059074082780564,PTPRM;VEGFC;GHRL
response to calcium ion (GO:0051592),3/79,0.7625315297227274,1,0,0,0.7594936708860759,0.2059074082780564,CRHBP;KCNIP2;BRAF
vesicle organization (GO:0016050),5/127,0.7670589994510474,1,0,0,0.7874015748031495,0.20881225056066524,SNX18;EXOC8;C2CD4B;WASL;SYT6
protein lipidation (GO:0006497),5/127,0.7670589994510474,1,0,0,0.7874015748031495,0.20881225056066524,VNN2;PGAP3;PIGP;TEX101;WIPI2
positive regulation of nucleic acid-templated transcription (GO:1903508),22/502,0.768406764337457,1,0,0,0.8764940239043825,0.23090011910631883,ARHGEF11;ARNT2;CD74;NOTCH1;NCF1;CITED2;EGF;SS18L1;NCOA4;GATA6;RHOG;RFX3;ILF2;RUNX3;MT3;BMP7;NPAS3;NR5A2;DVL3;MAPRE3;TAF3;NFE2L2
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,UBC;LTBP1
regulation of axonogenesis (GO:0050770),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,NTRK2;ARHGAP35
regulation of RNA splicing (GO:0043484),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,SRPK1;BRDT
positive regulation of DNA biosynthetic process (GO:2000573),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,PDGFRB;PRKCQ
negative regulation of cellular response to growth factor stimulus (GO:0090288),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,NOTCH1;NOG
cellular response to DNA damage stimulus (GO:0006974),14/329,0.7692648817416109,1,0,0,0.8510638297872339,0.22325099505247945,ATF2;LIG1;TREX1;DOT1L;FANCA;ALKBH7;APTX;ALKBH8;BATF;CDK3;IKBKG;RAD9B;NOP53;FAN1
regulation of cellular macromolecule biosynthetic process (GO:2000112),28/631,0.770473920663443,1,0,0,0.8874801901743264,0.23140999107322574,ATF2;ZNF792;ZNF350;NOTCH1;FOXO4;ZNF728;PTTG2;ZNF689;ZNF225;APBB3;TCFL5;WWTR1;ARNT2;TCF7L2;ZNF19;ZNF282;ASCC1;RFX3;RUNX3;PTP4A3;TOX2;NR5A2;PRKCQ;ZNF358;ZNF699;ZNF611;TOX;BRDT
nuclear-transcribed mRNA catabolic process (GO:0000956),7/174,0.7726216545178958,1,0,0,0.8045977011494252,0.20755869048599532,RBM8A;PDE12;RPS29;EXOSC9;RPL39;PATL1;RPL19
regulation of striated muscle contraction (GO:0006942),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,ANK2
very long-chain fatty acid metabolic process (GO:0000038),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,ACAA1
synaptic vesicle endocytosis (GO:0048488),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,C2CD4B
lung development (GO:0030324),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,PKD1
cortical cytoskeleton organization (GO:0030865),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,DLG1
regulation of embryonic development (GO:0045995),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,CDX1
regulation of neutrophil chemotaxis (GO:0090022),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,CD74
positive regulation of interleukin-1 secretion (GO:0050716),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,PANX1
negative regulation of lymphocyte proliferation (GO:0050672),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,TNFRSF13B
B cell proliferation (GO:0042100),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,IFNA21
synaptic vesicle recycling (GO:0036465),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,C2CD4B
semaphorin-plexin signaling pathway (GO:0071526),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SEMA3G
regulation of cellular biosynthetic process (GO:0031326),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,IL12B
striated muscle tissue development (GO:0014706),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,BMP7
regulation of myoblast differentiation (GO:0045661),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,NOTCH1
viral process (GO:0016032),9/220,0.7763020553794393,1,0,0,0.8181818181818181,0.20717475374678998,CD8B;RPS29;PACS1;UBC;UBP1;RPL39;AP2A2;VPS28;RPL19
ribosome assembly (GO:0042255),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,NOP53;MDN1
granulocyte chemotaxis (GO:0071621),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,CCL18;CCL16
protein import (GO:0017038),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,POM121L2;NXT1
BMP signaling pathway (GO:0030509),3/81,0.7771926567464108,1,0,0,0.7407407407407407,0.18671630360614933,NOG;PDCD4;BMP7
positive regulation of cell migration (GO:0030335),9/221,0.7807391307190912,1,0,0,0.8144796380090498,0.2015952796875224,CCR1;PDGFRB;SPAG9;APELA;NOTCH1;EGF;TRIP6;GCNT2;SEMA3G
response to endoplasmic reticulum stress (GO:0034976),4/106,0.7826130830889017,1,0,0,0.7547169811320754,0.1849938504751301,RASGRF2;RASGRF1;TRIB3;BBC3
regulation of anatomical structure morphogenesis (GO:0022603),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,CDX1;HEY2;TNFAIP3
generation of neurons (GO:0048699),5/130,0.784373955308741,1,0,0,0.7692307692307693,0.18682260656936742,NTRK2;PRUNE1;PCSK9;RUNX3;POU3F2
regulation of Rho protein signal transduction (GO:0035023),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,GPR17;TNFAIP1
epidermal growth factor receptor signaling pathway (GO:0007173),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,KIF16B;EGF
protein homotetramerization (GO:0051289),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,TDO2;ACACB
regulation of actin cytoskeleton reorganization (GO:2000249),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,RAPGEF3
smoothened signaling pathway (GO:0007224),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,DISP3
beta-catenin-TCF complex assembly (GO:1904837),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,TCF7L2
acylglycerol catabolic process (GO:0046464),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,ABHD2
regulation of leukocyte chemotaxis (GO:0002688),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CXCL9
negative regulation of DNA biosynthetic process (GO:2000279),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,ANKRD1
multivesicular body assembly (GO:0036258),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,VPS28
fatty-acyl-CoA biosynthetic process (GO:0046949),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,ACSL3
regulation of ARF protein signal transduction (GO:0032012),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,AGAP2
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,LATS1
protein localization to lysosome (GO:0061462),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,NCOA4
regulation of developmental growth (GO:0048638),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,LATS1
positive regulation of phospholipase C activity (GO:0010863),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,PDGFRB
aminoglycan metabolic process (GO:0006022),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CSPG5
phosphatidylinositol 3-kinase signaling (GO:0014065),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,ERBB3
response to estradiol (GO:0032355),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CRHBP
regulation of blood coagulation (GO:0030193),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,SERPINE2
nuclear envelope organization (GO:0006998),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,ANKLE1
regulation of sodium ion transmembrane transport (GO:1902305),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,DLG1
negative regulation of cell morphogenesis involved in differentiation (GO:0010771),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,ITGB1BP1
chondroitin sulfate metabolic process (GO:0030204),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CSPG5
negative regulation of response to external stimulus (GO:0032102),4/107,0.7887401751709202,1,0,0,0.747663551401869,0.1774342589951246,NLRP14;NLRX1;TNFAIP3;GHRL
Ras protein signal transduction (GO:0007265),9/223,0.7894214255919177,1,0,0,0.8071748878923766,0.1908605175379942,ARHGEF11;CNKSR1;RAB30;CDC42EP5;PLK2;RHOG;RAB39B;RAB17;RAPGEF3
ubiquitin-dependent ERAD pathway (GO:0030433),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,DERL2;MAN1B1
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,EGF;UBC
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,NTRK2;SS18L1
sodium ion transport (GO:0006814),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,SLC23A1;SCNN1A
"DNA-templated transcription, elongation (GO:0006354)",4/108,0.7947283904475327,1,0,0,0.7407407407407407,0.1701887925469081,CCNH;ELP2;ELOB;TAF3
regulation of dendritic spine development (GO:0060998),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,CAMK2B
negative regulation of cell-cell adhesion (GO:0022408),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,EPCAM
regulation of ubiquitin-protein transferase activity (GO:0051438),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,TRIB3
alpha-amino acid metabolic process (GO:1901605),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,NOX4
regulation of protein tyrosine kinase activity (GO:0061097),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,ERBB3
secondary alcohol metabolic process (GO:1902652),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,LCAT
skeletal system morphogenesis (GO:0048705),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,ANKRD11
anterograde axonal transport (GO:0008089),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,NEFL
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,TNFAIP3
multivesicular body organization (GO:0036257),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,VPS28
positive regulation of interleukin-1 beta production (GO:0032731),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,PANX1
positive regulation of bone mineralization (GO:0030501),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,BMP7
positive regulation of multicellular organismal process (GO:0051240),8/202,0.7969426233488249,1,0,0,0.792079207920792,0.17978027212892997,WWTR1;APELA;NOTCH1;BAD;GCNT2;IL12B;RFX3;GHRL
protein modification process (GO:0036211),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,UBL4A;RPN1;ST8SIA4
regulation of mitotic nuclear division (GO:0007088),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,PDGFRB;EGF;BMP7
"negative regulation of transcription, DNA-templated (GO:0045892)",36/813,0.7995222429879919,1,0,0,0.8856088560885608,0.19814694551020204,ZNF350;NOTCH1;TSHZ3;CITED2;GATA6;UBP1;ARHGAP35;DMBX1;PRDX5;BCLAF1;CHCHD3;SIN3B;CCDC85B;HEY2;UBC;E2F8;TCFL5;HEXIM1;TCF7L2;POU2F1;ZNF282;NOG;RFX3;DUSP26;MT3;BMP7;DKK1;RUNX3;GFI1B;DLG1;SFRP2;PDCD4;TRIB3;TNP1;NOP53;TAF3
regulation of Wnt signaling pathway (GO:0030111),4/109,0.8005792983505415,1,0,0,0.7339449541284404,0.1632438094873767,MACF1;SFRP2;DKK1;TLR2
positive regulation of gene expression (GO:0010628),34/771,0.8009120872205036,1,0,0,0.8819714656290532,0.19580127414932463,ATF2;NOTCH1;NCF1;CITED2;GATA6;NPAS3;TRMT112;MAPK9;MAPK8;DVL3;ARHGEF11;NTRK2;CD74;ARNT2;YTHDF1;EGF;SS18L1;NCOA4;NOG;RHOG;RFX3;ANK2;BRAF;MT3;BMP7;DKK1;ILF2;RUNX3;NR5A2;TLR9;MAPRE3;TAF3;NFE2L2;TLR2
renal system development (GO:0072001),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,PCSK9;PKD1
regulation of extrinsic apoptotic signaling pathway (GO:2001236),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,TCF7L2;MADD
sterol metabolic process (GO:0016125),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,LCAT;CYP8B1
cell morphogenesis (GO:0000902),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,RHOG;NOX4
macroautophagy (GO:0016236),4/110,0.8062945339593786,1,0,0,0.7272727272727272,0.1565863101665403,UBC;WIPI2;DYNLL1;VPS28
negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,TLR9
protein deacetylation (GO:0006476),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,SIN3B
7-methylguanosine mRNA capping (GO:0006370),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,CCNH
positive regulation of calcium ion transport into cytosol (GO:0010524),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,CXCL9
oxoacid metabolic process (GO:0043436),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,BPNT1
ceramide biosynthetic process (GO:0046513),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,ST8SIA4
microtubule bundle formation (GO:0001578),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,NCKAP5L
7-methylguanosine RNA capping (GO:0009452),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,CCNH
endodermal cell differentiation (GO:0035987),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,LAMA3
purine ribonucleoside triphosphate metabolic process (GO:0009205),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,BAD
substrate adhesion-dependent cell spreading (GO:0034446),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,RADIL
positive regulation of telomere maintenance via telomerase (GO:0032212),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,PRKCQ
positive regulation of telomere maintenance (GO:0032206),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,PRKCQ
aminoglycan catabolic process (GO:0006026),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,CHI3L2
global genome nucleotide-excision repair (GO:0070911),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,UBC
positive regulation of cellular biosynthetic process (GO:0031328),6/159,0.81225235415146535,1,0,0,0.7547169811320754,0.15693902349294486,PDGFRB;YTHDF1;EGF;CNEP1R1;TYRP1;GCK
extracellular matrix organization (GO:0030198),9/229,0.8139497618246632,1,0,0,0.7860262008733624,0.1618087068034026,ITGAM;CAPNS1;EXOC8;MMP16;BSG;LAMA3;PECAM1;COL9A2;TIMP1
actin cytoskeleton reorganization (GO:0031532),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,MINK1;RHOG
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,IL12B;IL22RA2
glycosaminoglycan metabolic process (GO:0030203),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,GCNT2;CSPG5
protein targeting to membrane (GO:0006612),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,NCF1;CHM
axonemal dynein complex assembly (GO:0070286),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,CCDC183
activation of MAPKK activity (GO:0000186),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,FRS2
positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,CD74
response to exogenous dsRNA (GO:0043330),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,IFNA21
intra-Golgi vesicle-mediated transport (GO:0006891),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,VTI1A
mRNA stabilization (GO:0048255),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,DAZ3
transcription initiation from RNA polymerase I promoter (GO:0006361),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,CCNH
positive regulation of biomineral tissue development (GO:0070169),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,BMP7
regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,PDGFRB
negative regulation of multi-organism process (GO:0043901),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,TIMP1
regulation of intracellular protein transport (GO:0033157),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,NDEL1
positive regulation of organelle organization (GO:0010638),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,STX18
cellular response to BMP stimulus (GO:0071773),3/87,0.8167521653641692,1,0,0,0.689655172413793,0.13959970848873965,NOG;PDCD4;BMP7
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",4/112,0.8173248241169633,1,0,0,0.7142857142857142,0.14408477257015773,RBM8A;RPS29;RPL39;RPL19
negative regulation of intracellular signal transduction (GO:1902532),6/161,0.8213866488058535,1,0,0,0.7453416149068323,0.14665440878370145,NLRX1;NDUFS3;TNFAIP3;TRIB3;CCDC22;NOP53
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),3/88,0.8227310669841436,1,0,0,0.6818181818181818,0.1330403886090264,USP5;TRIB3;NOP53
positive regulation of protein complex assembly (GO:0031334),3/88,0.8227310669841436,1,0,0,0.6818181818181818,0.1330403886090264,UNC13B;CDT1;BCLAF1
establishment of protein localization to organelle (GO:0072594),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,POM121L2;NXT1
second-messenger-mediated signaling (GO:0019932),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,CCR5;NUDT4
apoptotic mitochondrial changes (GO:0008637),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,BBC3
positive regulation of leukocyte migration (GO:0002687),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,CXCL9
negative regulation of DNA binding (GO:0043392),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,HEY2
positive regulation of muscle cell differentiation (GO:0051149),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,SPAG9
regulation of wound healing (GO:0061041),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,TNFAIP3
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,PRKCQ
positive regulation of DNA binding (GO:0043388),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,EGF
regulation of alcohol biosynthetic process (GO:1902930),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,ACACB
regulation of insulin receptor signaling pathway (GO:0046626),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,PRKCQ
regulation of interleukin-1 beta secretion (GO:0050706),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,PANX1
anterior/posterior pattern specification (GO:0009952),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,CDX1
macromolecule catabolic process (GO:0009057),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,KIF16B
"DNA-templated transcription, initiation (GO:0006352)",7/186,0.8273600898825334,1,0,0,0.7526881720430108,0.1426458959005734,WWTR1;NOTCH1;NR5A2;CCNH;NPPA;TAF3;GTF2I
negative regulation of protein modification process (GO:0031400),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,WWTR1;CDK5RAP3
ribosomal large subunit biogenesis (GO:0042273),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,NOP53;MDN1
protein O-linked glycosylation (GO:0006493),4/115,0.832896768257819,1,0,0,0.6956521739130435,0.12719691976114322,GALNT7;MUCL1;GALNT15;RFNG
epithelium development (GO:0060429),4/115,0.832896768257819,1,0,0,0.6956521739130435,0.12719691976114322,APELA;ZNF358;PKD1;ACTL8
positive regulation of RNA metabolic process (GO:0051254),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,TRMT112
lipid phosphorylation (GO:0046834),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PI4KB
regulation of cyclin-dependent protein kinase activity (GO:1904029),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CDK5RAP3
regulation of heart rate by cardiac conduction (GO:0086091),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,ANK2
antibacterial humoral response (GO:0019731),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,RPL39
positive regulation of DNA replication (GO:0045740),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CDT1
endothelial cell migration (GO:0043542),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PTP4A3
regulation of mitotic spindle organization (GO:0060236),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,GNAI1
regulation of sodium ion transport (GO:0002028),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,DLG1
positive regulation of ATPase activity (GO:0032781),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,DYNLL1
regulation of phosphoprotein phosphatase activity (GO:0043666),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PDGFRB
positive regulation of telomerase activity (GO:0051973),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PRKCQ
neural crest cell development (GO:0014032),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,SEMA3G
sulfur compound catabolic process (GO:0044273),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CSPG5
positive regulation of JAK-STAT cascade (GO:0046427),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,NOTCH1;IL12B
glucose metabolic process (GO:0006006),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,GHRL;SLC25A11
negative regulation of neuron differentiation (GO:0045665),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,DISP3;BMP7
regulation of macroautophagy (GO:0016241),4/116,0.8378353080759515,1,0,0,0.689655172413793,0.1220232603840384,MAPK8;CAPNS1;EXOC8;IKBKG
regulation of mitotic cell cycle (GO:0007346),6/165,0.8385956609296656,1,0,0,0.7272727272727272,0.12801935886721602,BRINP2;DLG1;MCIDAS;MINK1;CDK5RAP3;GNAI1
positive regulation of cellular protein metabolic process (GO:0032270),3/91,0.8396768561291149,1,0,0,0.6593406593406593,0.11521197114942941,YTHDF1;BAD;ASPSCR1
phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),3/91,0.8396768561291149,1,0,0,0.6593406593406593,0.11521197114942941,OPRD1;GPR17;HTR2C
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),16/396,0.8421178050106696,1,0,0,0.8080808080808081,0.13885685946456197,EPHB6;PDGFRB;NTRK2;NCF1;VEGFC;FRS2;FOXO4;WASL;SOGA1;KALRN;AP2A2;CNKSR1;CD8B;ERBB3;KIF16B;UBC
regulation of receptor-mediated endocytosis (GO:0048259),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,DKK1
histone exchange (GO:0043486),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,ANP32E
organic hydroxy compound transport (GO:0015850),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,GHRL
regulation of nitric-oxide synthase activity (GO:0050999),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,WASL
lymphocyte proliferation (GO:0046651),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,IFNA21
sodium ion transmembrane transport (GO:0035725),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,SCNN1A
calcium ion transmembrane import into cytosol (GO:0097553),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,HTR2C
heart looping (GO:0001947),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,NOTCH1
histone deacetylation (GO:0016575),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,SIN3B
regulation of blood circulation (GO:1903522),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,KCNIP2
plasma membrane organization (GO:0007009),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,ANK2
endosome organization (GO:0007032),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,EXOC8
epithelial cell migration (GO:0010631),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,PTP4A3
acylglycerol metabolic process (GO:0006639),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,ABHD2
axonal transport (GO:0098930),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,NEFL
regulation of ubiquitin protein ligase activity (GO:1904666),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,FZR1
inner mitochondrial membrane organization (GO:0007007),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,CHCHD3
regulation of cell division (GO:0051302),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,SFRP2;KLHL13
negative regulation of apoptotic signaling pathway (GO:2001234),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,TCF7L2;NDUFS3
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),5/142,0.8437741668121552,1,0,0,0.704225352112676,0.11962703877312425,ITGAM;PECAM1;PTPRM;DSG1;PKD1
positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),8/215,0.8480666942392859,1,0,0,0.7441860465116279,0.12263888179781321,OPRD1;ATF2;UBC;TLR9;PRKCQ;RBCK1;IKBKG;TLR2
organelle assembly (GO:0070925),15/376,0.8487592565433657,1,0,0,0.7978723404255319,0.13083486229732733,NOTCH1;NCF1;IFT172;RFX3;WIPI2;TUBG1;DYNLL1;PATL1;HAUS1;EHD1;IFT43;MCIDAS;GOLGA6D;RAB17;VPS28
cellular response to light stimulus (GO:0071482),2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,OPN3;PDE6B
positive regulation of cellular protein localization (GO:1903829),2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,CDT1;CDK5RAP3
protein monoubiquitination (GO:0006513),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,UBE2R2
myelination (GO:0042552),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,MAL2
positive regulation of smooth muscle cell proliferation (GO:0048661),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,PDGFRB
phospholipid biosynthetic process (GO:0008654),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,CPNE6
negative regulation of G0 to G1 transition (GO:0070317),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,FOXO4
regulation of carbohydrate catabolic process (GO:0043470),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,GCK
response to steroid hormone (GO:0048545),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,ABHD2
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,UBC
positive regulation of multi-organism process (GO:0043902),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,APELA
brain development (GO:0007420),4/119,0.851921877903696,1,0,0,0.6722689075630252,0.10773811694664917,DMBX1;ARNT2;SLC23A1;CDK5RAP3
positive regulation of endothelial cell proliferation (GO:0001938),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,APELA;VEGFC
extrinsic apoptotic signaling pathway (GO:0097191),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,ERBB3;BAD
insulin receptor signaling pathway (GO:0008286),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,FOXO4;SOGA1
regulation of protein localization to plasma membrane (GO:1903076),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,DLG1;RHOG
vesicle fusion (GO:0006906),3/94,0.855203978006065,1,0,0,0.6382978723404255,0.09983953259459333,VTI1A;C2CD4B;SYT6
respiratory electron transport chain (GO:0022904),3/94,0.855203978006065,1,0,0,0.6382978723404255,0.09983953259459333,NDUFS3;UQCRFS1;ETFA
T cell differentiation (GO:0030217),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,CD3D
DNA damage checkpoint (GO:0000077),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,DOT1L
protein phosphorylation (GO:0006468),19/470,0.8593369939618483,1,0,0,0.8085106382978724,0.12256546221066864,PDGFRB;CAMK2B;NTRK2;MAST3;PLK2;MINK1;BRAF;RUNX3;PKD1;SRPK1;LATS1;MAPK9;MAPK8;CDK3;RPS6KA1;TLR9;PRKG2;PRKCQ;TLR2
regulation of cytoskeleton organization (GO:0051493),3/95,0.86007960317269,1,0,0,0.631578947368421,0.09519810454070905,PDGFRB;ARHGAP28;ARHGAP35
peptidyl-threonine phosphorylation (GO:0018107),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,CAMK2B;MAPK8
positive regulation of T cell activation (GO:0050870),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,IL12B;PRKCQ
skeletal muscle tissue development (GO:0007519),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,ANKRD1
regulation of type I interferon-mediated signaling pathway (GO:0060338),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,IFNA21
regulation of G0 to G1 transition (GO:0070316),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,FOXO4
regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,RAB17
regulation of RNA metabolic process (GO:0051252),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,BRDT
cellular response to amino acid starvation (GO:0034198),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,MAPK8
positive regulation of protein kinase activity (GO:0045860),6/172,0.8654695388328904,1,0,0,0.6976744186046511,0.10080216269543664,ERBB3;MMD;MINK1;IL12B;MAPRE3;DKK1
regulation of endothelial cell migration (GO:0010594),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,PTPRM;ITGB1BP1
cellular response to organonitrogen compound (GO:0071417),3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,CRHBP;GABRB2;RAPGEF3
mitochondrial respiratory chain complex assembly (GO:0033108),3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,SDHAF1;NDUFS3;SDHAF4
regulation of cell proliferation (GO:0042127),31/740,0.8696192082510379,1,0,0,0.8378378378378378,0.11704582430356938,IFITM1;CXCL9;NOTCH1;DOT1L;CUL1;DERL2;FOXO4;CCND2;CAPNS1;ERBB3;EPCAM;GCNT2;TIMP1;TCFL5;PDGFRB;NTRK2;WWTR1;TCF7L2;EGF;GKN1;GML;RHOG;VEGFC;LIFR;POU3F2;SFRP2;CDK3;NOX4;GHRL;ITGB1BP1;BIRC2
vascular endothelial growth factor receptor signaling pathway (GO:0048010),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,NCF1;VEGFC
cytoskeleton-dependent cytokinesis (GO:0061640),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,CECR2;SNX18
snRNA transcription (GO:0009301),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,POU2F1;RPRD1A
snRNA transcription from RNA polymerase II promoter (GO:0042795),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,POU2F1;RPRD1A
negative regulation of developmental process (GO:0051093),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,TIMP1;RAPGEF3
embryonic heart tube morphogenesis (GO:0003143),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,NOTCH1
regulation of cellular localization (GO:0060341),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,DVL3
cognition (GO:0050890),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,HLA-DRA
ameboidal-type cell migration (GO:0001667),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,SEMA3G
positive regulation of mitotic cell cycle phase transition (GO:1901992),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,CCND2
tRNA aminoacylation (GO:0043039),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,GATB
androgen receptor signaling pathway (GO:0030521),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,NCOA4
response to peptide hormone (GO:0043434),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,GNAI1
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,TAS2R42
phosphatidic acid biosynthetic process (GO:0006654),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,PLA2G2A
negative regulation of catabolic process (GO:0009895),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,AGAP2
neuron migration (GO:0001764),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,NTRK2
regulation of cholesterol biosynthetic process (GO:0045540),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,ACACB
regulation of ATPase activity (GO:0043462),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,TNNI3
determination of heart left/right asymmetry (GO:0061371),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,NOTCH1
organelle membrane fusion (GO:0090174),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,C2CD4B;SYT6
"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",4/125,0.8769959948339774,1,0,0,0.64,0.08400182624919345,CCR1;OPRD1;HTR2C;GNAI1
odontogenesis (GO:0042476),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,ANKRD11
regulation of phagocytosis (GO:0050764),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,TLR2
regulation of cholesterol metabolic process (GO:0090181),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,ACACB
phosphatidic acid metabolic process (GO:0046473),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,PLA2G2A
DNA duplex unwinding (GO:0032508),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,UBC
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,DSG1
telomere organization (GO:0032200),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,DOT1L
negative regulation of STAT cascade (GO:1904893),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,NYX
sensory perception of bitter taste (GO:0050913),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,TAS2R42
gluconeogenesis (GO:0006094),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,SLC25A11
cytoskeleton organization (GO:0007010),4/126,0.8807972251377655,1,0,0,0.6349206349206349,0.08058910728074854,CECR2;MAST3;SYNE3;SYNE1
lysosomal transport (GO:0007041),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,NCOA4;PCSK9
regulation of phosphatase activity (GO:0010921),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,ZCCHC9;CDK5RAP3
positive regulation of intracellular protein transport (GO:0090316),5/152,0.8823360987788662,1,0,0,0.6578947368421052,0.08235673104394964,TCF7L2;ITGAM;ITGB1BP1;IFNL3;RAPGEF3
cellular macromolecule biosynthetic process (GO:0034645),14/367,0.8828719435755342,1,0,0,0.7629427792915531,0.09504368306369082,DUT;EGF;TREX1;TOP3A;REV1;GATB;TNFAIP1;ILF2;RPS29;POLL;RAD9B;RPL39;EIF4G2;RPL19
rRNA processing (GO:0006364),7/202,0.883563654381017,1,0,0,0.6930693069306931,0.08579639534037632,RPS29;EXOSC9;SRFBP1;NOL11;RPL39;MDN1;RPL19
positive regulation of protein localization to nucleus (GO:1900182),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,CDK5RAP3
regulation of telomerase activity (GO:0051972),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,PRKCQ
cellular response to retinoic acid (GO:0071300),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,BRINP2
regulation of immune response (GO:0050776),9/251,0.885573985210392,1,0,0,0.7171314741035857,0.08714529562675144,NLRP14;IFITM1;NLRX1;CD8B;KIR2DS2;ERAP1;CD1C;CD3D;BIRC2
lymphocyte differentiation (GO:0030098),2/73,0.8859324931436037,1,0,0,0.547945205479452,0.06636412280550928,CD3D;IFNA21
positive regulation of cytokine secretion (GO:0050715),2/73,0.8859324931436037,1,0,0,0.547945205479452,0.06636412280550928,CD14;TLR2
metal ion transport (GO:0030001),3/101,0.8864097011888528,1,0,0,0.594059405940594,0.07162931796059352,KCNIP2;SLC23A1;ATOX1
positive regulation of mitochondrion organization (GO:0010822),4/128,0.8880944399025825,1,0,0,0.625,0.07417324400200773,BAD;FBXO7;IFNL3;BBC3
regulation of protein processing (GO:0070613),4/128,0.8880944399025825,1,0,0,0.625,0.07417324400200773,CPB2;C6;SERPINE2;TNP1
intracellular protein transport (GO:0006886),13/347,0.8899297776255123,1,0,0,0.7492795389048991,0.08737552575629592,OPRD1;CD74;ANKLE1;NXT1;RAB39B;MT3;PKD1;EHD1;POM121L2;RAB30;TBC1D3L;RAB17;VPS28
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,ZMAT4
response to unfolded protein (GO:0006986),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,DNAJB5
regulation of ATP metabolic process (GO:1903578),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,GCK
ER to Golgi vesicle-mediated transport (GO:0006888),6/180,0.8915261259625002,1,0,0,0.6666666666666666,0.07654702432386451,F9;LMAN2L;VTI1A;ANK2;DYNLL1;YIF1B
C-terminal protein lipidation (GO:0006501),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,VNN2;TEX101
detection of chemical stimulus involved in sensory perception of taste (GO:0050912),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,TAS2R42
hexose biosynthetic process (GO:0019319),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,SLC25A11
unsaturated fatty acid metabolic process (GO:0033559),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,ACAA1
regulation of dendrite morphogenesis (GO:0048814),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,SS18L1
protein N-linked glycosylation via asparagine (GO:0018279),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,RPN1
mitotic nuclear envelope disassembly (GO:0007077),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,CNEP1R1
regulation of steroid biosynthetic process (GO:0050810),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,ACACB
posttranscriptional regulation of gene expression (GO:0010608),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,GCNT2
regulation of cellular response to stress (GO:0080135),3/104,0.8978388517991447,1,0,0,0.5769230769230769,0.0621719302632217,CAMK2B;CRHBP;IER3
monovalent inorganic cation transport (GO:0015672),3/104,0.8978388517991447,1,0,0,0.5769230769230769,0.0621719302632217,SLC36A1;KCNIP2;SLC23A1
peptide metabolic process (GO:0006518),3/104,0.8978388517991447,1,0,0,0.5769230769230769,0.0621719302632217,F9;GDAP1L1;ERAP1
positive regulation of lymphocyte activation (GO:0051251),3/104,0.8978388517991447,1,0,0,0.5769230769230769,0.0621719302632217,TLR9;IL12B;PRKCQ
"phagocytosis, engulfment (GO:0006911)",3/104,0.8978388517991447,1,0,0,0.5769230769230769,0.0621719302632217,ITGAM;MEGF10;RHOG
hemopoiesis (GO:0030097),2/76,0.8990559259149057,1,0,0,0.5263157894736842,0.056005282852014004,TNFRSF13B;RUNX3
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),2/76,0.8990559259149057,1,0,0,0.5263157894736842,0.056005282852014004,TCF7L2;TNFAIP3
hexose metabolic process (GO:0019318),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,GHRL
protein polymerization (GO:0051258),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,COBL
peptidyl-asparagine modification (GO:0018196),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,RPN1
mitochondrial gene expression (GO:0140053),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,GATB
protein complex subunit organization (GO:0071822),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,CDT1
ERAD pathway (GO:0036503),2/77,0.9031081450221422,1,0,0,0.5194805194805194,0.05294180301649679,DERL2;MAN1B1
response to ionizing radiation (GO:0010212),2/77,0.9031081450221422,1,0,0,0.5194805194805194,0.05294180301649679,DMC1;RAD9B
regulation of cytokinesis (GO:0032465),2/77,0.9031081450221422,1,0,0,0.5194805194805194,0.05294180301649679,KLHL13;E2F8
protein complex disassembly (GO:0043241),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,DVL3
cellular response to ionizing radiation (GO:0071479),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,RAD9B
regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,CCND2
nuclear envelope disassembly (GO:0051081),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,CNEP1R1
tRNA aminoacylation for protein translation (GO:0006418),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,LRRC47
RNA secondary structure unwinding (GO:0010501),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,DDX39B
regulation of generation of precursor metabolites and energy (GO:0043467),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,GCK
regulation of fibroblast proliferation (GO:0048145),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,CD74
mitotic spindle assembly (GO:0090307),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,BIRC2
icosanoid metabolic process (GO:0006690),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,HPGD
aminoglycan biosynthetic process (GO:0006023),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,GCNT2
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,NDUFS3
positive regulation of translation (GO:0045727),2/78,0.9070080241695482,1,0,0,0.5128205128205128,0.0500533240880421,YTHDF1;DAZ3
viral life cycle (GO:0019058),3/107,0.9082222841413132,1,0,0,0.5607476635514018,0.053981004122237344,UBC;UBP1;VPS28
peptide cross-linking (GO:0018149),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,LCE3B
negative regulation of JAK-STAT cascade (GO:0046426),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,NYX
"positive regulation of gene expression, epigenetic (GO:0045815)",1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,KMT2B
histone H4 acetylation (GO:0043967),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,EP400
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,BMP7
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,BAD;BBC3
steroid biosynthetic process (GO:0006694),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,OSBPL3;CYP8B1
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,CITED2;UBC
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),22/565,0.9109322248970361,1,0,0,0.7787610619469026,0.07264811253638653,HEXIM1;TCF7L2;ZNF350;NOTCH1;CITED2;NOG;GATA6;DUSP26;DKK1;RUNX3;ARHGAP35;GFI1B;DLG1;CHCHD3;SIN3B;HEY2;UBC;TRIB3;NOP53;TAF3;E2F8;TCFL5
negative regulation of hydrolase activity (GO:0051346),3/108,0.9114649563237461,1,0,0,0.5555555555555555,0.051501184313357255,ZCCHC9;TNNI3;PTX3
endocytosis (GO:0006897),9/263,0.9139369295123392,1,0,0,0.6844106463878327,0.061592656530010545,EHD1;SNX18;HEATR5A;RHOG;PECAM1;CD14;WASL;SYP;PI4KB
"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,RINT1;STX18
regulation of protein serine/threonine kinase activity (GO:0071900),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,TRIB3;CDK5RAP3
cellular response to hormone stimulus (GO:0032870),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,QRFPR;GCK
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),3/109,0.9146032191683431,1,0,0,0.5504587155963303,0.049136668628761794,BAD;ARL6IP5;BBC3
viral gene expression (GO:0019080),3/110,0.9176399007049346,1,0,0,0.5454545454545454,0.04688194382454664,RPS29;RPL39;RPL19
epidermis development (GO:0008544),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,CALML5;LAMA3
protein catabolic process (GO:0030163),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,PSMA4;PSMA2
glutathione metabolic process (GO:0006749),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,GDAP1L1
protein autoubiquitination (GO:0051865),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,RNF208
establishment of protein localization to mitochondrion (GO:0072655),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,FBXO7
plasma membrane bounded cell projection assembly (GO:0120031),8/241,0.9193661993761398,1,0,0,0.6639004149377593,0.05581461249509647,EHD1;NOTCH1;IFT43;MCIDAS;IFT172;RFX3;RAB17;DYNLL1
negative regulation of cell proliferation (GO:0008285),13/363,0.9210371440620816,1,0,0,0.7162534435261708,0.0589153649673029,IFITM1;NOTCH1;GML;NOG;CUL1;TNFAIP3;FOXO4;RUNX3;SFRP2;DUSP10;IL12B;NOX4;ITGB1BP1
modulation of chemical synaptic transmission (GO:0050804),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,GRID1;CEL
mitotic sister chromatid segregation (GO:0000070),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,TUBG1;ZWINT
C-terminal protein amino acid modification (GO:0018410),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,VNN2;TEX101
central nervous system development (GO:0007417),7/217,0.9215003330125441,1,0,0,0.6451612903225806,0.05274331644604892,DMBX1;ARNT2;PROP1;SLC23A1;CELSR1;PKD1;CDK5RAP3
protein oligomerization (GO:0051259),7/217,0.9215003330125441,1,0,0,0.6451612903225806,0.05274331644604892,EHD1;PANX1;CPSF7;KCNC2;TNFAIP3;CD3D;AASS
negative regulation of gene expression (GO:0010629),24/618,0.9216475634259478,1,0,0,0.7766990291262135,0.06337272291423056,HEXIM1;CCR1;OPRD1;TCF7L2;ZNF350;NOTCH1;POU2F1;TSHZ3;ZNF282;CITED2;GATA6;RFX3;UBP1;MT3;BMP7;ARHGAP35;DMBX1;BCLAF1;SFRP2;CCDC85B;HEY2;PDCD4;TRIB3;TNP1
fatty acid oxidation (GO:0019395),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,ACAA1
myeloid leukocyte differentiation (GO:0002573),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,BATF
neurogenesis (GO:0022008),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,PCSK9
regulation of cellular component organization (GO:0051128),4/140,0.9241810645107653,1,0,0,0.5714285714285714,0.04505558244276368,ARHGEF11;LATS1;PRKCQ;RAB17
positive regulation of homeostatic process (GO:0032846),2/83,0.9243958207118659,1,0,0,0.4819277108433735,0.03788670924051055,PLEKHM1;DEF8
protein maturation (GO:0051604),2/83,0.9243958207118659,1,0,0,0.4819277108433735,0.03788670924051055,MMP16;PMPCA
viral transcription (GO:0019083),3/113,0.9261680268010687,1,0,0,0.5309734513274336,0.04072545470868394,RPS29;RPL39;RPL19
regulation of organelle organization (GO:0033043),3/113,0.9261680268010687,1,0,0,0.5309734513274336,0.04072545470868394,CDT1;TBC1D3L;STX18
positive regulation of developmental process (GO:0051094),3/113,0.9261680268010687,1,0,0,0.5309734513274336,0.04072545470868394,APELA;RPS6KA1;RAPGEF3
peptidyl-tyrosine modification (GO:0018212),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,PDGFRB
response to organonitrogen compound (GO:0010243),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,QRFPR
regulation of telomere maintenance via telomerase (GO:0032210),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,PRKCQ
telomere maintenance (GO:0000723),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,ZSCAN4
mitochondrial ATP synthesis coupled electron transport (GO:0042775),2/85,0.9304527474425885,1,0,0,0.47058823529411764,0.03392187580644571,NDUFS3;UQCRFS1
B cell differentiation (GO:0030183),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,IFNA21
triglyceride metabolic process (GO:0006641),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,MOGAT2
axonogenesis (GO:0007409),7/223,0.9333684881308107,1,0,0,0.6278026905829596,0.043290264071117746,LRFN3;PLPPR4;TLR9;FRS2;PRKCQ;LRRC55;ARHGAP35
cellular protein complex assembly (GO:0043623),4/144,0.9336516399151867,1,0,0,0.5555555555555555,0.03813993714585849,PSMD11;VBP1;CUL1;EIF4H
sphingolipid metabolic process (GO:0006665),3/116,0.9338791037872658,1,0,0,0.5172413793103448,0.035383597412689746,GALC;SPTLC3;SUMF1
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),3/116,0.9338791037872658,1,0,0,0.5172413793103448,0.035383597412689746,CD74;ERBB3;IL12B
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),1/53,0.9342669389173686,1,0,0,0.3773584905660377,0.02565776594269266,UBC
positive regulation of protein import into nucleus (GO:0042307),1/53,0.9342669389173686,1,0,0,0.3773584905660377,0.02565776594269266,EGF
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/53,0.9342669389173686,1,0,0,0.3773584905660377,0.02565776594269266,IL12B
cellular response to nutrient levels (GO:0031669),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,PCSK9
negative regulation of supramolecular fiber organization (GO:1902904),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,CHADL
rRNA metabolic process (GO:0016072),6/200,0.9385668961689758,1,0,0,0.6,0.038040687368497916,RPS29;EXOSC9;NOL11;RPL39;MDN1;RPL19
ncRNA processing (GO:0034470),7/227,0.9403773436361361,1,0,0,0.6167400881057269,0.037913514016226925,POP7;RPS29;EXOSC9;NOL11;RPL39;MDN1;RPL19
long-chain fatty acid metabolic process (GO:0001676),1/55,0.9406924613791231,1,0,0,0.3636363636363636,0.022232368682920493,ACAA1
negative regulation of cellular protein metabolic process (GO:0032269),2/89,0.9412159961600209,1,0,0,0.449438202247191,0.02722814686661418,SERPINE2;CDK5RAP3
regulation of cell cycle process (GO:0010564),2/90,0.9436483877912323,1,0,0,0.4444444444444444,0.025778512347182387,YTHDF2;KLHL13
DNA-dependent DNA replication (GO:0006261),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,GINS3
organonitrogen compound catabolic process (GO:1901565),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,ERAP1
autophagosome organization (GO:1905037),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,WIPI2
ATP metabolic process (GO:0046034),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,BAD
glycosaminoglycan catabolic process (GO:0006027),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,CSPG5
regulation of glycolytic process (GO:0006110),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,GCK
response to retinoic acid (GO:0032526),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,BRINP2
translation (GO:0006412),7/232,0.9482160577150395,1,0,0,0.603448275862069,0.032087091033292194,TRMT112;RPS29;EIF4H;GATB;RPL39;FTSJ1;RPL19
receptor metabolic process (GO:0043112),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,KIF16B
autophagosome assembly (GO:0000045),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,WIPI2
organonitrogen compound biosynthetic process (GO:1901566),5/181,0.9515523934975361,1,0,0,0.5524861878453038,0.027436756715576553,TYW5;SPTLC3;MGST3;CHAT;LCAT
mitotic cytokinesis (GO:0000281),1/59,0.95172205472190885,1,0,0,0.3389830508474576,0.01677364276098951,SNX18
keratinocyte differentiation (GO:0030216),1/59,0.95172205472190885,1,0,0,0.3389830508474576,0.01677364276098951,LCE3B
skin development (GO:0043588),2/94,0.9524527851404014,1,0,0,0.42553191489361697,0.02072967770905844,LCE3B;PKD1
cellular protein metabolic process (GO:0044267),17/484,0.9540936323796084,1,0,0,0.7024793388429752,0.03301193836471135,UBL4A;ABCA3;RPN1;GATA6;GATB;PCSK9;TTF1;LTBP1;F9;RPS29;NPPA;UBC;ST8SIA4;TIMP1;RPL39;CHGB;RPL19
nucleosome assembly (GO:0006334),1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,ANP32E
membrane lipid biosynthetic process (GO:0046467),1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,SPTLC3
regulation of B cell activation (GO:0050864),2/95,0.9544392929248489,1,0,0,0.42105263157894735,0.019634205791927362,TLR9;TNFAIP3
negative regulation of cellular process (GO:0048523),19/534,0.9563372996738451,1,0,0,0.7116104868913856,0.0317695685544962,IFITM1;NOTCH1;HPGD;BAD;GML;CUL1;FOXO4;RUNX3;MT3;BMP7;DUS2;SFRP2;ERBB3;CCDC85B;PDE12;PDCD4;NDUFS3;NOX4;ITGB1BP1
potassium ion transport (GO:0006813),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,KCNIP2
regulation of vesicle fusion (GO:0031338),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,TBC1D3L
positive regulation of cellular amide metabolic process (GO:0034250),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,YTHDF1
regulation of translation (GO:0006417),6/213,0.9584257625041144,1,0,0,0.5633802816901409,0.02392291337420207,YTHDF1;RPS6KA1;EIF4H;YBX2;EIF1B;EIF4G2
diterpenoid metabolic process (GO:0016101),1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,RARRES2
regulation of T cell proliferation (GO:0042129),1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,IL12B
axon guidance (GO:0007411),4/158,0.9589416360981469,1,0,0,0.5063291139240506,0.021227881051499004,PTPRM;FRS2;PRKCQ;ARHGAP35
histone modification (GO:0016570),2/98,0.9599334606764933,1,0,0,0.4081632653061224,0.01669033008887676,SIN3B;MT3
synapse assembly (GO:0007416),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,NRXN2
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,GNAI1
negative regulation of dephosphorylation (GO:0035305),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,ZCCHC9
regulation of programmed cell death (GO:0043067),8/268,0.9609037393600166,1,0,0,0.5970149253731343,0.023809577425732153,MINK1;MADD;UBC;ANP32E;CHM;BMP7;NOP53;BIRC2
steroid metabolic process (GO:0008202),2/99,0.9616193258375976,1,0,0,0.40404040404040403,0.015812774876077424,ACAA1;CYP8B1
glycosaminoglycan biosynthetic process (GO:0006024),2/99,0.9616193258375976,1,0,0,0.40404040404040403,0.015812774876077424,GCNT2;CSPG5
small GTPase mediated signal transduction (GO:0007264),2/99,0.9616193258375976,1,0,0,0.40404040404040403,0.015812774876077424,CNKSR1;PLK2
protein complex assembly (GO:0006461),5/189,0.9626287537032391,1,0,0,0.5291005291005291,0.020152090838798885,TCF7L2;NCF1;BAD;TNFAIP3;ITGB1BP1
NADH dehydrogenase complex assembly (GO:0010257),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,NDUFS3
mitochondrial respiratory chain complex I biogenesis (GO:0097031),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,NDUFS3
mitochondrial respiratory chain complex I assembly (GO:0032981),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,NDUFS3
positive regulation of endocytosis (GO:0045807),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,VPS28
protein homooligomerization (GO:0051260),5/190,0.9638364264942945,1,0,0,0.5263157894736842,0.01938614780477967,EHD1;TDO2;KCNC2;ACACB;CD3D
Golgi vesicle transport (GO:0048193),8/271,0.9640587797991024,1,0,0,0.5904059040590406,0.021610633998612776,RINT1;F9;LMAN2L;STX18;VTI1A;ANK2;DYNLL1;YIF1B
chromatin assembly (GO:0031497),1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,ANP32E
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,CDK5RAP3
cellular response to organic substance (GO:0071310),3/133,0.9652081031256262,1,0,0,0.45112781954887216,0.015975135331615462,MAPK9;MAPK8;QRFPR
detection of chemical stimulus involved in sensory perception (GO:0050907),2/102,0.9662779974899206,1,0,0,0.39215686274509803,0.013452432976578837,OR6K3;OR4K5
intracellular steroid hormone receptor signaling pathway (GO:0030518),1/66,0.9663236546235302,1,0,0,0.30303030303030304,0.010380743845736572,NCOA4
sphingolipid biosynthetic process (GO:0030148),1/66,0.9663236546235302,1,0,0,0.30303030303030304,0.010380743845736572,SPTLC3
positive regulation of cytokine production (GO:0001819),6/220,0.9665160191559073,1,0,0,0.5454545454545454,0.018576766948830876,TLR9;IL12B;PRKCQ;CD14;POLR3K;TLR2
protein transport (GO:0015031),10/326,0.9671185035772418,1,0,0,0.6134969325153374,0.02051180575920934,EHD1;MACF1;CD74;RAB30;TBC1D3L;SYS1;LMAN2L;RAB39B;ITGB1BP1;RAB17
plasma membrane invagination (GO:0099024),2/103,0.9677062755799263,1,0,0,0.38834951456310673,0.01274822216284486,SNX18;ITGAM
phagocytosis (GO:0006909),3/135,0.9677952919812572,1,0,0,0.4444444444444444,0.014548750798032252,ITGAM;PECAM1;CD14
cellular protein localization (GO:0034613),10/327,0.9679731707578697,1,0,0,0.6116207951070336,0.01990881238463938,EHD1;CD74;RAB30;DLG1;TBC1D3L;HEY2;RAB39B;ANK2;WIPI2;RAB17
epidermal cell differentiation (GO:0009913),1/67,0.9680129340715097,1,0,0,0.29850746268656714,0.00970442691065804,LCE3B
negative regulation of phosphatase activity (GO:0010923),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,ZCCHC9
mitochondrion organization (GO:0007005),4/167,0.9701315449758973,1,0,0,0.47904191616766467,0.01452627703097372,CHCHD3;MX1;FBXO7;SLC25A36
regulation of endocytosis (GO:0030100),1/69,0.9711417402987961,1,0,0,0.2898550724637681,0.00848778197469868,RAB17
regulation of vesicle-mediated transport (GO:0060627),3/138,0.9713377151896119,1,0,0,0.43478260869565216,0.012643943360258838,RINT1;TBC1D3L;RAB17
positive regulation of cellular catabolic process (GO:0031331),2/106,0.9716500119085215,1,0,0,0.3773584905660377,0.010852682798281577,BAD;PLK2
ribosome biogenesis (GO:0042254),6/226,0.9722745936369446,1,0,0,0.5309734513274336,0.014929386199993113,RPS29;EXOSC9;NOL11;RPL39;MDN1;RPL19
positive regulation of endothelial cell migration (GO:0010595),1/70,0.972589533427257,1,0,0,0.2857142857142857,0.007940897858985217,ITGB1BP1
cellular response to starvation (GO:0009267),2/107,0.9728581476955978,1,0,0,0.3738317757009345,0.01028672748442257,MAPK8;PCSK9
positive regulation of epithelial cell proliferation (GO:0050679),2/107,0.9728581476955978,1,0,0,0.3738317757009345,0.01028672748442257,BAD;VEGFC
gene expression (GO:0010467),13/411,0.9738104657729227,1,0,0,0.6326034063260341,0.016788401128473414,NXT1;ZBTB25;RBM8A;GATB;ILF2;DDX39B;PABPN1;RPS29;NOX4;SRSF4;RPL39;SRSF11;RPL19
phosphorylation (GO:0016310),12/386,0.9739635599056209,1,0,0,0.6217616580310881,0.016402936083347492,LATS1;CAMK2B;MAPK9;MAPK8;PLK2;CDK3;RPS6KA1;MINK1;PRKG2;BRAF;RUNX3;SRPK1
histone acetylation (GO:0016573),1/71,0.9739647545480367,1,0,0,0.28169014084507044,0.00743103163098366,EP400
regulation of protein activation cascade (GO:2000257),2/108,0.9740164985643297,1,0,0,0.37037037037037035,0.009750754261227252,CPB2;C6
regulation of complement activation (GO:0030449),2/109,0.9751270159817813,1,0,0,0.3669724770642202,0.009243135290725672,CPB2;C6
cell-cell junction organization (GO:0045216),1/72,0.9752710378445755,1,0,0,0.27777777777777773,0.006955516411879717,DSG1
lipid biosynthetic process (GO:0008610),1/72,0.9752710378445755,1,0,0,0.27777777777777773,0.006955516411879717,ACSM3
response to metal ion (GO:0010038),1/72,0.9752710378445755,1,0,0,0.27777777777777773,0.006955516411879717,MT3
B cell activation (GO:0042113),1/73,0.9765118358730951,1,0,0,0.273972602739726,0.0065118926107079,IFNA21
protein N-linked glycosylation (GO:0006487),1/73,0.9765118358730951,1,0,0,0.273972602739726,0.0065118926107079,RPN1
peptide biosynthetic process (GO:0043043),4/174,0.9767898202808095,1,0,0,0.45977011494252873,0.010797139189834055,RPS29;GATB;RPL39;RPL19
protein autophosphorylation (GO:0046777),4/175,0.9776183591008238,1,0,0,0.45714285714285713,0.010347845016468711,PDGFRB;CAMK2B;NTRK2;MINK1
positive regulation of epithelial cell migration (GO:0010634),1/74,0.9776904281936729,1,0,0,0.2702702702702703,0.00609789044447976,ITGB1BP1
retinoid metabolic process (GO:0001523),1/75,0.9788099305759348,1,0,0,0.26666666666666666,0.005711413813620137,RARRES2
cAMP-mediated signaling (GO:0019933),1/75,0.9788099305759348,1,0,0,0.26666666666666666,0.005711413813620137,RAPGEF3
regulation of humoral immune response (GO:0002920),2/113,0.9791273621981581,1,0,0,0.35398230088495575,0.007466743623819164,CPB2;C6
proteolysis (GO:0006508),8/291,0.9798395812272108,1,0,0,0.549828178694158,0.011198027954317282,CPB2;TINAGL1;F9;MMP16;TMPRSS5;ERAP1;PMPCA;DPP3
nucleic acid-templated transcription (GO:0097659),1/76,0.9798733026216075,1,0,0,0.2631578947368421,0.005350525977491548,ILF2
regulation of immune effector process (GO:0002697),2/114,0.9800255952144739,1,0,0,0.3508771929824561,0.007079505295714906,CPB2;C6
sensory perception of mechanical stimulus (GO:0050954),1/78,0.9818427613794292,1,0,0,0.2564102564102564,0.004698488267500739,MYO1A
regulation of cellular response to heat (GO:1900034),1/78,0.9818427613794292,1,0,0,0.2564102564102564,0.004698488267500739,CAMK2B
visual perception (GO:0007601),1/78,0.9818427613794292,1,0,0,0.2564102564102564,0.004698488267500739,MYO9A
peptidyl-tyrosine phosphorylation (GO:0018108),1/79,0.982754056231908,1,0,0,0.2531645569620253,0.004404148673065393,PDGFRB
positive regulation of B cell activation (GO:0050871),2/119,0.9839830371412186,1,0,0,0.3361344537815126,0.005427435548267131,CD74;TLR9
positive regulation of protein targeting to mitochondrion (GO:1903955),1/81,0.9844418345091214,1,0,0,0.24691358024691357,0.003871719481130927,IFNL3
sensory perception of light stimulus (GO:0050953),1/81,0.9844418345091214,1,0,0,0.24691358024691357,0.003871719481130927,MYO9A
sensory perception of sound (GO:0007605),1/81,0.9844418345091214,1,0,0,0.24691358024691357,0.003871719481130927,MYO1A
positive regulation of DNA metabolic process (GO:0051054),1/82,0.9852227825319085,1,0,0,0.24390243902439024,0.003631094688901337,PDGFRB
regulation of acute inflammatory response (GO:0002673),2/121,0.9853427079965097,1,0,0,0.3305785123966942,0.004881246751261704,CPB2;C6
sulfur compound biosynthetic process (GO:0044272),2/122,0.9859797526526971,1,0,0,0.32786885245901637,0.004629330959126898,MGST3;CSPG5
negative regulation of translation (GO:0017148),1/88,0.9891512672040396,1,0,0,0.22727272727272727,0.002479093046554197,YTHDF2
regulation of protein targeting to mitochondrion (GO:1903214),1/88,0.9891512672040396,1,0,0,0.22727272727272727,0.002479093046554197,IFNL3
cellular response to acid chemical (GO:0071229),1/91,0.9907047643496917,1,0,0,0.21978021978021978,0.002052462844095697,BRINP2
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),2/133,0.9914288561400509,1,0,0,0.3007518796992481,0.0025888984552419132,PLPP4;WASL
Fc-gamma receptor signaling pathway (GO:0038094),2/134,0.9918061738095247,1,0,0,0.29850746268656714,0.002455994057658477,PLPP4;WASL
Fc receptor mediated stimulatory signaling pathway (GO:0002431),2/135,0.9921672304002093,1,0,0,0.2962962962962963,0.002329957591894398,PLPP4;WASL
translational termination (GO:0006415),1/96,0.9928157700996559,1,0,0,0.20833333333333331,0.0015021168229316978,TRMT112
mitochondrial translation (GO:0032543),1/107,0.9959244354269028,1,0,0,0.18691588785046725,7.633443590547408e-4,GATB
RNA metabolic process (GO:0016070),3/191,0.9966900326912492,1,0,0,0.3141361256544502,0.0010415049325140204,LIG1;DDX39B;PABPN1
adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),1/134,0.99898625000142,1,0,0,0.14925373134328357,1.5138271502198073e-4,GNAI1
response to lipid (GO:0033993),1/140,0.9992556166555725,1,0,0,0.14285714285714285,1.0638007646789553e-4,CXCL9
receptor-mediated endocytosis (GO:0006898),2/188,0.9993161305762219,1,0,0,0.21276595744680848,1.4555390832707665e-4,PI4KB;AP2A2
